<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MUC1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>MUC1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/P15941" target="_blank" class="term-link">
                        P15941
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Aliases:</span>
                <div class="aliases">
                    
                    <span class="badge">PUM</span>
                    
                    <span class="badge">DF3</span>
                    
                    <span class="badge">CA 15-3</span>
                    
                    <span class="badge">Episialin</span>
                    
                    <span class="badge">EMA</span>
                    
                    <span class="badge">Mucin-1</span>
                    
                    <span class="badge">Polymorphic epithelial mucin</span>
                    
                </div>
            </div>
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "MUC1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="P15941" data-a="DESCRIPTION: MUC1 (Mucin-1) is a heavily glycosylated type I tr..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>MUC1 (Mucin-1) is a heavily glycosylated type I transmembrane protein that functions as both a protective barrier at epithelial surfaces and a signaling molecule. In normal epithelia, MUC1 localizes to the apical membrane where it provides lubrication, pathogen defense, and negative regulation of inflammation via TLR signaling suppression. The cytoplasmic tail (MUC1-CT) functions as a signaling scaffold that interacts with multiple growth factor receptors, kinases, and transcription factors. In carcinomas, MUC1 is overexpressed and loses apical polarity, with MUC1-CT translocating to the nucleus where it acts as a transcriptional coregulator, modulating p53, NF-Œ∫B, and Wnt/Œ≤-catenin pathways to promote cell survival, proliferation, and metastasis.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016324" target="_blank" class="term-link">
                                    GO:0016324
                                </a>
                            </span>
                            <span class="term-label">apical plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0016324" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> MUC1 is specifically localized to the apical plasma membrane in normal polarized epithelial cells, which is its primary and defining cellular location. This apical localization is critical for its barrier, lubrication, and pathogen defense functions. Supported by IBA phylogenetic inference and extensive literature documentation. In cancer cells, this polarity is lost and MUC1 appears across the entire cell surface, but the apical membrane remains the core physiological location.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This represents the primary and most functionally significant cellular localization of MUC1 in normal epithelial cells. Apical membrane localization is essential for all of MUC1&#39;s protective barrier functions and is evolutionarily conserved across species.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Apical localization in normal epithelia: Prevents unwanted cell-cell and cell-ECM interactions. Steric hindrance: Bulky glycan chains impede adhesion molecule interactions.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">See deep research file for comprehensive analysis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005576" target="_blank" class="term-link">
                                    GO:0005576
                                </a>
                            </span>
                            <span class="term-label">extracellular region</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005576" data-r="GO_REF:0000044" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The MUC1 ectodomain (N-terminal subunit) extends 200-500 nm into the extracellular space and is also released by ectodomain shedding via ADAM17/TACE cleavage. The shed ectodomain is found in serum (CA 15-3 biomarker) and extracellular fluids. While technically correct, this term is too generic.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While MUC1 does have extensive extracellular presence, this term is too generic. The more specific term &#34;extracellular space&#34; (GO:0005615) better captures the location of shed MUC1 fragments, which is already annotated with experimental evidence (HDA). The membrane-associated extracellular domain is better captured by the plasma membrane annotations.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005615" target="_blank" class="term-link">
                                    extracellular space
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Extended structure projects 200-500 nm above cell surface. Ectodomain shedding: TACE (ADAM17): Constitutive and phorbol ester-stimulated shedding. Releases MUC1-N while MUC1-C remains membrane-associated.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005634" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The MUC1 cytoplasmic tail (MUC1-CT) translocates to the nucleus where it functions as a transcriptional coregulator, interacting with p53, NF-Œ∫B, and Œ≤-catenin to regulate gene transcription. This is a well-documented cancer-associated function supported by experimental evidence (IDA) from PMID:15710329 showing chromatin localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Nuclear localization of MUC1-CT is a critical signaling function, particularly in cancer cells. The cytoplasmic tail contains nuclear localization signals and interacts with transcription factors at chromatin. This is supported by multiple lines of experimental evidence showing functional roles in transcriptional regulation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Nuclear translocation: MUC1-CT/Œ≤-catenin complex translocates to nucleus. MUC1-CT and p53 co-occupy p21 promoter. Nuclear localization signal: RLS/RRK motif interacts with nucleoporin-62, importin-Œ≤1.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Chromatin immunoprecipitation assays demonstrate that MUC1 coprecipitates with p53 on the p53-responsive elements of the p21 gene promoter and coactivates p21 gene transcription.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005737" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The MUC1 cytoplasmic tail (MUC1-CT, 72 amino acids) is present in the cytoplasm where it serves as a signaling scaffold, interacting with kinases (Src, GSK3Œ≤, PKCŒ¥), adaptor proteins (Grb2), and other signaling molecules before nuclear translocation or other trafficking events.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The cytoplasmic tail is a fundamental structural component of MUC1 that mediates critical signaling functions. It serves as the platform for phosphorylation events and protein-protein interactions that regulate MUC1 signaling pathways.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Cytoplasmic tail (MUC1-CT): 1204-1255 (72 aa). 7 conserved tyrosine residues. Multiple Ser/Thr phosphorylation sites. MUC1-CT functions as a signaling scaffold integrating multiple pathways.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005886" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> MUC1 is a type I transmembrane protein with a transmembrane domain (aa 1181-1203). In normal epithelial cells it is specifically at the apical plasma membrane, while in cancer cells it loses polarity and distributes across the entire plasma membrane. This annotation is supported by multiple lines of experimental evidence (IDA, TAS).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core structural feature of MUC1 as a transmembrane protein. The plasma membrane localization is fundamental to all MUC1 functions, though in normal cells this is more specifically the apical plasma membrane.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Transmembrane domain: 1181-1203. Loss of polarity in cancer: Present across entire cell surface (not just apical). Recycling: Endocytosis and return to plasma membrane via palmitoylation-dependent mechanism.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016324" target="_blank" class="term-link">
                                    GO:0016324
                                </a>
                            </span>
                            <span class="term-label">apical plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0016324" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate of IBA annotation for same term (GO:0016324). MUC1 apical plasma membrane localization is well-established and represents the primary physiological localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a duplicate annotation with different evidence code (IEA vs IBA) for the same valid localization. Both are correct and can be retained as they come from different inference methods.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Apical plasma membrane: Exclusively localized, highly polarized in normal epithelial cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11152665" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11152665
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The c-Src tyrosine kinase regulates signaling of the human D...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:11152665" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:11152665 demonstrates MUC1 interaction with Src kinase (P12931), GSK3Œ≤, and Œ≤-catenin. Src phosphorylates MUC1-CT at Tyr-1229 and the Src SH2 domain binds pYEKV motif. This regulates Œ≤-catenin signaling. The generic &#34;protein binding&#34; term should be replaced with more specific molecular function terms.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The term &#34;protein binding&#34; is uninformative. This paper demonstrates specific signaling functions: Src kinase binding, Œ≤-catenin binding (which has its own GO term), and kinase substrate activity. These represent distinct molecular functions that should be captured with more specific GO terms.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019901" target="_blank" class="term-link">
                                    protein kinase binding
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008013" target="_blank" class="term-link">
                                    beta-catenin binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11152665" target="_blank" class="term-link">
                                        PMID:11152665
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">c-Src phosphorylates the MUC1 cytoplasmic domain at a YEKV motif located between sites involved in interactions with GSK3 beta and beta-catenin.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11483589" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11483589
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The epidermal growth factor receptor regulates interaction o...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:11483589" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:11483589 demonstrates MUC1 interaction with EGFR (P00533) and regulation of Œ≤-catenin signaling. EGFR phosphorylates MUC1-CT at Tyr-1229, modulating Œ≤-catenin binding. This represents specific receptor tyrosine kinase binding and signaling adapter functions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Generic &#34;protein binding&#34; should be replaced with more informative molecular function terms capturing MUC1&#39;s role as a substrate and binding partner for EGFR, a receptor tyrosine kinase.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005154" target="_blank" class="term-link">
                                    epidermal growth factor receptor binding
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019901" target="_blank" class="term-link">
                                    protein kinase binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11483589" target="_blank" class="term-link">
                                        PMID:11483589
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. [The paper demonstrates direct EGFR-MUC1 interaction and EGFR-mediated phosphorylation of MUC1]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/16888623" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:16888623
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    MUC1 oncoprotein blocks nuclear targeting of c-Abl in the ap...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:16888623" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:16888623 shows MUC1 blocks nuclear targeting of c-Abl (P00519) in response to DNA damage. This demonstrates a specific protein-protein interaction that inhibits Abl nuclear import and the apoptotic response.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this demonstrates protein binding, the functional context suggests this should be captured as a more specific regulatory interaction, potentially related to DNA damage response regulation rather than generic protein binding.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019901" target="_blank" class="term-link">
                                    protein kinase binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage [PMID:16888623]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16888623" target="_blank" class="term-link">
                                        PMID:16888623
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Aug 3. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/21258405" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:21258405
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Galectin-3 regulates MUC1 and EGFR cellular distribution and...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:21258405" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:21258405 examines Galectin-3 regulation of MUC1 and EGFR cellular distribution in pancreatic cancer cells. This demonstrates MUC1-EGFR interaction in the context of trafficking regulation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This further supports EGFR binding, which is a more informative annotation than generic protein binding.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005154" target="_blank" class="term-link">
                                    epidermal growth factor receptor binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells [PMID:21258405]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21258405" target="_blank" class="term-link">
                                        PMID:21258405
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/21798038" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:21798038
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Non-cysteine linked MUC1 cytoplasmic dimers are required for...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:21798038" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:21798038 demonstrates non-cysteine linked MUC1-CT dimers are required for Src recruitment and ICAM-1 binding induced cell invasion. This shows MUC1 homodimerization and binding to ICAM-1 and Src.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This paper demonstrates multiple specific binding activities: protein homodimerization, ICAM-1 binding, and Src binding. These should be captured with more specific terms.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042802" target="_blank" class="term-link">
                                    identical protein binding
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019901" target="_blank" class="term-link">
                                    protein kinase binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21798038" target="_blank" class="term-link">
                                        PMID:21798038
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/22962849" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:22962849
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cooperative interaction of MUC1 with the HGF/c-Met pathway d...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:22962849" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:22962849 examines cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. This demonstrates MUC1 interaction with Met receptor tyrosine kinase (P08581).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Specific receptor tyrosine kinase binding is more informative than generic protein binding.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019901" target="_blank" class="term-link">
                                    protein kinase binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">MET: Phosphorylates cytoplasmic tail. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis [PMID:22962849]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/22962849" target="_blank" class="term-link">
                                        PMID:22962849
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/24658140" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:24658140
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The mammalian-membrane two-hybrid assay (MaMTH) for probing ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:24658140" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:24658140 describes a mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions. This is a methods paper and the specific interaction with EGFR (P00533) supports EGFR binding.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This represents EGFR binding detected by a membrane two-hybrid method. Should use more specific EGFR binding term.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005154" target="_blank" class="term-link">
                                    epidermal growth factor receptor binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells [PMID:24658140]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/24658140" target="_blank" class="term-link">
                                        PMID:24658140
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/31980649" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:31980649
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Extensive rewiring of the EGFR network in colorectal cancer ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005515" data-r="PMID:31980649" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:31980649 examines extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D). This further supports MUC1-EGFR interaction in cancer signaling networks.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This supports EGFR binding in the context of oncogenic KRAS signaling networks.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005154" target="_blank" class="term-link">
                                    epidermal growth factor receptor binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D) [PMID:31980649]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/31980649" target="_blank" class="term-link">
                                        PMID:31980649
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030330" target="_blank" class="term-link">
                                    GO:0030330
                                </a>
                            </span>
                            <span class="term-label">DNA damage response, signal transduction by p53 class mediator</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0030330" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 demonstrates that MUC1-CT directly binds p53 and modulates p53-responsive gene transcription following genotoxic stress. MUC1 coprecipitates with p53 on the p21 promoter and coactivates p21 transcription while attenuating Bax transcription. This shifts the p53 response from apoptosis toward growth arrest.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a well-documented core function of MUC1-CT in cancer cells. MUC1 directly participates in p53-mediated DNA damage signaling by physically interacting with p53 at chromatin and modulating its transcriptional activity. This is supported by direct experimental evidence including chromatin immunoprecipitation and functional assays.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas. The present work demonstrates that MUC1 associates with the p53 tumor suppressor, and that this interaction is increased by genotoxic stress. The MUC1 cytoplasmic domain binds directly to p53 regulatory domain.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Direct interaction: MUC1-CT binds p53 regulatory domain (aa 363-393). Chromatin localization: MUC1-CT and p53 co-occupy p21 promoter. Repression of p53 activity: MUC1-CT/KLF4 complex binds PE21 element, represses TP53 transcription.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031571" target="_blank" class="term-link">
                                    GO:0031571
                                </a>
                            </span>
                            <span class="term-label">mitotic G1 DNA damage checkpoint signaling</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0031571" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 shows MUC1 promotes p53-dependent G1 growth arrest in response to DNA damage by coactivating p21 (CDKN1A) transcription. This represents participation in the G1 DNA damage checkpoint pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation accurately captures MUC1&#39;s role in promoting cell cycle arrest at the G1/S checkpoint following DNA damage. By enhancing p21 transcription, MUC1 contributes to p53-mediated checkpoint activation. This is a specific and well-supported biological process annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">MUC1 promotes selection of the p53-dependent growth arrest response and suppresses the p53-dependent apoptotic response to DNA damage. [MUC1 coactivates p21 gene transcription, which mediates G1 arrest]</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Blocks p53-mediated cell cycle arrest and apoptosis. Confers resistance to genotoxic stress. Promotes survival of cells with DNA damage.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000052
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005886" data-r="GO_REF:0000052" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is immunofluorescence-based evidence for plasma membrane localization. MUC1 is a transmembrane protein with well-documented plasma membrane localization. This duplicates other plasma membrane annotations but with experimental imaging evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Direct experimental visualization of MUC1 at the plasma membrane provides independent support for this core localization. Multiple lines of evidence for the same localization strengthen the annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Plasma membrane: Type I transmembrane protein with transmembrane domain 1181-1203.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045944" target="_blank" class="term-link">
                                    GO:0045944
                                </a>
                            </span>
                            <span class="term-label">positive regulation of transcription by RNA polymerase II</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0045944" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 demonstrates that MUC1-CT coactivates p21 gene transcription by RNA polymerase II. MUC1 functions as a transcriptional coregulator that enhances p53-dependent transcription of specific target genes while repressing others (e.g., Bax).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This accurately captures MUC1-CT&#39;s role as a transcriptional coregulator that positively regulates specific RNA Pol II-dependent genes. The experimental evidence demonstrates direct chromatin occupancy and transcriptional enhancement. This is a core signaling function of MUC1-CT in the nucleus.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">MUC1 coprecipitates with p53 on the p53-responsive elements of the p21 gene promoter and coactivates p21 gene transcription.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Target gene activation: Cyclin D1, c-Myc, ZEB1, Slug, Snail (via Œ≤-catenin). Target genes: Bcl-xL (anti-apoptotic), ZEB1, EZH2 (via NF-Œ∫B).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6790022
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005886" data-r="Reactome:R-HSA-6790022" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome pathway annotation for &#34;Expression of STAT3-upregulated plasma membrane proteins&#34; includes MUC1 as a STAT3-regulated plasma membrane protein. This supports plasma membrane localization but in a specific regulatory context.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation correctly places MUC1 at the plasma membrane, which is its core structural location. The Reactome pathway context adds information about STAT3-mediated regulation of MUC1 expression.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Type I transmembrane protein with plasma membrane localization.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8858500
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005886" data-r="Reactome:R-HSA-8858500" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome pathway annotation for &#34;CLEC10A binds Tn-MUC1&#34; describes interaction between C-type lectin receptor CLEC10A and tumor-associated Tn antigen on MUC1 at the plasma membrane. This represents recognition of aberrantly glycosylated MUC1.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation correctly places MUC1 at the plasma membrane where it interacts with CLEC10A. The pathway describes recognition of tumor-associated glycoforms of MUC1.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Truncated glycans exposing Tn, sTn, T antigens in cancer tissue. Plasma membrane localization.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6786012
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-6786012" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome pathway &#34;CHST4 transfers SO4(2-) from PAPS to Core 2 mucins&#34; describes sulfation of MUC1 in the Golgi lumen. MUC1 transits through the Golgi during biosynthesis where it undergoes extensive O-glycosylation and other modifications.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While MUC1 does transit through the Golgi lumen during biosynthesis and post-translational modification, this is not a primary functional location. The Golgi annotations represent MUC1 as a SUBSTRATE for glycosyltransferases rather than MUC1 performing an active function. These are valid but non-core localizations representing transient biosynthetic trafficking.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Transit time: Median ~142 minutes ER to Golgi to surface (mouse model). Extensive O-glycosylation occurs during Golgi transit.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5694487
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-5694487" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome pathway &#34;A4GNT transfers GlcNAc to core 2 mucins&#34; describes glycosylation of MUC1 in the Golgi. Multiple Reactome glycosylation pathways annotate MUC1 to Golgi lumen as the site where O-glycan modifications occur.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same rationale as other Golgi annotations - this represents biosynthetic trafficking and modification rather than a core functional location. MUC1 is the substrate, not the enzyme.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation: Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid in Golgi.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23533145
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    In-depth proteomic analyses of exosomes isolated from expres...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0070062" data-r="PMID:23533145" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:23533145 identified MUC1 in exosomes isolated from expressed prostatic secretions in urine using proteomic analysis. MUC1 is found in extracellular exosomes released from epithelial cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> MUC1 is legitimately found in extracellular exosomes, representing shed ectodomain or exosomal secretion. However, this is a consequence of shedding/secretion rather than a core functional location. The biological significance is uncertain - exosomal MUC1 may serve as a biomarker but is not a primary site of MUC1 function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Shed ectodomain: Released by ADAM17/MT1-MMP cleavage. Isoforms 5, 7, 9, Y: Secreted into extracellular space.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link">
                                        PMID:23533145
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">2013 Apr 23. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031982" target="_blank" class="term-link">
                                    GO:0031982
                                </a>
                            </span>
                            <span class="term-label">vesicle</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19190083" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19190083
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Characterization of exosome-like vesicles released from huma...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0031982" data-r="PMID:19190083" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:19190083 characterized exosome-like vesicles released from human tracheobronchial ciliated epithelium and identified MUC1 by proteomics. This is related to the extracellular exosome annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Similar to exosome annotations - MUC1 is found in secreted vesicles but this represents shedding/secretion rather than a core functional location. This is a very generic term that could apply to many cellular compartments.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Recycling: Endocytosis and return to plasma membrane. Vesicular trafficking for biosynthesis and endocytosis.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19190083" target="_blank" class="term-link">
                                        PMID:19190083
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005615" target="_blank" class="term-link">
                                    GO:0005615
                                </a>
                            </span>
                            <span class="term-label">extracellular space</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/16502470" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:16502470
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human colostrum: identification of minor proteins in the aqu...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005615" data-r="PMID:16502470" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:16502470 identified MUC1 in the aqueous phase of human colostrum proteome. Shed MUC1 ectodomain is found in various body fluids including serum (CA 15-3 biomarker), colostrum, and other secretions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The extracellular space is a legitimate and functionally relevant location for shed MUC1 ectodomain. Unlike the generic &#34;extracellular region&#34; term, this more specifically captures the soluble, secreted forms of MUC1 that serve as biomarkers and may have biological functions in body fluids.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">CA 15-3 (Cancer Antigen 15-3): Soluble MUC1 ectodomain fragments in serum. Ectodomain shedding: ADAM17/TACE releases MUC1-N into extracellular space.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16502470" target="_blank" class="term-link">
                                        PMID:16502470
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Human colostrum: identification of minor proteins in the aqueous phase by proteomics.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0033629" target="_blank" class="term-link">
                                    GO:0033629
                                </a>
                            </span>
                            <span class="term-label">negative regulation of cell adhesion mediated by integrin</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/7698991" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:7698991
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Episialin (MUC1) overexpression inhibits integrin-mediated c...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0033629" data-r="PMID:7698991" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:7698991 directly demonstrated that MUC1 (Episialin) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. The large extracellular domain sterically blocks integrin-ECM interactions, creating an anti-adhesive barrier.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core biological function of MUC1 in normal epithelial cells, where apical MUC1 prevents unwanted adhesion. The anti-adhesive function is well-documented and represents a primary physiological role. In cancer, loss of polarity extends this anti-adhesive effect to the entire cell surface, promoting metastasis.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/7698991" target="_blank" class="term-link">
                                        PMID:7698991
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the integrin-mediated adhesion to extracellular matrix of transfectants of a melanoma cell line (A375), a transformed epithelial cell line (MDCK-ras-e) and a human breast epithelial cell line (HBL-100) is reduced by high levels of episialin</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Anti-Adhesive Function: Apical localization in normal epithelia: Prevents unwanted cell-cell and cell-ECM interactions. Steric hindrance: Bulky glycan chains impede adhesion molecule interactions.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19199708" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19199708
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Proteomic analysis of human parotid gland exosomes by multid...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0070062" data-r="PMID:19199708" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:19199708 identified MUC1 in human parotid gland exosomes by MudPIT proteomic analysis. Duplicate exosome annotation from different tissue source.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same rationale as other exosome annotations - valid but non-core localization representing secretion/shedding.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Extracellular exosomes contain shed MUC1 ectodomain.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19199708" target="_blank" class="term-link">
                                        PMID:19199708
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19056867" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19056867
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Large-scale proteomics and phosphoproteomics of urinary exos...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0070062" data-r="PMID:19056867" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:19056867 performed large-scale proteomics and phosphoproteomics of urinary exosomes and identified MUC1. Another independent exosome identification.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same rationale as other exosome annotations - valid but non-core.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">MUC1 found in exosomes from multiple tissue sources.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19056867" target="_blank" class="term-link">
                                        PMID:19056867
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">2008 Dec 3. Large-scale proteomics and phosphoproteomics of urinary exosomes.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070062" target="_blank" class="term-link">
                                    GO:0070062
                                </a>
                            </span>
                            <span class="term-label">extracellular exosome</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15326289" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15326289
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification and proteomic profiling of exosomes in human ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0070062" data-r="PMID:15326289" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15326289 identified and profiled exosomes in human urine and found MUC1. This has IDA evidence (direct assay) rather than HDA (high-throughput).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same rationale - exosome localization is valid but represents shedding/secretion, not core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Urinary exosomes contain MUC1 from epithelial cell shedding.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15326289" target="_blank" class="term-link">
                                        PMID:15326289
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Identification and proteomic profiling of exosomes in human urine.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902166" target="_blank" class="term-link">
                                    GO:1902166
                                </a>
                            </span>
                            <span class="term-label">negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:1902166" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 demonstrates that MUC1 suppresses the p53-dependent apoptotic response to DNA damage while promoting growth arrest. MUC1 coactivates p21 (pro-arrest) but attenuates Bax transcription (pro-apoptotic), thereby blocking intrinsic apoptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a well-documented oncogenic function of MUC1-CT. By modulating p53 target gene selection, MUC1 shifts the cellular response from apoptosis to growth arrest, promoting survival of damaged cells. This is a core cancer-associated function supported by direct experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Conversely, MUC1 attenuates activation of Bax transcription.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Consequences: Blocks p53-mediated cell cycle arrest and apoptosis. Confers resistance to genotoxic stress. Promotes survival of cells with DNA damage.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1964505
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-1964505" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5096532
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-5096532" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5096537
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-5096537" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-6785524
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-6785524" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-913675
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-913675" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914005
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914005" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914006
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914006" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914008
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914008" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914010
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914010" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914017
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914017" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-977071
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-977071" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-1964501
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-1964501" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914012
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914012" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-914018
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-914018" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-981497
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-981497" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-981809
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-981809" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005796" target="_blank" class="term-link">
                                    GO:0005796
                                </a>
                            </span>
                            <span class="term-label">Golgi lumen</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-981814
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005796" data-r="Reactome:R-HSA-981814" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Reactome O-glycosylation pathway annotation. MUC1 transits through the Golgi lumen during biosynthesis where it undergoes extensive O-glycosylation by various glycosyltransferases.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Golgi lumen localization represents transient biosynthetic trafficking where MUC1 serves as a substrate for glycosyltransferases. This is valid but non-core - the Golgi is not a primary functional location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi based on its role as a substrate in different O-glycan biosynthesis reactions.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">O-Glycosylation accounts for 50-90% of total molecular mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic acid. Transit time: Median ~142 minutes ER to Golgi to surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                    GO:0000785
                                </a>
                            </span>
                            <span class="term-label">chromatin</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0000785" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 demonstrates MUC1-CT localization to chromatin by chromatin immunoprecipitation. MUC1 coprecipitates with p53 on the p21 promoter, showing direct chromatin association.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a key cellular component annotation for MUC1-CT&#39;s nuclear transcriptional regulatory function. Direct chromatin association is required for MUC1-CT to function as a transcriptional coregulator. This is supported by ChIP evidence showing MUC1 at specific gene promoters.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Chromatin immunoprecipitation assays demonstrate that MUC1 coprecipitates with p53 on the p53-responsive elements of the p21 gene promoter and coactivates p21 gene transcription.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Chromatin localization: MUC1-CT and p53 co-occupy p21 promoter. Chromatin occupancy: MUC1-CT and p65 (NF-Œ∫B) co-occupy promoters.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000978" target="_blank" class="term-link">
                                    GO:0000978
                                </a>
                            </span>
                            <span class="term-label">RNA polymerase II cis-regulatory region sequence-specific DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0000978" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 shows MUC1-CT binds to the p21 promoter (a cis-regulatory region) via association with p53. MUC1-CT also binds the PE21 element to repress TP53 transcription via interaction with KLF4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> MUC1-CT demonstrates sequence-specific DNA binding activity at RNA Pol II regulatory elements, though this may be mediated through transcription factor partners (p53, NF-Œ∫B, Œ≤-catenin, KLF4) rather than direct DNA contact. The ChIP evidence supports functional association with specific cis-regulatory sequences. This is a core molecular function for MUC1-CT&#39;s transcriptional regulatory role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">MUC1 coprecipitates with p53 on the p53-responsive elements of the p21 gene promoter and coactivates p21 gene transcription.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Repression of p53 activity: MUC1-CT/KLF4 complex binds PE21 element, represses TP53 transcription. MUC1-CT and p65 co-occupy promoters.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002039" target="_blank" class="term-link">
                                    GO:0002039
                                </a>
                            </span>
                            <span class="term-label">p53 binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0002039" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 demonstrates direct binding between MUC1 cytoplasmic domain and p53 regulatory domain (aa 363-393). This interaction is increased by genotoxic stress and modulates p53 transcriptional activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core molecular function of MUC1-CT. Direct p53 binding is central to MUC1&#39;s role in DNA damage response, cell cycle regulation, and apoptosis suppression. This is well-documented with multiple lines of evidence including co-immunoprecipitation, ChIP, and functional assays.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas. The present work demonstrates that MUC1 associates with the p53 tumor suppressor, and that this interaction is increased by genotoxic stress. The MUC1 cytoplasmic domain binds directly to p53 regulatory domain.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Direct interaction: MUC1-CT binds p53 regulatory domain (aa 363-393). MUC1-CT and p53 co-occupy p21 promoter.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003712" target="_blank" class="term-link">
                                    GO:0003712
                                </a>
                            </span>
                            <span class="term-label">transcription coregulator activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0003712" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 demonstrates MUC1-CT functions as a transcriptional coregulator, coactivating p21 transcription while repressing Bax. MUC1-CT also coactivates transcription with NF-Œ∫B, Œ≤-catenin, and estrogen receptor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core molecular function of MUC1-CT in the nucleus. MUC1-CT does not directly bind DNA alone but functions as a coregulator that modulates the activity of multiple transcription factors. This represents the primary molecular mechanism by which MUC1-CT influences gene expression. Extensively supported by literature.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">MUC1 coprecipitates with p53 on the p53-responsive elements of the p21 gene promoter and coactivates p21 gene transcription. Conversely, MUC1 attenuates activation of Bax transcription.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Transcription factors: TP53, ESR1 (estrogen receptor Œ±), KLF4, NF-Œ∫B p65. MUC1-CT functions as a signaling scaffold and transcriptional coregulator.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010944" target="_blank" class="term-link">
                                    GO:0010944
                                </a>
                            </span>
                            <span class="term-label">negative regulation of transcription by competitive promoter binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15710329
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human MUC1 oncoprotein regulates p53-responsive gene transcr...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0010944" data-r="PMID:15710329" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:15710329 shows MUC1-CT represses Bax transcription while coactivating p21, suggesting differential regulation of p53 target genes. MUC1-CT/KLF4 complex also competes for binding to the PE21 element to repress TP53 transcription.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This captures MUC1-CT&#39;s ability to negatively regulate specific genes through competitive binding mechanisms. By occupying regulatory elements with transcription factors, MUC1-CT can block access of other regulatory factors or modulate the transcriptional outcome. This is a specific and well-supported regulatory mechanism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                        PMID:15710329
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">MUC1 attenuates activation of Bax transcription.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Repression of p53 activity: MUC1-CT/KLF4 complex binds PE21 element, represses TP53 transcription.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/1697589" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:1697589
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Molecular cloning and expression of human tumor-associated p...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005886" data-r="PMID:1697589" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PMID:1697589 is the original molecular cloning paper for human MUC1, describing it as a tumor-associated polymorphic epithelial mucin. This paper established MUC1 as a transmembrane protein localized to the plasma membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a traceable author statement from the original MUC1 cloning paper establishing its plasma membrane localization. This is a fundamental structural annotation for MUC1 as a type I transmembrane protein.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/MUC1/MUC1-notes.md
                                    
                                </span>
                                
                                <div class="support-text">Type I transmembrane protein with transmembrane domain 1181-1203. Plasma membrane is the primary structural location.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/1697589" target="_blank" class="term-link">
                                        PMID:1697589
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005198" target="_blank" class="term-link">
                                    GO:0005198
                                </a>
                            </span>
                            <span class="term-label">structural molecule activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005198" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050830" target="_blank" class="term-link">
                                    GO:0050830
                                </a>
                            </span>
                            <span class="term-label">defense response to Gram-positive bacterium</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0050830" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005102" target="_blank" class="term-link">
                                    GO:0005102
                                </a>
                            </span>
                            <span class="term-label">signaling receptor binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0005102" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034122" target="_blank" class="term-link">
                                    GO:0034122
                                </a>
                            </span>
                            <span class="term-label">negative regulation of toll-like receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0034122" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060070" target="_blank" class="term-link">
                                    GO:0060070
                                </a>
                            </span>
                            <span class="term-label">canonical Wnt signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0060070" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045893" target="_blank" class="term-link">
                                    GO:0045893
                                </a>
                            </span>
                            <span class="term-label">positive regulation of DNA-templated transcription</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0045893" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051092" target="_blank" class="term-link">
                                    GO:0051092
                                </a>
                            </span>
                            <span class="term-label">positive regulation of NF-kappaB transcription factor activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0051092" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007169" target="_blank" class="term-link">
                                    GO:0007169
                                </a>
                            </span>
                            <span class="term-label">cell surface receptor protein tyrosine kinase signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0007169" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008283" target="_blank" class="term-link">
                                    GO:0008283
                                </a>
                            </span>
                            <span class="term-label">cell population proliferation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P15941" data-a="GO:0008283" data-r="" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Added to align core_functions with existing annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function term not present in existing_annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Forming physical barrier at apical epithelial surface by projecting 200-500 nm glycosylated ectodomain to provide lubrication, hydration, and steric hindrance against pathogen attachment and cell-cell adhesion</h3>
                <span class="vote-buttons" data-g="P15941" data-a="FUNCTION: Forming physical barrier at apical epithelial surf..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005198" target="_blank" class="term-link">
                            structural molecule activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0033629" target="_blank" class="term-link">
                                negative regulation of cell adhesion mediated by integrin
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050830" target="_blank" class="term-link">
                                defense response to Gram-positive bacterium
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016324" target="_blank" class="term-link">
                                apical plasma membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/7698991" target="_blank" class="term-link">
                                PMID:7698991
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. The integrin-mediated adhesion to extracellular matrix of transfectants is reduced by high levels of episialin.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/MUC1/MUC1-notes.md
                            
                        </span>
                        
                        <div class="finding-text">Extended structure projects 200-500 nm above cell surface. Anti-Adhesive Function: Apical localization in normal epithelia prevents unwanted cell-cell and cell-ECM interactions. Steric hindrance: Bulky glycan chains impede adhesion molecule interactions.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Suppressing TLR-mediated inflammatory signaling by binding TLR cytoplasmic domains and blocking recruitment of MyD88 and TRIF adaptor proteins</h3>
                <span class="vote-buttons" data-g="P15941" data-a="FUNCTION: Suppressing TLR-mediated inflammatory signaling by..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005102" target="_blank" class="term-link">
                            signaling receptor binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034122" target="_blank" class="term-link">
                                negative regulation of toll-like receptor signaling pathway
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                plasma membrane
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                cytoplasm
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/MUC1/MUC1-notes.md
                            
                        </span>
                        
                        <div class="finding-text">Negative regulator of TLR signaling: Interacts with TLR2, TLR3, TLR4, TLR5, TLR7, TLR9. TLR5 mechanism: MUC1-CT blocks MyD88 recruitment upon flagellin binding. TLR3 mechanism: MUC1-CT prevents TRIF adapter binding, suppresses IFN-Œ≤ response.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Coregulating p53-mediated transcription by binding p53 at chromatin to enhance p21 expression while suppressing Bax transcription in response to DNA damage</h3>
                <span class="vote-buttons" data-g="P15941" data-a="FUNCTION: Coregulating p53-mediated transcription by binding..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003712" target="_blank" class="term-link">
                            transcription coregulator activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030330" target="_blank" class="term-link">
                                DNA damage response, signal transduction by p53 class mediator
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031571" target="_blank" class="term-link">
                                mitotic G1 DNA damage checkpoint signaling
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902166" target="_blank" class="term-link">
                                negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                chromatin
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                                PMID:15710329
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">MUC1 associates with the p53 tumor suppressor, and this interaction is increased by genotoxic stress. The MUC1 cytoplasmic domain binds directly to p53 regulatory domain. MUC1 coprecipitates with p53 on the p53-responsive elements of the p21 gene promoter and coactivates p21 gene transcription. Conversely, MUC1 attenuates activation of Bax transcription.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/MUC1/MUC1-notes.md
                            
                        </span>
                        
                        <div class="finding-text">Direct interaction: MUC1-CT binds p53 regulatory domain (aa 363-393). Chromatin localization: MUC1-CT and p53 co-occupy p21 promoter. Consequences: Blocks p53-mediated apoptosis. Confers resistance to genotoxic stress. Promotes survival of cells with DNA damage.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Activating Œ≤-catenin-mediated transcription by binding Œ≤-catenin, preventing its GSK3Œ≤-mediated degradation, and promoting nuclear translocation to activate Wnt target genes</h3>
                <span class="vote-buttons" data-g="P15941" data-a="FUNCTION: Activating Œ≤-catenin-mediated transcription by bin..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008013" target="_blank" class="term-link">
                            beta-catenin binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060070" target="_blank" class="term-link">
                                canonical Wnt signaling pathway
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045893" target="_blank" class="term-link">
                                positive regulation of DNA-templated transcription
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                cytoplasm
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11152665" target="_blank" class="term-link">
                                PMID:11152665
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">c-Src-mediated phosphorylation of MUC1 increases binding of MUC1 and beta-catenin. c-Src phosphorylates the MUC1 cytoplasmic domain at a YEKV motif. The c-Src SH2 domain binds directly to pYEKV and inhibits the interaction between MUC1 and GSK3 beta.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/MUC1/MUC1-notes.md
                            
                        </span>
                        
                        <div class="finding-text">Nuclear translocation: MUC1-CT/Œ≤-catenin complex translocates to nucleus. Target gene activation: Cyclin D1, c-Myc, ZEB1, Slug, Snail (via Œ≤-catenin). Phosphorylation-dependent: Tyr-1229 phosphorylation increases Œ≤-catenin binding. Ser-1227 phosphorylation decreases Œ≤-catenin binding.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Activating NF-Œ∫B-mediated transcription by binding NF-Œ∫B p65 in nucleus, blocking IŒ∫BŒ± interaction, and promoting transcription of survival and EMT genes</h3>
                <span class="vote-buttons" data-g="P15941" data-a="FUNCTION: Activating NF-Œ∫B-mediated transcription by binding..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003712" target="_blank" class="term-link">
                            transcription coregulator activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051092" target="_blank" class="term-link">
                                positive regulation of NF-kappaB transcription factor activity
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045893" target="_blank" class="term-link">
                                positive regulation of DNA-templated transcription
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                chromatin
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/MUC1/MUC1-notes.md
                            
                        </span>
                        
                        <div class="finding-text">Nuclear interaction: MUC1-CT binds NF-Œ∫B p65 in nucleus. Mechanism: Blocks p65 interaction with IŒ∫BŒ± inhibitor. Target genes: Bcl-xL (anti-apoptotic), ZEB1, EZH2 (EMT/stemness). Chromatin occupancy: MUC1-CT and p65 co-occupy promoters.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Binding and modulating receptor tyrosine kinase signaling by interacting with EGFR, HER2, and other RTKs as a phosphorylation substrate and signaling adapter</h3>
                <span class="vote-buttons" data-g="P15941" data-a="FUNCTION: Binding and modulating receptor tyrosine kinase si..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005154" target="_blank" class="term-link">
                            epidermal growth factor receptor binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007169" target="_blank" class="term-link">
                                cell surface receptor protein tyrosine kinase signaling pathway
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008283" target="_blank" class="term-link">
                                cell population proliferation
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                plasma membrane
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                cytoplasm
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11483589" target="_blank" class="term-link">
                                PMID:11483589
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. EGFR phosphorylates MUC1-CT at Tyr-1229, modulating Œ≤-catenin binding.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/MUC1/MUC1-notes.md
                            
                        </span>
                        
                        <div class="finding-text">Growth factor receptors: EGFR, HER2/ERBB2, ERBB3, ERBB4, MET, PDGFRB, FGFR3, IGF1R. MUC1 expression inhibits degradation of ligand-activated ErbB1 following growth factor stimulation, thereby increasing cellular pools of active receptor and prolonging mitogenic signaling.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000052.md" target="_blank" class="term-link">
                            GO_REF:0000052
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on curation of immunofluorescence data</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11152665" target="_blank" class="term-link">
                            PMID:11152665
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">c-Src phosphorylates MUC1-CT at YEKV motif and regulates interactions with GSK3Œ≤ and Œ≤-catenin</div>
                        
                        <div class="finding-text">"c-Src phosphorylates the MUC1 cytoplasmic domain at a YEKV motif located between sites involved in interactions with GSK3 beta and beta-catenin."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11483589" target="_blank" class="term-link">
                            PMID:11483589
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15326289" target="_blank" class="term-link">
                            PMID:15326289
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification and proteomic profiling of exosomes in human urine.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15710329" target="_blank" class="term-link">
                            PMID:15710329
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">MUC1-CT binds p53 and modulates p53-dependent transcription in response to DNA damage</div>
                        
                        <div class="finding-text">"The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas. The present work demonstrates that MUC1 associates with the p53 tumor suppressor, and that this interaction is increased by genotoxic stress. The MUC1 cytoplasmic domain binds directly to p53 regulatory domain."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">MUC1 promotes p53-dependent growth arrest while suppressing apoptosis in response to DNA damage</div>
                        
                        <div class="finding-text">"MUC1 promotes selection of the p53-dependent growth arrest response and suppresses the p53-dependent apoptotic response to DNA damage."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16502470" target="_blank" class="term-link">
                            PMID:16502470
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Human colostrum: identification of minor proteins in the aqueous phase by proteomics.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16888623" target="_blank" class="term-link">
                            PMID:16888623
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/1697589" target="_blank" class="term-link">
                            PMID:1697589
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19056867" target="_blank" class="term-link">
                            PMID:19056867
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Large-scale proteomics and phosphoproteomics of urinary exosomes.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19190083" target="_blank" class="term-link">
                            PMID:19190083
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19199708" target="_blank" class="term-link">
                            PMID:19199708
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21258405" target="_blank" class="term-link">
                            PMID:21258405
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21798038" target="_blank" class="term-link">
                            PMID:21798038
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/22962849" target="_blank" class="term-link">
                            PMID:22962849
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23533145" target="_blank" class="term-link">
                            PMID:23533145
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24658140" target="_blank" class="term-link">
                            PMID:24658140
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31980649" target="_blank" class="term-link">
                            PMID:31980649
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D).</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/7698991" target="_blank" class="term-link">
                            PMID:7698991
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">MUC1 overexpression inhibits integrin-mediated cell adhesion to extracellular matrix through steric hindrance</div>
                        
                        <div class="finding-text">"Episialin (MUC1) is a transmembrane molecule with a large mucin-like extracellular domain protruding high above the cell surface. The molecule is located at the apical side of most glandular epithelial cells, whereas in carcinoma cells it is often present at the entire surface and it is frequently expressed in abnormally large quantities. We have previously shown that overexpression of episialin reduces cell-cell interactions. Here we show that the integrin-mediated adhesion to extracellular matrix of transfectants of a melanoma cell line (A375), a transformed epithelial cell line (MDCK-ras-e) and a human breast epithelial cell line (HBL-100) is reduced by high levels of episialin."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-1964501
                        
                    </span>
                </div>
                
                <div class="reference-title">Addition of galactose to Core 6 glycoprotein</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-1964505
                        
                    </span>
                </div>
                
                <div class="reference-title">C1GALT1 transfers Galactose to the Tn antigen forming Core 1 glycoproteins (T antigens)</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5096532
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective GALNT12 does not transfer GalNAc to mucins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5096537
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective GALNT3 does not transfer GalNAc to mucins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5694487
                        
                    </span>
                </div>
                
                <div class="reference-title">A4GNT transfers GlcNAc to core 2 mucins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6785524
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective C1GALT1C1 does not bind C1GALT1</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6786012
                        
                    </span>
                </div>
                
                <div class="reference-title">CHST4 transfers SO4(2-) from PAPS to Core 2 mucins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-6790022
                        
                    </span>
                </div>
                
                <div class="reference-title">Expression of STAT3-upregulated plasma membrane proteins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-8858500
                        
                    </span>
                </div>
                
                <div class="reference-title">CLEC10A binds Tn-MUC1</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-913675
                        
                    </span>
                </div>
                
                <div class="reference-title">GALNTs transfer GalNAc to Mucins to form Tn antigens</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914005
                        
                    </span>
                </div>
                
                <div class="reference-title">Addition of GlcNAc to the Tn antigen via an alpha-1,3 linkage forms a Core 5 glycoprotein</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914006
                        
                    </span>
                </div>
                
                <div class="reference-title">Addition of galactose to the Tn antigen via an alpha-1,3 linkage forms a Core 8 glycoprotein</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914008
                        
                    </span>
                </div>
                
                <div class="reference-title">Addition of GlcNAc to the Tn antigen via a beta-1,6 linkage forms a Core 6 glycoprotein</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914010
                        
                    </span>
                </div>
                
                <div class="reference-title">B3GNT6 transfers GlcNAc to Tn antigen</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914012
                        
                    </span>
                </div>
                
                <div class="reference-title">GCNTs transfer GlcNAc from UDP-GlcNAc to Core 1 mucins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914017
                        
                    </span>
                </div>
                
                <div class="reference-title">Addition of GalNAc to the Tn antigen via an alpha-1,6 linkage forms a Core 7 glycoprotein</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-914018
                        
                    </span>
                </div>
                
                <div class="reference-title">GCNT3 transfers GlcNAc to Core 3 mucin</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-977071
                        
                    </span>
                </div>
                
                <div class="reference-title">ST6GAL1 transfers sialic acid to Tn antigens to form sTn antigens</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-981497
                        
                    </span>
                </div>
                
                <div class="reference-title">ST3GAL1-4 transfers sialic acid to the T antigen at the alpha 3 position</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-981809
                        
                    </span>
                </div>
                
                <div class="reference-title">ST6GALNAC3/4 transfers sialic acid to the sialyl T antigen to form the disialyl T antigen</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-981814
                        
                    </span>
                </div>
                
                <div class="reference-title">ST6GALNAC2 transfers sialic acid to Core 1 mucins</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/MUC1/MUC1-deep-research-openai.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on MUC1 function</div>
                
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What are the specific structural requirements for MUC1-CT palmitoylation that enable its lipid raft association and membrane recycling?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: Cell biologists specializing in protein trafficking, Structural biologists studying palmitoylation</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="Q: What are the specific structural requirements for ..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> How do different VNTR polymorphisms (21-125 repeats) quantitatively affect MUC1&#39;s barrier function and pathogen defense capabilities in vivo?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: Immunologists studying mucosal immunity, Geneticists studying MUC1 polymorphisms</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="Q: How do different VNTR polymorphisms (21-125 repeat..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What determines whether MUC1-CT acts as a p53 activator versus inhibitor in different cellular contexts, and what is the role of tyrosine phosphorylation in this switch?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: Cancer biologists studying p53 regulation, Signal transduction researchers</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="Q: What determines whether MUC1-CT acts as a p53 acti..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> How do the different O-glycosylation patterns (normal vs cancer) mechanistically affect MUC1&#39;s protein-protein interactions and signaling capabilities?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: Glycobiologists specializing in mucin glycosylation, Structural biologists</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="Q: How do the different O-glycosylation patterns (nor..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the precise mechanism by which MUC1-CT suppresses different TLR pathways, and are there tissue-specific differences in this regulation?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: Immunologists studying TLR signaling, Epithelial biologists</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="Q: What is the precise mechanism by which MUC1-CT sup..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> How does MUC1 mechanistically contribute to ADTKD2 pathogenesis, and what cellular processes are disrupted by the frameshift mutations?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: Nephrologists specializing in tubulointerstitial disease, Kidney development biologists</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="Q: How does MUC1 mechanistically contribute to ADTKD2..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Determine crystal structure of MUC1-CT in complex with Œ≤-catenin and p53 to understand competitive binding and nuclear complex formation</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: MUC1-CT binds Œ≤-catenin and p53 through overlapping or adjacent interaction surfaces, and phosphorylation alters binding preferences</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: structural analysis</p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="EXPERIMENT: Determine crystal structure of MUC1-CT in complex ..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Use CRISPR to generate cells with VNTR alleles of defined lengths (e.g., 21, 41, 85, 125 repeats) and measure pathogen binding, shedding efficiency, and TLR signaling suppression</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Longer VNTR alleles provide better pathogen defense through enhanced steric hindrance and releasable decoy function</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: genetic manipulation</p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="EXPERIMENT: Use CRISPR to generate cells with VNTR alleles of ..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Perform time-resolved mass spectrometry to map the complete phosphorylation dynamics of MUC1-CT tyrosines upon EGFR, PDGFRB, and Src activation, and correlate with protein interaction changes</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Different kinases create distinct phosphorylation codes that recruit specific signaling complexes (Grb2 vs Œ≤-catenin vs PI3K)</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: phosphoproteomics</p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="EXPERIMENT: Perform time-resolved mass spectrometry to map the..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Use proximity labeling (BioID/APEX) to identify the complete MUC1-CT interactome in normal epithelial cells versus cancer cells, comparing apical membrane, cytoplasmic, and nuclear compartments</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: MUC1-CT interactome shifts from structural/trafficking proteins in normal cells to signaling/transcriptional proteins in cancer cells</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: interactomics</p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="EXPERIMENT: Use proximity labeling (BioID/APEX) to identify th..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Measure the effect of specific O-glycosylation patterns (controlled via glycosyltransferase knockout/overexpression) on MUC1 ectodomain shedding kinetics, drug penetration, and immune recognition</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Aberrant cancer-associated glycosylation (short glycans) accelerates shedding, creates drug resistance barrier, and generates tumor-specific epitopes</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: glycobiology</p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="EXPERIMENT: Measure the effect of specific O-glycosylation pat..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Use kidney organoids derived from ADTKD2 patient iPSCs to identify the molecular pathways disrupted by MUC1 frameshift mutations and test therapeutic interventions</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Mutant MUC1 accumulates in ER causing ER stress and activating fibrotic pathways in tubular epithelial cells</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: disease modeling</p>
                    
                </div>
                <span class="vote-buttons" data-g="P15941" data-a="EXPERIMENT: Use kidney organoids derived from ADTKD2 patient i..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(MUC1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15941" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-03T21:37:03.957008'<br />
end_time: '2025-11-03T21:37:03.959254'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: P15941<br />
  gene_symbol: MUC1<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 155</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene MUC1 (P15941) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="overview-of-muc1-mucin-1-in-humans">Overview of MUC1 (Mucin-1) in Humans</h1>
<p><strong>MUC1 (mucin-1)</strong> is a human gene encoding a <strong>transmembrane glycoprotein</strong> of the mucin family. MUC1 is characterized by extensive <strong>O-linked glycosylation</strong> and a high molecular weight core protein (120‚Äì225 kDa, reaching 250‚Äì500 kDa with glycosylation) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14">pmc.ncbi.nlm.nih.gov</a>). It is a single-pass type I membrane protein that undergoes autoproteolytic cleavage into two subunits: an extracellular <strong>N-terminal subunit (MUC1-N)</strong> and a smaller <strong>C-terminal subunit (MUC1-C)</strong> comprising a short external peptide, a transmembrane segment, and a cytoplasmic tail (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight">pmc.ncbi.nlm.nih.gov</a>). These subunits remain non-covalently associated at the cell surface as a heterodimer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight">pmc.ncbi.nlm.nih.gov</a>). The MUC1 gene is located on chromosome 1q22 and is thought to have evolved from a secreted mucin gene (MUC5B) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%2C%20which%20is%20localized%20to,C">pmc.ncbi.nlm.nih.gov</a>). MUC1‚Äôs extracellular domain contains a <strong>variable number tandem repeat (VNTR)</strong> region (20-amino-acid tandem repeats, 25‚Äì125 copies) rich in serine, threonine, and proline that carry dense O-glycans (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of">pmc.ncbi.nlm.nih.gov</a>). These glycosylated repeats account for 50‚Äì90% of the protein‚Äôs mass and form a rigid, ‚Äú<strong>tower-like</strong>‚Äù structure extending 200‚Äì500 nm above the cell surface (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=amino%20acids%20in%20length%2C%20tethers,kinase%20%28Kato%20et">pubmed.ncbi.nlm.nih.gov</a>). Immediately downstream of the tandem repeats is a conserved SEA domain (sea-urchin sperm protein, enterokinase, agrin) that undergoes <strong>autoproteolysis</strong> at a GSVVV motif, splitting the protein into MUC1-N and MUC1-C (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by">pmc.ncbi.nlm.nih.gov</a>). The subunit MUC1-C consists of a 28-amino-acid transmembrane helix and a 72-amino-acid <strong>cytoplasmic tail</strong>, which is highly conserved across species (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000">pmc.ncbi.nlm.nih.gov</a>). The cytoplasmic tail contains seven tyrosine residues and multiple serine/threonine sites that serve as docking sites for intracellular signaling proteins when phosphorylated (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). Importantly, the MUC1 protein is <strong>polymorphic</strong> due to VNTR length variation and alternative splicing, but the transmembrane and cytoplasmic regions are largely invariant, underscoring their critical functional roles (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20polymorphic%20transmembrane,1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=determines%20the%20speciffic%20spatial%20structure,8">pmc.ncbi.nlm.nih.gov</a>).</p>
<h1 id="localization-and-expression">Localization and Expression</h1>
<p>MUC1 is predominantly expressed at the <strong>apical surface of epithelial cells</strong> in a wide range of tissues, including the <strong>gastrointestinal tract, respiratory tract, urogenital tract, breast, pancreas, and others</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4">pmc.ncbi.nlm.nih.gov</a>). In normal epithelia, MUC1 shows a polarized distribution, being confined to the lumen-facing membrane where it contributes to the <strong>extracellular glycocalyx</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC16%2C%20MUC17%2C%20MUC21%2C%20and%20MUC22%29.,12">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14">pmc.ncbi.nlm.nih.gov</a>). It is notably absent from tissues like skin epidermis and mesenchymal cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4">pmc.ncbi.nlm.nih.gov</a>), reflecting its specialized role in mucosal interfaces. At the cell surface, the large extracellular MUC1-N subunit protrudes outward and is heavily glycosylated, whereas the MUC1-C subunit spans the membrane and has a short external piece plus a cytosolic tail. This <strong>topology</strong> allows MUC1 to function both <strong>outside the cell and within the cell</strong>: the <strong>extracellular domain</strong> interacts with the environment (microbes, molecules, neighboring cells), and the <strong>cytoplasmic tail</strong> engages in intracellular signaling. MUC1 is anchored to the plasma membrane, but its extracellular component can be <strong>shed</strong>. Proteolytic enzymes (e.g. ADAM17/TACE or metalloproteases) can cleave within the SEA domain to release the large MUC1-N subunit from the cell surface (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Ligtenberg%20et%20al,2004%3B%20Thathiah%20and%20Carson">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=TNF,Lind%C3%A9n%20et%20al">pmc.ncbi.nlm.nih.gov</a>). Shedding of MUC1 is often stimulated by cell stress or inflammation and results in the shed mucin becoming part of the soluble mucus layer. The remaining MUC1-C fragment stays in the membrane and can be endocytosed and recycled to the surface (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%29,2000">pmc.ncbi.nlm.nih.gov</a>). In addition, evidence suggests that the MUC1-C subunit can undergo further proteolysis by <strong>Œ≥-secretase</strong>, releasing the cytoplasmic tail into the cytosol (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells">pmc.ncbi.nlm.nih.gov</a>). This released tail has been observed to <strong>translocate to the nucleus</strong> in some contexts, especially in cancer cells, where it can influence gene transcription (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151">pmc.ncbi.nlm.nih.gov</a>). Thus, MUC1‚Äôs localization is dynamic: it primarily resides on the cell membrane at the cell-exterior interface, but fragments can localize to the <strong>extracellular milieu</strong> (shed ectodomain), <strong>endosomal compartments</strong> (during recycling), and even the <strong>nucleus</strong> (intracellular domain in certain signaling events).</p>
<h1 id="protective-barrier-function">Protective Barrier Function</h1>
<p>One of the primary physiological roles of MUC1 is to <strong>protect and lubricate mucosal surfaces</strong>. As a <strong>cell-surface mucin</strong>, MUC1 contributes to the formation of a <strong>protective barrier</strong> on epithelial cells that face external environments (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition">www.frontiersin.org</a>). The dense sugar-coated tandem repeats give MUC1 a hydrated, gel-like character that helps trap water and form mucus, preventing desiccation and mechanical damage to epithelia. MUC1 and other mucins line the <strong>respiratory airways, gastrointestinal tract, and urogenital tract</strong>, where they form part of the first line of defense against pathogens (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Introduction">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,9">pmc.ncbi.nlm.nih.gov</a>). Because of its towering length (~200‚Äì500 nm) above the cell surface, MUC1 can sterically hinder microorganisms from reaching the cell membrane (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20family%20of%20cell%20surface,may%20play%20an%20important%20biological">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20all%20of%20the,The%20extracellular%20region%20that%20is">pmc.ncbi.nlm.nih.gov</a>). In essence, pathogens encounter a ‚Äúforest‚Äù of mucin molecules that block access to underlying receptors on the epithelial surface. </p>
<p>Moreover, <strong>MUC1 can function as a releasable decoy for pathogens</strong>. The extracellular domain of MUC1 provides binding sites (glycan epitopes) that many bacteria and viruses adhere to (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=surface%20by%20nearly%20all%20epithelial,most%20extensively%20studied%20of%20the">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=environment%2C%20MUC1%20has%20been%20demonstrated,mucin%20regulates%20inflammation">pubmed.ncbi.nlm.nih.gov</a>). Upon binding of a microbe, MUC1-N can be shed from the cell surface (through the SEA-domain cleavage or protease action), carrying away the bound pathogen in the shed mucus (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Thathiah%20et%20al,2009">pmc.ncbi.nlm.nih.gov</a>). This mechanism helps clear pathogens from the surface: for example, when <strong>Helicobacter pylori</strong> binds to MUC1 on gastric cells, it triggers MUC1‚Äôs auto-cleavage and shedding, thereby removing the bacterium from the cell interface (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%3B%20Vinall%20et%20al,2007">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016">pmc.ncbi.nlm.nih.gov</a>). In mouse models, the importance of MUC1 in pathogen defense is evident. <strong>Muc1-knockout mice</strong> show increased susceptibility to certain infections: in one study, Muc1-deficient mice had greater gastrointestinal colonization and inflammation from <em>Campylobacter jejuni</em>, demonstrating that MUC1 normally limits <em>C. jejuni</em> spread and dampens gut inflammation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=gastrointestinal%20and%20systemic%20spread%20of,another%20gastrointestinal%20pathogen%2C%20enteroaggregative%20Escherichia">pmc.ncbi.nlm.nih.gov</a>). Similarly, MUC1 on gastric mucosa and even on immune cells helps restrict <em>H. pylori</em> infection; mice lacking Muc1 had higher stomach colonization, and human studies found that individuals with genetically shorter MUC1 VNTR alleles (producing a smaller extracellular domain) are at higher risk for <em>H. pylori</em>-associated gastritis and cancer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Wotherspoon%20et%20al,ED">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016">pmc.ncbi.nlm.nih.gov</a>). These findings underscore MUC1‚Äôs role as a <strong>physical barrier and microbial decoy</strong>, protecting the host by binding pathogens and facilitating their removal.</p>
<p>Beyond bacteria, MUC1 also interferes with viruses and other particles. For instance, in the respiratory tract MUC1 can bind the flagellin of <em>Pseudomonas aeruginosa</em>, acting as an attachment site (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection">pmc.ncbi.nlm.nih.gov</a>). Interestingly, while this binding could help immobilize the bacteria, <strong>excess MUC1 in airway infections can sometimes dampen clearance</strong>. In a <em>P. aeruginosa</em> lung infection model, wild-type mice (with MUC1) had higher bacterial burdens than Muc1-knockout mice (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection">pmc.ncbi.nlm.nih.gov</a>). The absence of MUC1 led to a more vigorous early inflammatory response that cleared the bacteria faster (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection">pmc.ncbi.nlm.nih.gov</a>). This paradox is explained by MUC1‚Äôs secondary role in modulating inflammation (see below): MUC1 can suppress excessive inflammatory signals, which in the lung can lead to reduced early clearance of bacteria (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1">pmc.ncbi.nlm.nih.gov</a>). Nonetheless, in general, MUC1‚Äôs presence on mucosal surfaces is considered protective, reducing pathogen adhesion in contexts like the gut and serving as part of the <strong>mucosal immune barrier</strong>. It also contributes to the <strong>lubrication</strong> of epithelial linings, as its gel-like extracellular domain helps mucus flow. This lubricating function is crucial in organs like the <strong>mouth and gastrointestinal tract</strong> (aiding the passage of food) and the <strong>bladder</strong> (protecting urothelium from urine) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications">pmc.ncbi.nlm.nih.gov</a>).</p>
<h1 id="regulation-of-cell-adhesion-and-epithelial-integrity">Regulation of Cell Adhesion and Epithelial Integrity</h1>
<p>MUC1 also influences <strong>cell‚Äìcell and cell‚Äìmatrix adhesion</strong>, due in part to its bulky extracellular domain. In normal epithelia, MUC1 is thought to provide an <strong>anti-adhesive shield</strong> on the apical surface ‚Äì its dense glycan chains can impede interactions between the cell and other cells or microbes. This helps prevent unwanted adhesion of pathogens, but it also means MUC1 can reduce cell‚Äìcell contacts on the apical side, potentially facilitating cell turnover and migration in tissues (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,studies%20have%20shown%20that%20MUC1">pmc.ncbi.nlm.nih.gov</a>). In polarized epithelial sheets, lateral junctions (like E-cadherin-based adherens junctions) are usually protected from MUC1‚Äôs interference by the restricted apical localization. However, if MUC1 loses its polarized distribution (as can occur in injury or carcinoma), its presence over the entire cell surface can disrupt cell adhesion. The large extracellular domain can sterically hinder adhesion receptors such as cadherins and integrins, thereby <strong>reducing cell aggregation</strong> and promoting a motile, invasive phenotype (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>). This phenomenon is especially noted in cancer: tumor cells often overexpress MUC1 and mis-localize it across the cell membrane, which can <strong>impair cell‚Äìcell cohesion</strong> and enhance detachment and metastasis (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=interactions%20with%20cell%20surface%20receptors,monoclonal%20antibody%20TAB004%20overcomes%20anoikis">www.frontiersin.org</a>). For example, elevated MUC1 on carcinoma cells correlates with an inability of E-cadherin to form tight junctions, partly because MUC1‚Äôs extracellular domain physically blocks close cell-cell apposition. Thus, in a normal setting MUC1 helps delineate the apical surface and prevent inappropriate adhesion, while in pathological contexts its anti-adhesive property contributes to <strong>loss of epithelial integrity</strong>.</p>
<p>Notably, the cytoplasmic tail of MUC1 can also interact with the cell‚Äôs structural machinery. MUC1‚Äôs intracellular domain associates with Œ≤-catenin ‚Äì a key component of adherens junctions and the Wnt signaling pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). In normal cells, this interaction might sequester some Œ≤-catenin at the cell membrane or cytosol, affecting adhesion complexes. In cancer cells, evidence suggests MUC1-C sequesters Œ≤-catenin and can even help transport it to the nucleus, thereby <strong>activating Wnt target genes</strong> that promote epithelial‚Äìmesenchymal transition (EMT) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated">pmc.ncbi.nlm.nih.gov</a>). A study in renal carcinoma showed MUC1-C drives EMT through Œ≤-catenin signaling and activation of EMT transcription factors (e.g. Snail) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated">pmc.ncbi.nlm.nih.gov</a>). By modulating such partners, MUC1 can influence cytoskeletal organization and cell morphology during migration and wound healing. Indeed, MUC1 has been implicated in <strong>epithelial repair processes</strong>: after injury, MUC1 levels rise, and it may participate in EMT and cell migration to cover wounds (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=extracellular%20domain%2C%20a%2028,cancer%20cases%20exhibiting%20its%20abnormal">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=MUC1%20serves%20as%20a%20protective,C%20participates%20in">www.frontiersin.org</a>). This role in regeneration aligns with observations that MUC1 can be induced by factors like TGF-Œ≤ or hypoxia, which are involved in EMT and tissue remodeling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,a%20crucial%20role%20in%20RCC">pmc.ncbi.nlm.nih.gov</a>). In summary, MUC1 acts as a modulator of adhesion ‚Äì maintaining <strong>epithelial barrier integrity</strong> when properly localized, but when dysregulated, contributing to <strong>cell detachment and EMT</strong>.</p>
<h1 id="signaling-roles-and-pathway-involvement">Signaling Roles and Pathway Involvement</h1>
<p>Although MUC1 was long viewed as a passive barrier molecule, research has revealed that its <strong>C-terminal cytoplasmic tail actively participates in cell signaling</strong>. The 72-amino-acid MUC1 cytoplasmic tail (MUC1-CT) contains multiple conserved motifs that become phosphorylated by kinases and serve as docking sites for signaling proteins (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). This allows MUC1 to function as a <strong>signaling adaptor or scaffold</strong> that can influence various biochemical pathways:</p>
<ul>
<li>
<p><strong>Growth Factor and Kinase Signaling:</strong> MUC1-CT interacts with several oncogenic signaling proteins. For example, it can bind the <strong>epidermal growth factor receptor (EGFR)</strong> and src-family kinases, and it contains an SH2-binding motif that recruits the adaptor <strong>Grb2</strong> when a specific tyrosine is phosphorylated (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2001a%20%29%3B%20PLC,29">pmc.ncbi.nlm.nih.gov</a>). Through Grb2 and the adaptor <strong>Shc</strong>, MUC1 can link to the Ras‚ÄìMAPK pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). MUC1 also associates with <strong>phosphoinositide 3-kinase (PI3K)</strong>, likely via the PI3K p85 subunit‚Äôs SH2 domain, to modulate the PI3K‚ÄìAKT survival pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). These interactions suggest that when a growth factor stimulus (such as EGF) occurs, MUC1 gets phosphorylated (e.g., by EGFR or Src) and then helps propagate signals that promote cell proliferation or survival (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing">pmc.ncbi.nlm.nih.gov</a>). Indeed, experiments have shown that EGF binding to EGFR leads to MUC1 tail phosphorylation, enabling binding of Grb2 and activation of downstream mitogenic signaling (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=protein%20kinase,2007">pubmed.ncbi.nlm.nih.gov</a>). Thus, MUC1 can augment signals from growth factor receptors and integrate into classic pathways like <strong>Ras/MAPK and PI3K/AKT</strong>.</p>
</li>
<li>
<p><strong>Wnt/Œ≤-Catenin Pathway:</strong> MUC1‚Äôs interaction with <strong>Œ≤-catenin</strong> is a well-documented example of its signaling role. Œ≤-Catenin is involved in cell‚Äìcell adhesion (at E-cadherin junctions) and in Wnt signaling (as a transcriptional co-activator in the nucleus). MUC1-CT binds Œ≤-catenin on the same armadillo repeat region that E-cadherin binds (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). In carcinoma cells, overexpressed MUC1 can compete with E-cadherin, sequestering Œ≤-catenin away from cell junctions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). The MUC1‚ÄìŒ≤-catenin complex can then translocate to the nucleus. Studies by Yamamoto et al. and others found that MUC1‚Äôs tail, once phosphorylated, forms a complex with Œ≤-catenin and potentiates Œ≤-catenin‚Äôs ability to activate Wnt target genes, such as <strong>cyclin D1 and c-Myc</strong>, promoting cell cycle progression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated">pmc.ncbi.nlm.nih.gov</a>). This positions MUC1 as an <strong>influencer of the Wnt pathway</strong>, particularly in oncogenic contexts. Consistent with this, MUC1-C has been shown to drive EMT and invasiveness via Wnt/Œ≤-catenin signaling in cancer models (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated">pmc.ncbi.nlm.nih.gov</a>).</p>
</li>
<li>
<p><strong>NF-Œ∫B and Inflammation Signaling:</strong> The MUC1 cytoplasmic tail has been reported to interact with the <strong>NF-Œ∫B pathway</strong>. In inflammatory environments, MUC1-C can translocate to the nucleus and bind the p65 subunit of NF-Œ∫B, a transcription factor controlling many immune and survival genes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151">pmc.ncbi.nlm.nih.gov</a>). One study in prostate cancer found MUC1-C/p65 complexes on chromatin, leading to increased expression of genes like <strong>ZEB1 and EZH2</strong> that drive EMT and stemness (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151">pmc.ncbi.nlm.nih.gov</a>). By serving as a co-factor for NF-Œ∫B, MUC1 may amplify or sustain the transcription of specific target genes. In general, MUC1‚Äôs ability to modulate NF-Œ∫B and other transcription factors links it to pathways of <strong>inflammation, apoptosis, and cell survival</strong>.</p>
</li>
<li>
<p><strong>Intrinsic Apoptotic Pathways:</strong> Emerging evidence suggests MUC1-C can localize to mitochondria and affect apoptosis. The C-terminal subunit has been detected on the outer mitochondrial membrane in some cancer cells, where it interferes with pro-apoptotic signaling. For instance, MUC1 has been reported to block the release of mitochondrial apoptogenic factors (like cytochrome c) upon drug treatment, thereby conferring <strong>chemotherapy resistance</strong> by inhibiting apoptosis (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=promoting%20its%20degradation%20%2817%20%29,25">www.frontiersin.org</a>). This is not a classical signaling pathway, but it illustrates MUC1‚Äôs multifunctional role in cell survival mechanisms.</p>
</li>
<li>
<p><strong>Other interactions:</strong> MUC1-CT binds to various other molecules: it can associate with <strong>GSK3Œ≤</strong> (a kinase in Wnt and other pathways), <strong>Protein kinase CŒ¥</strong>, and elements of T-cell signaling like ZAP-70 and Lck in immune cells (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=Blue%20bars%20mark%20the%20known,the%20CT%20contains%20the%20motif">pubmed.ncbi.nlm.nih.gov</a>). Many of these interactions depend on specific phosphorylation of MUC1 tyrosines. For example, phosphorylation on distinct tyrosines creates binding sites for either Œ≤-catenin or PI3K or Src-homology domains, allowing MUC1 to act as a platform for signaling complexes (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>). The <strong>CQC motif</strong> at the very end of the cytoplasmic tail is required for MUC1‚Äôs proper localization and perhaps its dimerization; mutation of this CQC motif disrupts MUC1 targeting to the membrane and attenuates its signaling functions (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007">pubmed.ncbi.nlm.nih.gov</a>). This motif includes cysteine residues that are palmitoylated, anchoring MUC1-C in lipid rafts at the plasma membrane (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007">pubmed.ncbi.nlm.nih.gov</a>). Loss of these modifications can send MUC1 to other cellular locations and alter signal outputs.</p>
</li>
</ul>
<p>Overall, through its cytoplasmic tail, MUC1 <strong>integrates into multiple signaling networks</strong>. Under normal conditions, these interactions may help fine-tune epithelial responses to growth factors, stress, or inflammatory signals. In disease states (especially cancer), the same signaling roles of MUC1 are often co-opted to promote unchecked proliferation, survival, and metastasis.</p>
<h1 id="modulation-of-inflammation-and-immune-response">Modulation of Inflammation and Immune Response</h1>
<p>MUC1 plays a significant role in regulating <strong>immune responses</strong> at mucosal surfaces. Not only does it act as a physical barrier to pathogens, it also functions as a <strong>negative regulator of pathogen-induced signaling</strong>, preventing excessive inflammation. The cytoplasmic tail of MUC1 has been shown to interact with pattern recognition receptor signaling, especially <strong>Toll-like receptors (TLRs)</strong> on immune and epithelial cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=inflammation,with%20TLRs%20at%20the%20cell">pmc.ncbi.nlm.nih.gov</a>). When a pathogen is detected, TLRs typically activate NF-Œ∫B and other pathways to induce pro-inflammatory cytokines. MUC1 is unusual in that it is <strong>upregulated by inflammatory stimuli</strong> (such as tumor necrosis factor alpha, TNF-Œ±, or pathogen components) and then acts in a feedback manner to dampen the inflammatory response (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Several studies illustrate MUC1‚Äôs anti-inflammatory role: for example, binding of <em>Pseudomonas</em> flagellin to cell-surface MUC1 triggers phosphorylation of the MUC1-CT (via EGFR), allowing the MUC1 tail to associate with <strong>TLR5</strong> and block MyD88 recruitment (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>). MyD88 is the adaptor protein needed for downstream TLR signaling, so MUC1 essentially <strong>competitively inhibits TLR signaling</strong> in this context (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>). Kato et al. (2012) demonstrated that in airway epithelial cells, this mechanism reduced activation of the NF-Œ∫B pathway and lowered production of IL-8 and TNF-Œ± during <em>P. aeruginosa</em> infection (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>). Similarly, MUC1-CT can interact with <strong>TLR3</strong> (the receptor for viral double-stranded RNA) and prevent the adapter TRIF from binding, thereby suppressing the type I interferon response and cell death triggered by viral RNA sensing (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence">pmc.ncbi.nlm.nih.gov</a>). This was shown using synthetic dsRNA (poly I:C) in lung epithelial models, where wild-type cells (with MUC1) had milder cytokine responses and apoptosis compared to cells lacking the MUC1 tail (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Broadly, MUC1 seems to serve as a <strong>universal attenuator of TLR signaling</strong>. Ueno et al. (2008) tested various TLR agonists (for TLR2, 3, 4, 7, 9) and found that the presence of MUC1-CT was required to limit the inflammatory response to each of these stimuli (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating">pmc.ncbi.nlm.nih.gov</a>). In macrophages or monocytes, which also express MUC1, the MUC1-CT similarly reduces pro-inflammatory cytokine release upon challenge (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=including%20Pam_,CT%20is%20required%20for%20the">pmc.ncbi.nlm.nih.gov</a>). There is evidence linking MUC1‚Äôs anti-inflammatory effects with induction of <strong>IL-10</strong> (an anti-inflammatory cytokine) and interferons, suggesting MUC1 might skew responses toward resolution of inflammation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Kato%20et%20al,role%20in%20controlling%20disease%20severity">pmc.ncbi.nlm.nih.gov</a>). Furthermore, because TLR-driven inflammation is a prerequisite for inflammasome activation, MUC1‚Äôs braking effect on TLRs also means it can indirectly <strong>suppress inflammasome pathways</strong> (reducing maturation of IL-1Œ≤ and IL-18) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=formation%20of%20the%20inflammasome%20complex,as%20the%20NLRP%2C%20or%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Figure%202B%29,Figure%202C">pmc.ncbi.nlm.nih.gov</a>). This helps prevent overactivation of immune responses that could damage tissue.</p>
<p>In essence, MUC1 provides a check on the innate immune system: it allows initial pathogen sensing, but as infection proceeds, increased MUC1 on the cell surface helps <strong>prevent an overzealous inflammatory reaction</strong> that can harm host tissues (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell">pmc.ncbi.nlm.nih.gov</a>). This modulator function is beneficial in preventing chronic inflammation and tissue injury. However, it can be a double-edged sword; as noted earlier, in acute infections like <em>P. aeruginosa</em> pneumonia, MUC1‚Äôs suppression of inflammation can slow bacterial clearance (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1">pmc.ncbi.nlm.nih.gov</a>). The overall effect of MUC1 on immunity appears context-dependent ‚Äì balancing pathogen clearance with prevention of immunopathology. This role is conserved across species (the cytoplasmic tail is homologous from humans to mammals like mice (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000">pmc.ncbi.nlm.nih.gov</a>)), highlighting its importance in immune homeostasis.</p>
<h1 id="clinical-significance-and-applications">Clinical Significance and Applications</h1>
<p>MUC1‚Äôs distinctive features in normal and disease states have made it a focus of clinical interest, especially in <strong>cancer diagnosis and therapy</strong>. In healthy tissue, MUC1 is mostly confined to the apical surface of epithelial cells and carries long, complex glycan chains. In many <strong>epithelial cancers</strong>, MUC1 is <strong>overexpressed</strong> and abnormally glycosylated, and it loses its polarized distribution (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>). Over 90% of human <strong>breast carcinomas</strong> overexpress MUC1, often to a very high level (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>). Similar overexpression is observed in other adenocarcinomas (e.g. ovarian, lung, pancreatic, prostate), where MUC1 is found across the entire cell surface and even in circulation as shed fragments. Tumor-associated MUC1 typically has shorter glycans (due to altered glycosyltransferase activity in cancers), exposing cryptic peptide epitopes and carbohydrate antigens (such as the <strong>Tn, sTn, and T antigen</strong> clusters) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=In%20cancer%20cells%2C%20the%20long,Friedenreich%2C%20CD176%2C%20T%20antigen%29%2C%20and">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,10%E2%80%9312">pmc.ncbi.nlm.nih.gov</a>). These tumor-specific epitopes make MUC1 a useful <strong>biomarker</strong> and an immunotherapeutic target. For instance, the serum <strong>CA15-3 test</strong> for breast cancer monitors circulating MUC1 fragments carrying the cancer-associated sialyl-T antigen. An abnormally high level of MUC1 in patient serum can indicate tumor burden and is used in monitoring breast cancer progression or recurrence (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Clinically, MUC1 expression correlates with disease outcomes. <strong>Abnormally high MUC1 levels are associated with poor prognosis</strong> in multiple cancers, including breast, lung, pancreatic, renal, and others (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,pancreatic%20ductal%20carcinoma%2C%20and%20thymic">pmc.ncbi.nlm.nih.gov</a>). The presence of MUC1 contributes to tumor progression by enhancing proliferation, invasion, and immune evasion (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>). MUC1 functions as an <strong>oncoprotein</strong> in these settings ‚Äì for example, MUC1 can drive cancer cell growth by activating pro-tumorigenic pathways (Wnt/Œ≤-catenin, NF-Œ∫B, etc.) and conferring resistance to apoptosis and therapy (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can">www.frontiersin.org</a>). Due to this central role, MUC1 was ranked the <strong>second most promising cancer antigen</strong> (out of 75) by an NIH-led consortium for developing cancer immunotherapies (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=strong%20antitumor%20effects,in%20cancer%20research%20by%20the">pmc.ncbi.nlm.nih.gov</a>). This has spurred numerous efforts to target MUC1 in cancer treatment.</p>
<p><strong>Cancer vaccines targeting MUC1</strong> are one active area of research. MUC1‚Äôs immunogenic VNTR domain (with repetitive peptide epitopes) can be used to raise antibodies and T-cells. In fact, MUC1 was one of the first tumor antigens tested in vaccine trials. Various vaccine formulations ‚Äì from synthetic MUC1 peptides conjugated to carriers, to dendritic cells loaded with MUC1 antigen, to viral vector vaccines encoding MUC1 ‚Äì have been developed (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=In%20recent%20years%2C%20new%20discoveries,manner%2C%20with%20objective%20remission%20being">pmc.ncbi.nlm.nih.gov</a>). As an example, <strong>TG4010</strong> is a modified vaccinia Ankara (MVA) virus vaccine that delivers the human MUC1 gene plus IL-2; it has been tested in <strong>phase I/II trials</strong> for cancers like non-small cell lung cancer and showed a favorable safety profile (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=TG4010%20is%20a%20cancer%20vaccine,In%20metastatic%20RCC">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=telomerase%2C%20survivin%2C%20and%20MAGE,like%20receptor%209%20%28TLR9%29%20agonist">pmc.ncbi.nlm.nih.gov</a>). In a clinical study for metastatic renal cancer, an RNA vaccine including MUC1 (among other tumor antigens) induced MUC1-specific T-cell responses in patients, with some experiencing stable disease or partial remission (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=detected%20in%20the%2011%20patients,133%5D%20demonstrated%20that">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=CD4,like%20receptor%209%20%28TLR9%29%20agonist">pmc.ncbi.nlm.nih.gov</a>). Another approach used autologous dendritic cells pulsed with a MUC1 peptide (containing a helper T-cell epitope PADRE) in renal carcinoma, resulting in cytotoxic T-cells that could kill MUC1-expressing tumor cells and minor tumor regressions in a subset of patients (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=development%20of%20research%20strategies%20targeting,patients%20with%20metastatic%20RCC%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%28DC,A1%29%20using%20adjuvant%20granulocyte%E2%80%93macrophage%20colony">pmc.ncbi.nlm.nih.gov</a>). These early-phase trials affirm that MUC1 vaccines can safely generate an immune response. More recently, <strong>liposomal MUC1 glycopeptide vaccines</strong> (like L-BLP25) were tested in lung cancer, and <strong>MUC1 peptide conjugates</strong> are under investigation for breast and prostate cancer immunoprevention (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20CAR,NCT00852007">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Antibody-based therapies</strong> targeting MUC1 are also being explored. Monoclonal antibodies that recognize tumor-specific MUC1 epitopes (for example, the antibody <strong>TAB004</strong> that binds a cancer-specific glycoform of MUC1) have shown promising preclinical results ‚Äì binding to tumor cells and inducing their destruction (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=stemness%20of%20cancer%20cells%2C%20primarily,As%20an%20oncogenic%20driver%2C%20MUC1">www.frontiersin.org</a>). MUC1-directed antibody‚Äìdrug conjugates (ADCs) are in development, in which an anti-MUC1 antibody delivers a cytotoxic drug to MUC1-expressing tumor cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=tandem%20repeats%20%28VNTRs%29.,in%20cancer%20research%20by%20the">pmc.ncbi.nlm.nih.gov</a>). There is also interest in <strong>CAR T-cell therapy</strong> against MUC1: chimeric antigen receptor T-cells engineered to attack MUC1-positive cancers. Given the widespread expression of MUC1 in tumors, several CAR T constructs have been designed. For instance, a fully human CAR T (designated P-MUC1C-ALLO1) targeting the MUC1-C core is currently in a phase I trial for solid tumors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20TG4010%20%20%7C%20MUC1,22">pmc.ncbi.nlm.nih.gov</a>). Early preclinical data suggest that MUC1-specific CAR T cells can selectively kill carcinoma cells while sparing normal cells that have MUC1 mostly sequestered on the apical side or with different glycosylation. </p>
<p>Beyond cancer, understanding MUC1‚Äôs function has implications in other diseases. A striking example is <strong>MUC1-associated familial kidney disease</strong>: certain mutations in MUC1 (frameshifts in the VNTR region) cause a misfolded protein that accumulates in kidney tubule cells, leading to medullary cystic kidney disease type 1 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11">pmc.ncbi.nlm.nih.gov</a>). This illustrates that proper MUC1 processing is important for cell health. Additionally, because MUC1 modulates inflammation, it is being studied in chronic inflammatory diseases of mucosal organs. Variants in MUC1 have been examined for associations with <strong>inflammatory bowel disease</strong> and <strong>respiratory conditions</strong>, though these areas are still emerging.</p>
<p>In summary, MUC1‚Äôs <strong>primary functions</strong> are to serve as a <strong>protective mucosal barrier and a modulator of signaling</strong> in epithelial cells. It carries out these roles at the <strong>cell surface</strong> (providing a shield and interacting with pathogens) and at the <strong>intracellular level</strong> (transducing signals via its cytoplasmic tail). In normal physiology, MUC1 protects tissues from infection and regulates inflammation, while maintaining epithelial integrity. In pathological states like cancer, MUC1 is co-opted to promote tumor growth and metastasis. Its ubiquitous overexpression in carcinomas and distinct tumor-associated forms have made it both a <strong>diagnostic marker</strong> and a <strong>target for immunotherapy</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=participates%20in%20epithelial%20cell%20renewal,This%20article%20reviews%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC">pmc.ncbi.nlm.nih.gov</a>). Ongoing research (as of 2023‚Äì2024) continues to uncover new aspects of MUC1 biology ‚Äì such as its role in immune evasion and epigenetic regulation in cancer (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=associated%20MUC1%20,25">www.frontiersin.org</a>) ‚Äì and to harness this knowledge in developing <strong>MUC1-targeted treatments</strong> to improve patient outcomes. </p>
<p><strong>References:</strong></p>
<ol>
<li>
<p>Chen X. <em>et al.</em> (2024). <em>MUC1 and MUC16: critical for immune modulation in cancer therapeutics</em>. Front. Immunol. <strong>15</strong>:1356913. DOI:10.3389/fimmu.2024.1356913 (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also">www.frontiersin.org</a>)</p>
</li>
<li>
<p>Dhar P, McAuley J. (2019). <em>The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation</em>. Front. Cell. Infect. Microbiol. <strong>9</strong>:117. DOI:10.3389/fcimb.2019.00117 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Long L. <em>et al.</em> (2023). <em>The research status and prospects of MUC1 in immunology</em>. Hum. Vaccin. Immunother. <strong>19</strong>(1):2172278. DOI:10.1080/21645515.2023.2172278 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Mao W. <em>et al.</em> (2024). <em>Research progress of MUC1 in genitourinary cancers</em>. Cell. Mol. Biol. Lett. <strong>29</strong>:135. DOI:10.1186/s11658-024-00654-x (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>McAuley JL. <em>et al.</em> (2007). <em>MUC1 cell surface mucin is a critical element of the mucosal barrier to infection</em>. J. Clin. Invest. <strong>117</strong>(8):2313‚Äì2324. DOI:10.1172/JCI26705 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Kato K. <em>et al.</em> (2012). <em>MUC1: The first mammalian membrane-tethered mucin to be implicated in tumor suppression.</em> Mucosal Immunol. <strong>5</strong>(3):309‚Äì320. DOI:10.1038/mi.2012.9 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Gnemmi V. <em>et al.</em> (2014). <em>MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma-secretase-dependent pathway</em>. Oncotarget <strong>5</strong>(3):754‚Äì765. DOI:10.18632/oncotarget.1776 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Leng Y. <em>et al.</em> (2007). <em>Nucleocytoplasmic shuttling of MUC1 cytoplasmic tail: a novel mechanism for signal transduction and transcriptional regulation</em>. Biochem. Biophys. Res. Commun. <strong>360</strong>(1):145‚Äì150. DOI:10.1016/j.bbrc.2007.06.049 (<a href="https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007">pubmed.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Ueno K. <em>et al.</em> (2008). <em>MUC1 mucin is a negative regulator of TLR signaling</em>. Am. J. Respir. Cell Mol. Biol. <strong>38</strong>(3):263‚Äì268. DOI:10.1165/rcmb.2007-0078OC (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
<li>
<p>Yamamoto M. <em>et al.</em> (1997). <em>MUC1 cytoplasmic domain mediates binding to beta-catenin</em>. J. Biol. Chem. <strong>272</strong>(16):12492‚Äì12494. DOI:10.1074/jbc.272.16.12492 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al">pmc.ncbi.nlm.nih.gov</a>)</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=416, start_index=296, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14')</li>
<li>AnnotationURLCitation(end_index=818, start_index=701, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight')</li>
<li>AnnotationURLCitation(end_index=1022, start_index=905, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight')</li>
<li>AnnotationURLCitation(end_index=1258, start_index=1134, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%2C%20which%20is%20localized%20to,C')</li>
<li>AnnotationURLCitation(end_index=1620, start_index=1459, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo')</li>
<li>AnnotationURLCitation(end_index=1791, start_index=1621, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of')</li>
<li>AnnotationURLCitation(end_index=2106, start_index=1950, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo')</li>
<li>AnnotationURLCitation(end_index=2248, start_index=2107, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=amino%20acids%20in%20length%2C%20tethers,kinase%20%28Kato%20et')</li>
<li>AnnotationURLCitation(end_index=2637, start_index=2467, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=region%20in%20the%20extracellular%20polypeptide,capable%20of%20inducing%20release%20of')</li>
<li>AnnotationURLCitation(end_index=2800, start_index=2638, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by')</li>
<li>AnnotationURLCitation(end_index=3071, start_index=2952, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000')</li>
<li>AnnotationURLCitation(end_index=3406, start_index=3248, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2')</li>
<li>AnnotationURLCitation(end_index=3517, start_index=3407, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=3867, start_index=3737, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20polymorphic%20transmembrane,1')</li>
<li>AnnotationURLCitation(end_index=4005, start_index=3868, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=determines%20the%20speciffic%20spatial%20structure,8')</li>
<li>AnnotationURLCitation(end_index=4376, start_index=4254, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4')</li>
<li>AnnotationURLCitation(end_index=4673, start_index=4537, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC16%2C%20MUC17%2C%20MUC21%2C%20and%20MUC22%29.,12')</li>
<li>AnnotationURLCitation(end_index=4794, start_index=4674, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14')</li>
<li>AnnotationURLCitation(end_index=4994, start_index=4872, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=Expression%20of%20MUC1%20is%20found,4')</li>
<li>AnnotationURLCitation(end_index=5892, start_index=5754, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Ligtenberg%20et%20al,2004%3B%20Thathiah%20and%20Carson')</li>
<li>AnnotationURLCitation(end_index=6002, start_index=5893, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=TNF,Lind%C3%A9n%20et%20al')</li>
<li>AnnotationURLCitation(end_index=6346, start_index=6247, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%29,2000')</li>
<li>AnnotationURLCitation(end_index=6654, start_index=6503, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia')</li>
<li>AnnotationURLCitation(end_index=6808, start_index=6655, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells')</li>
<li>AnnotationURLCitation(end_index=7120, start_index=6969, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia')</li>
<li>AnnotationURLCitation(end_index=7258, start_index=7121, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151')</li>
<li>AnnotationURLCitation(end_index=7950, start_index=7846, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11')</li>
<li>AnnotationURLCitation(end_index=8113, start_index=7951, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition')</li>
<li>AnnotationURLCitation(end_index=8557, start_index=8461, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Introduction')</li>
<li>AnnotationURLCitation(end_index=8646, start_index=8558, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,9')</li>
<li>AnnotationURLCitation(end_index=8950, start_index=8791, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20family%20of%20cell%20surface,may%20play%20an%20important%20biological')</li>
<li>AnnotationURLCitation(end_index=9105, start_index=8951, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20all%20of%20the,The%20extracellular%20region%20that%20is')</li>
<li>AnnotationURLCitation(end_index=9583, start_index=9424, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=surface%20by%20nearly%20all%20epithelial,most%20extensively%20studied%20of%20the')</li>
<li>AnnotationURLCitation(end_index=9745, start_index=9584, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=environment%2C%20MUC1%20has%20been%20demonstrated,mucin%20regulates%20inflammation')</li>
<li>AnnotationURLCitation(end_index=10082, start_index=9920, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by')</li>
<li>AnnotationURLCitation(end_index=10193, start_index=10083, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Thathiah%20et%20al,2009')</li>
<li>AnnotationURLCitation(end_index=10544, start_index=10426, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2003%20%3B%20Vinall%20et%20al,2007')</li>
<li>AnnotationURLCitation(end_index=10667, start_index=10545, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016')</li>
<li>AnnotationURLCitation(end_index=11175, start_index=11027, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al')</li>
<li>AnnotationURLCitation(end_index=11382, start_index=11176, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=gastrointestinal%20and%20systemic%20spread%20of,another%20gastrointestinal%20pathogen%2C%20enteroaggregative%20Escherichia')</li>
<li>AnnotationURLCitation(end_index=11837, start_index=11726, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Wotherspoon%20et%20al,ED')</li>
<li>AnnotationURLCitation(end_index=11960, start_index=11838, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016')</li>
<li>AnnotationURLCitation(end_index=12486, start_index=12318, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection')</li>
<li>AnnotationURLCitation(end_index=12936, start_index=12750, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection')</li>
<li>AnnotationURLCitation(end_index=13228, start_index=13042, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection')</li>
<li>AnnotationURLCitation(end_index=13605, start_index=13437, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Pseudomonas%20aeruginosa%20causes%20respiratory%20infections,aeruiginosa%20infection')</li>
<li>AnnotationURLCitation(end_index=13770, start_index=13606, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1')</li>
<li>AnnotationURLCitation(end_index=14432, start_index=14264, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications')</li>
<li>AnnotationURLCitation(end_index=15149, start_index=14981, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications')</li>
<li>AnnotationURLCitation(end_index=15303, start_index=15150, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,studies%20have%20shown%20that%20MUC1')</li>
<li>AnnotationURLCitation(end_index=15995, start_index=15828, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy')</li>
<li>AnnotationURLCitation(end_index=16231, start_index=15996, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=16674, start_index=16439, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=16901, start_index=16675, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=interactions%20with%20cell%20surface%20receptors,monoclonal%20antibody%20TAB004%20overcomes%20anoikis')</li>
<li>AnnotationURLCitation(end_index=17644, start_index=17534, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=18131, start_index=17977, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')</li>
<li>AnnotationURLCitation(end_index=18424, start_index=18270, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')</li>
<li>AnnotationURLCitation(end_index=18926, start_index=18722, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=extracellular%20domain%2C%20a%2028,cancer%20cases%20exhibiting%20its%20abnormal')</li>
<li>AnnotationURLCitation(end_index=19109, start_index=18927, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=MUC1%20serves%20as%20a%20protective,C%20participates%20in')</li>
<li>AnnotationURLCitation(end_index=19417, start_index=19269, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,a%20crucial%20role%20in%20RCC')</li>
<li>AnnotationURLCitation(end_index=20148, start_index=19990, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2')</li>
<li>AnnotationURLCitation(end_index=20259, start_index=20149, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=20801, start_index=20694, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=2001a%20%29%3B%20PLC,29')</li>
<li>AnnotationURLCitation(end_index=21021, start_index=20879, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=21317, start_index=21175, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Blue%20bars%20mark%20the%20known,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=21691, start_index=21528, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing')</li>
<li>AnnotationURLCitation(end_index=21811, start_index=21692, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing')</li>
<li>AnnotationURLCitation(end_index=22079, start_index=21979, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=protein%20kinase,2007')</li>
<li>AnnotationURLCitation(end_index=22664, start_index=22554, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=22892, start_index=22782, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=23314, start_index=23204, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=23469, start_index=23315, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')</li>
<li>AnnotationURLCitation(end_index=23841, start_index=23687, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=formation%20of%20an%20immune,that%20MUC1%20was%20directly%20regulated')</li>
<li>AnnotationURLCitation(end_index=24274, start_index=24137, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151')</li>
<li>AnnotationURLCitation(end_index=24575, start_index=24438, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=directly%20bind%20to%20nuclear%20factor,150%2C%20151')</li>
<li>AnnotationURLCitation(end_index=25538, start_index=25313, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can')</li>
<li>AnnotationURLCitation(end_index=25710, start_index=25539, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=promoting%20its%20degradation%20%2817%20%29,25')</li>
<li>AnnotationURLCitation(end_index=26207, start_index=26062, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=Blue%20bars%20mark%20the%20known,the%20CT%20contains%20the%20motif')</li>
<li>AnnotationURLCitation(end_index=26634, start_index=26476, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=the%20cell.%20The%20MUC1,GSK3%CE%B2%2C%20glycogen%20synthase%20kinase%203%CE%B2')</li>
<li>AnnotationURLCitation(end_index=26745, start_index=26635, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
<li>AnnotationURLCitation(end_index=27071, start_index=26984, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007')</li>
<li>AnnotationURLCitation(end_index=27277, start_index=27190, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007')</li>
<li>AnnotationURLCitation(end_index=28400, start_index=28238, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=28527, start_index=28401, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=inflammation,with%20TLRs%20at%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=29001, start_index=28855, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=29167, start_index=29002, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=29591, start_index=29428, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=suppresses%20TLR%20signaling%2C%20attenuating%20inflammation,CT%2C%20increasing')</li>
<li>AnnotationURLCitation(end_index=29754, start_index=29592, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=30061, start_index=29899, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=30204, start_index=30062, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=30519, start_index=30400, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=binding%20of%20P,CT%2C%20increasing')</li>
<li>AnnotationURLCitation(end_index=30662, start_index=30520, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=31058, start_index=30895, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney')</li>
<li>AnnotationURLCitation(end_index=31163, start_index=31059, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence')</li>
<li>AnnotationURLCitation(end_index=31521, start_index=31358, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Similar%20to%20its%20suppressive%20role,lung%20and%20human%20embryonic%20kidney')</li>
<li>AnnotationURLCitation(end_index=31626, start_index=31522, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=al,Adding%20credence')</li>
<li>AnnotationURLCitation(end_index=32035, start_index=31889, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the')</li>
<li>AnnotationURLCitation(end_index=32145, start_index=32036, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating')</li>
<li>AnnotationURLCitation(end_index=32411, start_index=32280, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=including%20Pam_,CT%20is%20required%20for%20the')</li>
<li>AnnotationURLCitation(end_index=32729, start_index=32620, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating')</li>
<li>AnnotationURLCitation(end_index=32873, start_index=32730, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Kato%20et%20al,role%20in%20controlling%20disease%20severity')</li>
<li>AnnotationURLCitation(end_index=33261, start_index=33102, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=formation%20of%20the%20inflammasome%20complex,as%20the%20NLRP%2C%20or%20the')</li>
<li>AnnotationURLCitation(end_index=33375, start_index=33262, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28Figure%202B%29,Figure%202C')</li>
<li>AnnotationURLCitation(end_index=33847, start_index=33701, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L271%20causes%20TLR,with%20TLRs%20at%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=34013, start_index=33848, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=causes%20TLR%20activation%2C%20causing%20production,with%20TLRs%20at%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=34468, start_index=34282, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=immunocompromised%20individuals%2C%20such%20as%20those,inflammatory%20responses%20to%20the%20infection')</li>
<li>AnnotationURLCitation(end_index=34633, start_index=34469, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=barrier%20to%20infection%20in%20the,engagement%20of%20NEU1%20desialylates%20MUC1')</li>
<li>AnnotationURLCitation(end_index=34993, start_index=34874, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=The%20cytoplasmic%20tail%20%28,2000')</li>
<li>AnnotationURLCitation(end_index=35726, start_index=35491, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=36048, start_index=35813, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=36641, start_index=36468, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=In%20cancer%20cells%2C%20the%20long,Friedenreich%2C%20CD176%2C%20T%20antigen%29%2C%20and')</li>
<li>AnnotationURLCitation(end_index=36746, start_index=36642, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,10%E2%80%9312')</li>
<li>AnnotationURLCitation(end_index=37255, start_index=37129, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC')</li>
<li>AnnotationURLCitation(end_index=37603, start_index=37463, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=2%2C3,pancreatic%20ductal%20carcinoma%2C%20and%20thymic')</li>
<li>AnnotationURLCitation(end_index=37944, start_index=37716, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable')</li>
<li>AnnotationURLCitation(end_index=38180, start_index=37945, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=38633, start_index=38405, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=ubiquitously%20expressed%20in%20mammalian%20epithelial,MUC%20proteins%20have%20attracted%20considerable')</li>
<li>AnnotationURLCitation(end_index=38859, start_index=38634, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=proliferation%2C%20EMT%2C%20epigenetic%20reprogramming%2C%20and,also%20indicated%20that%20MUC1%20can')</li>
<li>AnnotationURLCitation(end_index=39170, start_index=39023, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=strong%20antitumor%20effects,in%20cancer%20research%20by%20the')</li>
<li>AnnotationURLCitation(end_index=39807, start_index=39688, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199')</li>
<li>AnnotationURLCitation(end_index=39984, start_index=39808, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=In%20recent%20years%2C%20new%20discoveries,manner%2C%20with%20objective%20remission%20being')</li>
<li>AnnotationURLCitation(end_index=40374, start_index=40233, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=TG4010%20is%20a%20cancer%20vaccine,In%20metastatic%20RCC')</li>
<li>AnnotationURLCitation(end_index=40543, start_index=40375, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=telomerase%2C%20survivin%2C%20and%20MAGE,like%20receptor%209%20%28TLR9%29%20agonist')</li>
<li>AnnotationURLCitation(end_index=40913, start_index=40764, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=detected%20in%20the%2011%20patients,133%5D%20demonstrated%20that')</li>
<li>AnnotationURLCitation(end_index=41045, start_index=40914, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=CD4,like%20receptor%209%20%28TLR9%29%20agonist')</li>
<li>AnnotationURLCitation(end_index=41490, start_index=41313, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=development%20of%20research%20strategies%20targeting,patients%20with%20metastatic%20RCC%20to')</li>
<li>AnnotationURLCitation(end_index=41648, start_index=41491, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%28DC,A1%29%20using%20adjuvant%20granulocyte%E2%80%93macrophage%20colony')</li>
<li>AnnotationURLCitation(end_index=42063, start_index=41944, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=Bladder%20cancer%20%20,NCT03540199')</li>
<li>AnnotationURLCitation(end_index=42170, start_index=42064, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20CAR,NCT00852007')</li>
<li>AnnotationURLCitation(end_index=42700, start_index=42491, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=stemness%20of%20cancer%20cells%2C%20primarily,As%20an%20oncogenic%20driver%2C%20MUC1')</li>
<li>AnnotationURLCitation(end_index=43006, start_index=42856, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=tandem%20repeats%20%28VNTRs%29.,in%20cancer%20research%20by%20the')</li>
<li>AnnotationURLCitation(end_index=43497, start_index=43381, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=%7C%20TG4010%20%20%7C%20MUC1,22')</li>
<li>AnnotationURLCitation(end_index=44141, start_index=44037, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=glycoproteins%20,11')</li>
<li>AnnotationURLCitation(end_index=45368, start_index=45205, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=participates%20in%20epithelial%20cell%20renewal,This%20article%20reviews%20the')</li>
<li>AnnotationURLCitation(end_index=45495, start_index=45369, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=of%20cancer%20cells%20and%20mediating,RCC')</li>
<li>AnnotationURLCitation(end_index=45889, start_index=45654, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=46038, start_index=45890, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=associated%20MUC1%20,25')</li>
<li>AnnotationURLCitation(end_index=46488, start_index=46326, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=Mucin%201%20,mesenchymal%20transition')</li>
<li>AnnotationURLCitation(end_index=46724, start_index=46489, title='Frontiers | MUC1 and MUC16: critical for immune modulation in cancer therapeutics', type='url_citation', url='https://www.frontiersin.org/journals/plant-science/articles/10.3389/fimmu.2024.1356913/full#:~:text=tumorigenesis%20and%20progression%2C%20significant%20changes,activating%20pluripotency%20networks%20and%20also')</li>
<li>AnnotationURLCitation(end_index=47088, start_index=46927, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=%28A%29%20Schematic%20representation%20of%20MUC1,region%20and%20can%20undergo')</li>
<li>AnnotationURLCitation(end_index=47251, start_index=47089, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=which%20possess%20the%20GSVVV%20motif%2C,lumen%20provides%20a%20mechanism%20by')</li>
<li>AnnotationURLCitation(end_index=47535, start_index=47418, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=MUC1%20,The%20molecular%20weight')</li>
<li>AnnotationURLCitation(end_index=47656, start_index=47536, title='The research status and prospects of MUC1 in immunology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10012890/#:~:text=to%20the%20apical%20surface%20of,14')</li>
<li>AnnotationURLCitation(end_index=47973, start_index=47805, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=MUC1%20is%20a%20highly%20glycosylated,cancers%20and%20its%20clinical%20applications')</li>
<li>AnnotationURLCitation(end_index=48141, start_index=47974, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=As%20a%20member%20of%20membrane,attractive%20target%20for%20cancer%20immunotherapy')</li>
<li>AnnotationURLCitation(end_index=48468, start_index=48320, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=Campylobacter%20jejuni%20is%20an%20intestinal,Palacios%20et%20al')</li>
<li>AnnotationURLCitation(end_index=48591, start_index=48469, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=triggered%20shedding%20via%20self,2016')</li>
<li>AnnotationURLCitation(end_index=48931, start_index=48769, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=match%20at%20L259%20MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=49074, start_index=48932, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=MUC1,downstream%20signaling%20cascades%2C%20resulting%20in')</li>
<li>AnnotationURLCitation(end_index=49441, start_index=49290, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=have%20also%20found%20that%20MUC1,was%20induced%20by%20a%20hypoxia')</li>
<li>AnnotationURLCitation(end_index=49595, start_index=49442, title='Research progress of MUC1 in genitourinary cancers - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11533421/#:~:text=demonstrated%20that%20MUC1,migratory%20properties%20of%20RCC%20cells')</li>
<li>AnnotationURLCitation(end_index=49924, start_index=49837, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/31069176/#:~:text=PLC,2007')</li>
<li>AnnotationURLCitation(end_index=50234, start_index=50088, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=to%20the%20notion%20that%20MUC1,CT%20is%20required%20for%20the')</li>
<li>AnnotationURLCitation(end_index=50344, start_index=50235, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=anti,IFN%29%20correlating')</li>
<li>AnnotationURLCitation(end_index=50618, start_index=50508, title='The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6491460/#:~:text=,%CE%B4%20%28Ren%20et%20al')</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(MUC1-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15941" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: true<br />
start_time: '2025-11-03T21:37:05.918497'<br />
end_time: '2025-11-03T21:37:05.920817'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: P15941<br />
  gene_symbol: MUC1<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 54</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene MUC1 (P15941) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
This is a comprehensive request for a research report on MUC1 (P15941). Let me analyze the search results and plan the report structure.</p>
<p>Key areas to cover based on the user's requirements:<br />
1. Primary function of the gene/protein<br />
2. Biochemical function (what reactions/interactions it catalyzes or facilitates)<br />
3. Substrate specificity/functional interactions<br />
4. Cellular and subcellular localization<br />
5. Signaling and biochemical pathways<br />
6. Evidence from experimental and structural studies</p>
<p>Let me review the search results systematically:</p>
<p>From the search results, I can see:</p>
<p>Structure and basic info [1, 2, 3, 7]:<br />
- Type I transmembrane glycoprotein<br />
- VNTR (variable number tandem repeats) domain in extracellular region<br />
- SEA domain for autocleavage<br />
- Transmembrane domain<br />
- 72-amino acid cytoplasmic tail<br />
- Proteolytically cleaved into alpha and beta subunits<br />
- Extended structure 200-500nm above cell surface</p>
<p>Functions in normal tissue [1, 3, 6, 7]:<br />
- Lubrication and hydration<br />
- Physical barrier<br />
- Protection from proteolysis and pathogens<br />
- Cell surface hydration<br />
- Inhibitor of cell-cell and cell-ECM interactions</p>
<p>Functions in cancer [1, 8, 11, 13, 14, 15]:<br />
- Overexpression and aberrant glycosylation<br />
- Cell proliferation and survival<br />
- Metastasis and invasion<br />
- EMT (epithelial-mesenchymal transition)<br />
- Anti-apoptosis<br />
- Regulates signaling pathways (ERK, NF-Œ∫B, Wnt/Œ≤-catenin, PI3K-AKT, MAPK)</p>
<p>Cellular localization [10, 37, 39]:<br />
- Apical surface in normal polarized epithelial cells<br />
- Aberrant distribution in cancer cells</p>
<ul>
<li>Nuclear, cytoplasmic, mitochondrial and lysosomal localization in malignant contexts</li>
<li>Trafficking through exosomes</li>
</ul>
<p>Signaling pathways [1, 8, 13, 14, 15, 36, 37, 40]:<br />
- Receptor tyrosine kinase interactions (EGFR, HER2, FGFR3, IGF1R, MET, PDGFR)<br />
- Wnt/Œ≤-catenin signaling<br />
- NF-Œ∫B pathway<br />
- PI3K-AKT pathway<br />
- MAPK/ERK pathway<br />
- TLR signaling with anti-inflammatory effects<br />
- p53 pathway regulation</p>
<p>Post-translational modifications [19, 22, 46]:<br />
- O-glycosylation as the predominant modification<br />
- N-glycosylation<br />
- Phosphorylation on cytoplasmic tail tyrosines<br />
- Ubiquitination<br />
- Palmitoylation</p>
<p>Metabolism and shedding [3, 9, 20, 23]:<br />
- Surface delivery with median transit time of 142 minutes in mouse models<br />
- Endocytosis and recycling mechanisms<br />
- Proteolytic cleavage by TACE/ADAM17 and MT1-MMP<br />
- Œ≥-secretase processing<br />
- 12-16 hour half-life</p>
<p>Key interactions and pathways [1, 11, 13, 14]:<br />
- Œ≤-catenin, Grb2, and ErbB family engagement<br />
- p53 and NF-Œ∫B p65 signaling<br />
- GSK-3Œ≤ and Src family kinase involvement</p>
<p>Clinical significance [27, 28, 31, 43, 48, 49, 50]:<br />
- Elevated expression across multiple cancer types including lung, breast, pancreatic, gastric, and ovarian malignancies<br />
- Altered glycosylation patterns in disease states<br />
- Prognostic and therapeutic relevance<br />
- H. pylori-associated expression changes in gastric tissue<br />
- Mutations linked to medullary cystic kidney disease<br />
- Role as an endometrial receptivity indicator</p>
<p>The pathway involves multiple signaling nodes and regulatory mechanisms that control cellular adhesion and proliferation. Aberrant expression and modification patterns correlate with malignant transformation and disease progression across diverse tissue contexts.</p>
<p>For comprehensive coverage, the analysis should span molecular architecture through clinical translation. Beginning with structural organization and biosynthetic pathways, then examining physiological roles in epithelial homeostasis, immune regulation, and cancer biology. Signaling mechanisms, post-translational modifications, disease-associated mutations, and current biomarker applications complete the framework for understanding this multifunctional protein's impact on human health.<br />
</think></p>
<h1 id="comprehensive-functional-annotation-of-muc1-mucin-1-cell-surface-associated-structure-function-and-signaling-in-normal-and-malignant-contexts">Comprehensive Functional Annotation of MUC1 (Mucin 1, Cell Surface Associated): Structure, Function, and Signaling in Normal and Malignant Contexts</h1>
<p>The transmembrane glycoprotein MUC1 (mucin 1, cell surface associated) represents a multifunctional molecular entity that undergoes dramatic functional reprogramming during the transition from normal epithelial homeostasis to malignant transformation. In healthy epithelial tissues, MUC1 functions as a protective barrier contributing to lubrication, hydration, and defense against pathogenic invasion through its extended extracellular domain and regulative effects on cellular adhesion.[1][3] However, following neoplastic transformation, MUC1 undergoes aberrant glycosylation and cellular mislocalization while serving as a potent oncogenic driver that promotes cancer cell proliferation, invasion, metastasis, and evasion of apoptotic mechanisms through its participation in complex intracellular signaling networks.[1][11][13] This report provides a comprehensive analysis of MUC1's structural organization, biochemical functions, cellular localization patterns, involvement in signaling cascades, post-translational modification patterns, and its transition from a protective epithelial component to a cancer-promoting oncogene.</p>
<h2 id="molecular-architecture-and-structural-organization">Molecular Architecture and Structural Organization</h2>
<p>MUC1 is a large, type I transmembrane glycoprotein that undergoes constitutive proteolytic processing to generate a functionally significant heterodimeric complex.[1][2] The full-length MUC1 protein, designated MUC1F, initially exists as a single polypeptide chain that is rapidly processed during and shortly after synthesis in the endoplasmic reticulum.[9] The primary transcript encodes three distinct structural domains: an extracellular domain, a hydrophobic transmembrane domain, and a cytoplasmic tail domain of 72 amino acids.[1][3] The extracellular domain contains the characteristic variable number of tandem repeats (VNTR) region, which in humans consists of 20 to 125 copies of a 20-amino acid sequence (GSTAPPAHGVTSAPDTRPAP) that is particularly rich in serine, threonine, and proline residues.[6][24] These serine and threonine residues serve as primary sites for extensive O-linked glycosylation, resulting in a heavily glycosylated extracellular polypeptide that can double the protein's molecular mass.[1][46] The tandem repeat domain is followed by the sperm protein-enterokinase-agrin (SEA) domain, a 120-amino acid structure that possesses a highly conserved GSVVV motif responsible for autoproteolytic self-cleavage.[6][9] This autoproteolytic cleavage occurs spontaneously during protein folding in the endoplasmic reticulum, between the conserved glycine and serine residues within the SEA module, generating two molecular species: the longer N-terminal subunit (MUC1-N) and the shorter C-terminal subunit (MUC1-C).[9][38] These two subunits, despite their proteolytic separation, remain physically associated through stable non-covalent hydrogen bonding, forming a metabolic complex that persists during transit through the Golgi apparatus and delivery to the cell surface.[3][9]</p>
<p>The structural arrangement of full-length MUC1 creates a distinctive architecture that extends prominently above the cell surface. The heavily glycosylated tandem repeat domain, combined with its rigid extended structure imparted by proline residues and glycosylation, projects 200 to 500 nanometers above the apical cell surface, a distance substantially greater than most other cell-surface proteins including syndecans and integrins.[1][3][7] This remarkable extension positions MUC1 ideally for its barrier and adhesion-modulating functions, allowing it to tower above the cellular glycocalyx and create a protective mucous layer. The transmembrane domain consists of a single hydrophobic alpha-helix that anchors the protein within the lipid bilayer.[2][4] The cytoplasmic tail domain, occupying the carboxy terminus, is remarkably conserved across mammalian species and contains seven highly conserved tyrosine residues interspersed with serine and threonine phosphorylation sites.[1][8][11] These tyrosines and serine/threonine residues serve as primary targets for phosphorylation by various protein tyrosine kinases and serine/threonine kinases, enabling the cytoplasmic tail to function as a signaling nexus that recruits and coordinates interactions with numerous intracellular proteins including Œ≤-catenin, Grb2, ErbB receptor family members, Src family kinases, and glycogen synthase kinase 3Œ≤.[2][11][14]</p>
<p>Alternative splicing of the MUC1 gene generates multiple transcript variants and protein isoforms that differ in their extracellular domain composition.[51] The best-characterized isoforms include MUC1/TR (full-length with the complete tandem repeat domain), MUC1/Z, MUC1/Y, and MUC1/X, the latter three lacking all or portions of the tandem repeat region.[51][54] These shorter isoforms containing truncated extracellular domains have been detected in various tumor cell lines and may contribute to heterogeneity in MUC1-dependent processes within malignant tissues. The functional significance of individual isoforms remains incompletely characterized, though some evidence suggests that certain short isoforms may have tumor-suppressive properties.[51]</p>
<h2 id="biosynthesis-proteolytic-processing-and-membrane-trafficking">Biosynthesis, Proteolytic Processing, and Membrane Trafficking</h2>
<p>MUC1 undergoes a complex biosynthetic pathway involving multiple proteolytic processing steps and extensive post-translational modifications that culminate in its localization to specific cellular compartments.[3][9][39] Shortly after synthesis in the rough endoplasmic reticulum, MUC1F is rapidly directed through the secretory pathway, acquiring its initial post-translational modifications including N-linked glycosylation near the membrane-proximal region of the extracellular domain and beginning of O-linked glycosylation of the tandem repeats.[1][46] The protein transit through the endoplasmic reticulum to the Golgi apparatus occurs with a median time of approximately 142 minutes in mouse uterine epithelial cells.[3] During this transit, the SEA domain undergoes autoproteolytic cleavage, as described above, yet the resulting N-terminal and C-terminal subunits remain tightly associated through non-covalent interactions that are maintained through the secretory pathway.[9] This cleavage mechanism is particularly noteworthy because it represents a novel form of autoproteolysis catalyzed by conformational stress and the conserved serine hydroxyl within the GSVVV motif, involving an N-to-O-acyl rearrangement followed by hydrolytic resolution.[38][41] In the Golgi apparatus, MUC1 undergoes extensive additional O-glycosylation by multiple polypeptide N-acetyl-Œ±-galactosaminyltransferases (GalNAc-Ts), with at least 15 different human GALNT gene products potentially participating in this process depending on the cell and tissue type.[46] Recent comprehensive investigations have revealed that different GalNAc-T isoforms display distinct substrate specificities and site preferences, with two identifiable clusters of GalNAc-Ts initially catalyzing glycosylation at different threonine residues within the tandem repeat consensus sequences.[22] The O-glycosylation contributes 50 to 90 percent of the total molecular mass of MUC1 based on the number of tandem repeats and the expression levels of relevant glycosyltransferases.[43]</p>
<p>Following glycosylation and processing in the Golgi apparatus, MUC1 is directed to the cell surface through vesicular trafficking pathways that involve lipid raft-associated mechanisms.[39][42] In normal polarized epithelial cells, MUC1 is specifically targeted to and concentrated at the apical membrane, a localization pattern that is critical for its barrier function and protection of epithelial surfaces.[1][3] The membrane trafficking of MUC1 is regulated by multiple post-translational modifications beyond glycosylation, including palmitoylation, which modulates the efficiency of trafficking to the cell surface and subsequent endocytosis.[39][42] Upon arrival at the cell surface, MUC1 undergoes several potential fates that determine its final steady-state abundance and function. In normal epithelial cells, MUC1 exhibits a metabolic half-life of 12 to 16 hours, indicating that mechanisms exist for both its recycling through the Golgi apparatus and its eventual degradation through proteasomal and lysosomal pathways.[3][9] A significant portion of surface-localized MUC1 is subject to ectodomain shedding, a process whereby proteases release the large extracellular domain from the cell surface while the transmembrane and cytoplasmic domains remain membrane-associated.[3][9][20] Two major sheddases have been identified as responsible for this process under different cellular contexts: TACE (TNF-Œ± converting enzyme/ADAM17), which mediates constitutive and phorbol ester-stimulated shedding, and MT1-MMP (membrane type 1 matrix metalloproteinase), which is responsible for pervanadate-stimulated MUC1 ectodomain release.[20][23] The proteolytic cleavage occurs at the membrane-proximal region of the SEA domain or nearby regions, generating a membrane-associated C-terminal fragment containing the transmembrane and cytoplasmic domains.[9] The shed extracellular domain is released into the extracellular milieu, where it can interact with pathogens or circulating factors in a manner that contributes to immune defense and pathogen clearance.[6]</p>
<p>Following ectodomain shedding or in the absence of initial shedding, the remaining membrane-associated MUC1 containing the cytoplasmic tail undergoes further proteolytic processing by the membrane-embedded protease complex Œ≥-secretase (presenilin-dependent).[9] This Œ≥-secretase-mediated cleavage occurs at the cytosol-transmembrane boundary, generating a cytoplasmic fragment that can enter the nucleus and participate in transcriptional regulation.[9][46] However, the precise molecular mechanisms by which transmembrane domain-containing fragments reach the nucleus remain incompletely characterized, suggesting unconventional trafficking routes distinct from classical nuclear import pathways. The complete proteolytic cascade‚Äîconsisting of autoproteolytic cleavage in the SEA module, ectodomain shedding by sheddases, and Œ≥-secretase processing‚Äîrepresents a sophisticated regulatory mechanism that allows cells to dynamically control MUC1 function through selective proteolysis.</p>
<h2 id="function-of-muc1-in-normal-epithelial-tissues">Function of MUC1 in Normal Epithelial Tissues</h2>
<p>In healthy epithelial tissues, MUC1 serves critical protective and regulatory functions that maintain epithelial barrier integrity and defend against environmental challenges and pathogenic invasion.[1][3][6] The primary function of membrane-bound MUC1 in normal tissues is to act as a physical barrier that protects the apical cell membrane of epithelial cells from environmental damage, mechanical stress, pathogenic organisms, and degradative enzymes.[1][6][7] The extended structure of MUC1, projecting 200 to 500 nanometers above the cell surface, enables it to shield underlying cellular receptors and adhesion molecules from direct contact with potential pathogenic ligands and harmful environmental factors. MUC1 accomplishes this protective function through multiple interconnected mechanisms that operate in concert to maintain mucosal surface integrity.</p>
<p>The lubrication and hydration functions of MUC1 are particularly significant in mucosal tissues where surface wetness and frictionless movement are essential for normal physiological function.[1][3][6][21] The extensive O-glycosylation of MUC1, particularly through the accumulation of dense glycan structures, creates a highly hydrophilic surface layer that attracts and retains water molecules at the epithelial surface.[1][21] Recent tribological studies investigating MUC1's role in oral lubrication have demonstrated that MUC1 directly contributes to reducing friction forces during epithelial surface movement, with friction coefficient and energy dissipated both decreasing significantly in the presence of MUC1 compared to MUC1-deficient epithelial models.[21] These studies reveal that the absence of MUC1 expression results in increased frictional forces and enhanced tissue damage compared to epithelial tissues expressing normal MUC1 levels, highlighting the quantifiable protective benefit of this protein for preventing mechanical wear and trauma to mucosal surfaces.[21] Furthermore, MUC1 facilitates the anchoring of other salivary mucins, particularly the gel-forming mucin MUC5B, thereby modulating the composition and structure of the protective mucous pellicle that coats epithelial surfaces.[21]</p>
<p>In the normal oral mucosal epithelium, MUC1 functions in concert with other mucins (MUC5B and MUC7) to exert antimicrobial effects by continuously lubricating and stabilizing mucus on the cell surface while conferring protection against proteolysis and preventing dehydration.[1][41] This collaborative barrier function with other mucins extends to other mucosal surfaces including the respiratory, gastrointestinal, and reproductive tracts, where MUC1 constitutes a critical component of the first line of defense against microbial and parasitic pathogens.[1][3] The physical barrier function operates through what is termed "steric hindrance," whereby the towering glycosylated structure of MUC1 physically obstructs access by pathogens to underlying cellular receptors and adhesion molecules.[6][31] In the specific case of Helicobacter pylori infection, for example, MUC1 has been demonstrated to limit bacterial colonization through two complementary mechanisms: first, through steric hindrance that prevents bacterial attachment even to pathogens lacking specific MUC1 adhesins, and second, through acting as a "releasable decoy" for pathogens that do bind to MUC1, whereby the ectodomain is shed from the cell surface while bound to bacteria, physically removing the pathogen from the epithelial surface.[31][34] In an in vivo murine model of H. pylori infection, MUC1 expression limited the gastrointestinal and systemic spread of bacteria and significantly reduced intestinal inflammation compared to MUC1-deficient animals.[31]</p>
<p>Beyond its protective barrier functions, MUC1 in normal epithelial tissues plays a critical role in regulating cell-cell and cell-extracellular matrix interactions through its adhesion-modulating properties.[3][6][7] The extended structure and dense glycosylation of the tandem repeat domain, combined with the elevated expression and concentration of MUC1 at the apical surface in most simple epithelia, collectively function to modulate adhesive interactions by steric hindrance.[1][7] This anti-adhesive function of MUC1 is particularly important in reproductive tissue epithelia during critical periods such as the window of implantation, where precise regulation of epithelial-blastocyst interactions is essential for successful pregnancy.[3][7] The expression of MUC1 in normal epithelia can be dynamic, varying in response to hormonal influences, particularly steroid hormones and cytokine signals that regulate transcription of the MUC1 gene.[3] This dynamic regulation enables MUC1 expression to be modulated in response to physiological demands and environmental signals, allowing tissues to adjust their defensive capabilities in response to changing conditions. Recent research has also identified a role for MUC1 as an important scaffold for pluripotent stem cell propagation, with a transmembrane cleavage product (MUC1*) capable of helping to propagate large numbers of pluripotent stem cells for therapeutic interventions.[1]</p>
<h2 id="regulation-of-inflammation-and-innate-immune-responses">Regulation of Inflammation and Innate Immune Responses</h2>
<p>Beyond its direct physical barrier functions, MUC1 plays a sophisticated regulatory role in controlling inflammatory responses to infection and maintaining mucosal immune homeostasis through interactions with pattern recognition receptors and modulation of innate immune signaling.[1][6][24][33][36] MUC1 functions as a negative regulator of multiple Toll-like receptor (TLR) signaling pathways that would otherwise be activated by pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs).[36][33] Comprehensive studies have demonstrated that MUC1 suppresses TLR2, TLR3, TLR4, TLR5, TLR7, and TLR9 signaling, indicating a broad anti-inflammatory capacity of this molecule.[36] The cytoplasmic tail domain of MUC1 interacts constitutively with TLR3, and upon stimulation with the double-stranded RNA analog poly(I:C), MUC1 prevents the recruitment of the TIR-domain-containing adapter-inducing interferon-Œ≤ (TRIF) to the TLR3 signaling complex, thereby attenuating the activation of interferon regulatory factor-3 (IRF-3), NF-Œ∫B, and the production of interferon-Œ≤.[33] This counter-regulatory effect of MUC1 on TLR3 signaling results in decreased poly(I:C)-induced apoptosis and reduced inflammatory activation of epithelial cells. Similarly, MUC1 suppresses TLR5 signaling by interacting with TLR5 and competitively inhibiting the recruitment of the MyD88 adaptor protein to the TLR5 cytoplasmic domain.[36] The mechanism underlying the broad suppressive effect of MUC1 on diverse TLR pathways likely involves the MUC1 cytoplasmic tail's interactions with signaling molecules such as PI3K, Shc, Src family kinases, Œ≤-catenin, GSK-3Œ≤, and Grb-2/Sos that participate in the convergent NF-Œ∫B activation pathway common to all TLRs.[36]</p>
<p>Importantly, MUC1 can also play a pro-inflammatory role in certain contexts, particularly in the setting of established cancer or chronic infection.[1][24] MUC1 has been shown to act as an immunomodulatory switch that can exhibit either pro- or anti-inflammatory functions depending on the specific cellular and tissue context.[1][24] In infection-induced cancers and chronic inflammatory settings, the tumor form of MUC1 can establish specific interactions with dendritic cells and macrophages by controlling the recruitment of inflammatory cells, thereby promoting tumor escape from the immune system and creating a pro-inflammatory microenvironment that paradoxically facilitates cancer progression.[1][24] Additionally, altered MUC1 glycosylation in cancer cells promotes chronic inflammatory conditions that lead to malignant transformation and further cancer progression.[1][24] The ability of MUC1 to potentiate epithelial-mesenchymal transition (EMT) through activation of the inflammatory NF-Œ∫B p65 pathway, which then activates the EMT transcriptional repressor zinc-finger E-box-binding homeobox 1 (ZEB1), exemplifies how pro-inflammatory MUC1 signaling can contribute to cancer invasiveness and metastatic potential.[1] Thus, MUC1 functions as a dynamic regulator of inflammation whose activity is context-dependent and whose pathological activation in cancer contributes to disease progression.</p>
<h2 id="muc1-as-an-oncogenic-driver-structure-function-relationships-in-cancer">MUC1 as an Oncogenic Driver: Structure-Function Relationships in Cancer</h2>
<p>Following malignant transformation, MUC1 undergoes dramatic alterations in its expression patterns, cellular localization, and glycosylation characteristics that convert it from a protective epithelial component into a potent oncogenic driver promoting cancer cell proliferation, survival, invasion, metastasis, and evasion of death signals.[1][10][35] Multiple aspects of MUC1 structure contribute independently to its oncogenic function, with both the extracellular tandem repeat domain and the cytoplasmic tail domain being essential for MUC1-driven tumor formation.[11] This has been demonstrated conclusively through mouse models of mammary carcinogenesis showing that deletion of either the tandem repeat domain or the cytoplasmic tail domain independently abrogates MUC1's ability to drive early-onset tumor formation in transgenic animals.[11] These findings indicate that the adhesion-modulating functions of the extracellular domain and the cellular signaling functions of the cytoplasmic tail domain both contribute substantially to MUC1-mediated oncogenesis, and that neither domain is sufficient alone to promote tumorigenesis.</p>
<p>In cancer cells, MUC1 expression increases substantially while undergoing aberrant glycosylation that exposes the underlying peptide core and generates new carbohydrate epitopes, particularly the Thomsen-Friedenreich (TF or T), Tn, and sialyl-Tn (STn) antigens.[1][10][35] This aberrant glycosylation pattern reflects altered expression and activity of glycosyltransferases in cancer cells compared to normal epithelial cells, resulting in the generation of shorter, simpler glycan structures that expose previously hidden immunogenic epitopes on the MUC1 peptide backbone.[1][22][35] This glycosylation abnormality has attracted substantial clinical interest because these altered glycan epitopes can serve as tumor-associated antigens for development of cancer vaccines and immunotherapeutic approaches.[1][22]</p>
<p>Loss of epithelial polarity during malignant transformation leads to dramatic changes in MUC1 subcellular localization, with cancer cells exhibiting cytoplasmic and basally localized MUC1 in addition to or instead of the normal apical membrane localization.[10][32][35] This altered localization pattern is highly significant because it allows the MUC1 cytoplasmic tail to interact more promiscuously with intracellular signaling molecules and permits increased crosstalk between MUC1 and membrane receptor tyrosine kinases that normally reside exclusively at basolateral membrane domains in polarized epithelial cells.[14][32][35] The altered localization and increased availability of MUC1 to interact with signaling proteins constitutes a critical aspect of its oncogenic function, enabling enhanced activation of multiple downstream signaling pathways that promote cancer cell growth and survival.</p>
<h2 id="intracellular-signaling-pathways-activated-by-muc1">Intracellular Signaling Pathways Activated by MUC1</h2>
<p>The MUC1 cytoplasmic tail serves as a critical signaling hub that participates in and coordinates multiple interconnected cellular signaling pathways central to cancer cell biology.[13] These pathways include the Wnt/Œ≤-catenin pathway, NF-Œ∫B signaling, PI3K-AKT signaling, and MAPK/ERK signaling, with MUC1 acting to either promote or suppress activation of these pathways depending on the cellular context.[1][13][14] The MUC1 cytoplasmic tail contains multiple protein-binding motifs that facilitate interactions with dozens of signaling proteins, including receptor tyrosine kinases, adaptor proteins, and transcription factors.[2][14]</p>
<p>MUC1 functions as a direct activator of the NF-Œ∫B pathway, a critical survival signaling cascade frequently dysregulated in cancer.[40][43] The MUC1-C cytoplasmic domain binds directly to NF-Œ∫B p65 protein and, importantly, blocks the interaction between NF-Œ∫B p65 and its inhibitor IŒ∫BŒ±, thereby preventing the sequestration and degradation of p65 and promoting its nuclear translocation and transcriptional activation.[40] In carcinoma cells, MUC1-C and NF-Œ∫B p65 constitutively occupy the promoter of the anti-apoptotic Bcl-xL gene, with MUC1-C contributing to NF-Œ∫B-mediated transcriptional activation of this survival gene.[40] In non-malignant epithelial cells, MUC1-C interacts with NF-Œ∫B p65 in response to TNFŒ± stimulation, and TNFŒ± induces the recruitment of NF-Œ∫B p65-MUC1-C complexes to NF-Œ∫B target genes, including the MUC1 gene promoter itself, creating a positive feedback loop that amplifies MUC1 expression in response to inflammatory signals.[40] Importantly, synthetic peptide inhibitors of MUC1-C oligomerization can block the interaction between MUC1-C and NF-Œ∫B p65, decrease promoter occupancy, and suppress NF-Œ∫B-mediated gene transcription, demonstrating the potential for targeted inhibition of this pathway in therapeutic contexts.[40]</p>
<p>MUC1 also participates critically in the Wnt/Œ≤-catenin signaling pathway, one of the most frequently dysregulated pathways in human cancer.[1][11][13] The MUC1 cytoplasmic tail binds directly to Œ≤-catenin and facilitates its nuclear translocation in association with transcription factor TCF4, enabling activation of Wnt target genes that promote cell proliferation and survival.[1][11] In pancreatic cancer cells, MUC1 has been shown to enhance invasiveness through a mechanism dependent on the interaction between MUC1 and Œ≤-catenin, with this interaction leading to nuclear translocation of Œ≤-catenin and activation of EMT-promoting transcription factors including Snail and Slug.[45] The functional tyrosine residues in the MUC1 cytoplasmic tail are critical for stimulating the MUC1-Œ≤-catenin interaction and their nuclear translocation; mutation of all seven tyrosines to phenylalanine prevents this interaction and blocks EMT induction in response to MUC1 overexpression.[45] These findings directly establish the tyrosines of the MUC1 cytoplasmic tail as critical functional elements required for MUC1-mediated promotion of epithelial-mesenchymal transition.</p>
<p>MUC1 participates in regulation of the receptor tyrosine kinase (RTK) signaling pathways, particularly the EGFR and ErbB2 pathways, which drive proliferation and survival in numerous epithelial malignancies.[1][13][14] MUC1 can physically interact with EGFR, HER2 (ErbB2), FGFR3, IGF1R, MET, and PDGFRŒ≤, and it serves as a substrate for phosphorylation by these kinases on its cytoplasmic tail tyrosine residues.[1][13][15] Activation of MUC1 through receptor cross-talk with EGFR and other receptor tyrosine kinases triggers downstream signaling through AKT1, MAPK1/2, and Œ≤-catenin, promoting cancer cell proliferation, growth, angiogenesis, invasion and migration in multiple cancer types including non-small cell lung cancer, ovarian cancer, breast cancer, and endometrial cancer.[13] Notably, MUC1 expression inhibits the degradation of ligand-activated ErbB1 following growth factor stimulation, thereby increasing the cellular pools of active receptor over time and prolonging mitogenic signaling.[15] This MUC1-mediated protection against ErbB1 degradation occurs through inhibition of EGF-stimulated ubiquitination of the receptor and through promotion of receptor recycling rather than degradation, demonstrating a specific mechanism by which MUC1 can enhance RTK signaling intensity and duration in cancer cells.[15]</p>
<p>MUC1 regulates the MAPK pathway through multiple mechanisms involving phosphorylation-dependent interactions with signaling proteins.[8][13] In cells lacking the seven tyrosine residues of the MUC1 cytoplasmic tail (MUC1 Y0 mutant), heightened active ERK1/2 is observed with increased transcriptional activity of AP-1 and STAT3 compared to wild-type MUC1-expressing cells, while NF-Œ∫B transcriptional activity is paradoxically decreased.[8] These findings suggest that the phosphorylation status of MUC1 cytoplasmic tail tyrosines dynamically modulates the balance between different transcriptional programs, with consequences for cell proliferation, invasiveness, and cell cycle progression.[8]</p>
<p>MUC1 interacts with PI3K and influences the PI3K-AKT signaling pathway, though in some cellular contexts MUC1 has been shown to suppress PI3K-AKT signaling.[13][29] This suppression of the inhibitory PI3K-Akt pathway is associated with activation of AMPK and promotion of autophagy in the response to glucose deprivation, enabling cancer cells to maintain ATP production and survival under nutrient-limited conditions.[29] The ability of MUC1 to promote autophagy as a survival response to metabolic stress demonstrates how MUC1 can facilitate cancer cell adaptation to the harsh microenvironmental conditions within tumors, where nutrient availability is often limited.[29]</p>
<p>MUC1 localizes to subcellular compartments beyond the plasma membrane, including mitochondria and lysosomes, where it participates in cellular stress responses.[13][46] Following activation by ErbB receptors in the presence of the heregulin (HRG) ligand, activated MUC1 binds to heat shock proteins (HSP90 and HSP70) and translocates to mitochondria and lysosomes, respectively.[13] This unconventional localization of MUC1 to organelles involved in energy metabolism and autophagic degradation suggests that MUC1 may directly regulate mitochondrial function and lysosomal autophagy, both processes that are frequently dysregulated in cancer cells and that contribute to metabolic adaptation and therapy resistance.</p>
<h2 id="nuclear-functions-and-transcriptional-regulation">Nuclear Functions and Transcriptional Regulation</h2>
<p>A particularly important and extensively studied function of MUC1 involves its translocation to the nucleus where its cytoplasmic tail interacts with multiple transcription factors to directly modulate gene expression and cellular fate decisions.[14][37][40] MUC1 contains a non-classical nuclear localization signal (RLS/RRK motif) that interacts with nucleoporin-62 and importin-Œ≤1, enabling nuclear co-translocation of numerous associated proteins including Œ≤-catenin, Œ≥-catenin, p53, estrogen receptor Œ±, and NF-Œ∫B p65.[14][37] In the nucleus, MUC1-C forms physical complexes with multiple transcription factors that subsequently occupy response elements in the promoters of target genes and directly modulate their transcriptional activity.[14] The N-terminal MUC1 subunit can also accumulate in nuclear compartments under certain conditions, though the mechanisms and functional significance of nuclear MUC1-N remain less thoroughly characterized than those of the MUC1-C cytoplasmic tail.[46]</p>
<p>MUC1 plays a critical role in regulating p53-mediated gene transcription and the cellular response to genotoxic stress.[14][47] The MUC1-C cytoplasmic domain interacts constitutively with the p53 tumor suppressor protein, with this interaction being increased in response to genotoxic stress.[14] The MUC1-C cytoplasmic domain (amino acids 9-46) binds directly to the p53 regulatory domain (amino acids 363-393), and both MUC1-C and p53 occupy the promoter of the p53-responsive p21 gene in carcinoma cells.[14] MUC1-C occupancy of the p21 promoter is associated with recruitment of the CBP histone acetyltransferase, a decrease in HDAC1 histone deacetylase, and an increase in histone H4 acetylation, indicating that MUC1 modulates the chromatin architecture at p53-responsive promoters.[14] MUC1 has also been shown to repress the activation of p53 gene transcription and to block the binding of MUC1 and p53 to the PE21 promoter element, thereby repressing p53 activity in response to stress, which would normally promote apoptosis or cell cycle arrest in normal cells.[14][17] This repression of p53 function by MUC1 represents a critical mechanism by which MUC1 promotes cancer cell survival by disabling this central tumor suppressor pathway. However, in the specific case where the MUC1 cytoplasmic tail tyrosine at position 60 is mutated to phenylalanine (MUC1 Y60F), this mutant becomes a potent inducer of the ARF tumor suppressor, which in turn inhibits MDM2 and leads to p53 upregulation, demonstrating that the functional status of specific tyrosine residues in the MUC1 cytoplasmic tail profoundly influences whether MUC1 acts as a p53 inhibitor or a p53 activator.[47]</p>
<p>MUC1 also functions as a direct regulator of EGFR nuclear localization and transcriptional function in breast cancer cells.[37] MUC1 and EGFR interact in the nucleus and MUC1 promotes the accumulation of chromatin-bound EGFR at the cyclin D1 gene promoter, a critical cell cycle promoter gene essential for G1 to S phase transition.[37] This MUC1-mediated promotion of EGFR nuclear translocation and association with the cyclin D1 promoter provides a direct molecular link between MUC1 expression and accelerated cell cycle progression in response to growth factor signaling, independent of classical mitogenic signaling at the cell surface.</p>
<h2 id="post-translational-modifications-and-their-regulatory-functions">Post-Translational Modifications and Their Regulatory Functions</h2>
<p>MUC1 is subject to extensive and complex post-translational modifications that profoundly influence its function, localization, protein-protein interactions, and signaling capacity.[19][22][46] The most characteristic post-translational modification of MUC1 is O-linked glycosylation of the tandem repeat domain, which accounts for 50 to 90 percent of the total molecular mass of the protein depending on the number of tandem repeats and the expression of relevant glycosyltransferases.[43][46] O-linked glycosylation is initiated by members of the polypeptide N-acetylgalactosaminyltransferase (GALNT) family, with at least 15 different GALNT genes in the human genome potentially participating in MUC1 glycosylation depending on cell type and tissue context.[46] Comprehensive structural and biochemical investigations have revealed that individual GalNAc-T isoforms display distinct substrate site specificities, with two identifiable clusters of GalNAc-Ts initially catalyzing glycosylation at different threonine residues within the consensus sequences GSTA and GVTS within the MUC1 tandem repeats.[22] These initial glycosylation events are then followed by extension of the O-linked oligosaccharides through the sequential action of additional glycosyltransferases that add galactose, N-acetylgalactosamine (GalNAc), fucose, and sialic acid residues, with sialylation being particularly extensive on MUC1 glycans.[22][46] The specific pattern of O-glycosylation depends on the complement and expression levels of glycosyltransferases present in specific cell types and tissues, enabling tissue and cell-type specific glycosylation patterns of MUC1.[22][46]</p>
<p>The pattern of MUC1 glycosylation profoundly influences multiple aspects of MUC1 function, including its ability to interact with cellular receptors, immune cells, and pathogens, as well as its localization within the cell and its susceptibility to protease cleavage.[46][43] O-glycosylation can stabilize MUC1 at the cell surface by limiting endocytosis and by protecting the polypeptide chain from degradation by extracellular proteases.[46] Conversely, altered glycosylation patterns associated with malignant transformation create abnormal MUC1 epitopes that are recognized by anti-MUC1 antibodies and that may serve as tumor-associated antigens for immune recognition. Remarkably, the O-glycosylation of MUC1 has been shown to be responsible for MUC1-induced drug resistance in breast cancer cells, with the extracellular glycosylated modification of the MUC1-N subunit acting as a barrier that reduces intracellular drug penetration.[43] Removal of O-glycosylation through pharmacological inhibitors, enzymatic digestion, or genetic deletion of MUC1-related O-glycosyltransferases (GCNT3) markedly reinvigorates chemosensitivity in cancer cells, revealing a therapeutically actionable mechanism through which the glycosylation status of MUC1 directly influences cancer cell drug sensitivity.[43]</p>
<p>Beyond O-glycosylation, the MUC1 cytoplasmic tail undergoes phosphorylation on its seven tyrosine residues and multiple serine and threonine residues, modifications that critically regulate its interactions with signaling proteins and transcription factors.[8][46] Phosphorylation of MUC1 by various protein tyrosine kinases including MET and SRC enables specific interactions with signaling proteins such as p53 and HSP90, thereby directly modulating MUC1's ability to participate in particular signaling cascades.[46] The MUC1 cytoplasmic tail also undergoes ubiquitination, a modification that can target MUC1 for proteasomal degradation or can alter its signaling properties, though the specific ubiquitination sites and the functional consequences of this modification remain incompletely characterized for MUC1.[46] Additionally, the MUC1 cytoplasmic tail undergoes palmitoylation, a lipid modification that influences its association with membrane lipid rafts and affects its trafficking properties and endocytosis rates.[39][42]</p>
<h2 id="pathogenic-mutations-and-associated-genetic-diseases">Pathogenic Mutations and Associated Genetic Diseases</h2>
<p>While MUC1 is primarily known for its roles in epithelial homeostasis and cancer biology, inherited mutations in the MUC1 gene can cause medullary cystic kidney disease type 1 (MCKD1), an autosomal dominant inherited condition characterized by progressive kidney fibrosis and renal cyst formation leading to chronic kidney failure.[49] MCKD1 is caused by insertion of a cytosine nucleotide into the MUC1 gene in a specific region, resulting in production of an altered MUC1 protein.[49] The precise mechanism by which these MUC1 mutations cause kidney disease remains incompletely understood, though it is theorized that MUC1 plays an important role in normal kidney development and maintenance of tubular epithelial cell function through its signaling capabilities and its role in regulating cell growth, movement, and survival.[49] The fact that relatively specific mutations in MUC1 cause progressive organ failure demonstrates the biological importance of normal MUC1 function in maintaining long-term epithelial tissue homeostasis and preventing pathological remodeling and fibrosis.</p>
<p>Additionally, MUC1 VNTR (variable number tandem repeat) polymorphisms, which result from variations in the number of tandem repeat copies in the MUC1 gene, have been associated with susceptibility to gastric cancer and Helicobacter pylori-associated gastritis in population-based genetic studies.[28][31] Individuals carrying shorter MUC1 VNTR alleles that encode MUC1 proteins with shorter extracellular glycosylated domains are associated with increased disease susceptibility.[31] This association is mechanistically explained by the observation that shorter MUC1 VNTR variants are less efficient at sterically inhibiting bacterial attachment or acting as releasable decoys for H. pylori, thereby allowing increased bacterial binding to the epithelial surface and exacerbation of pathology.[28][31]</p>
<h2 id="clinical-applications-and-biomarker-significance">Clinical Applications and Biomarker Significance</h2>
<p>MUC1 has emerged as a significant clinical biomarker and therapeutic target due to its frequent overexpression and aberrant glycosylation in multiple human cancers.[1][27][48] MUC1 is commonly overexpressed in numerous epithelial adenocarcinomas including lung adenocarcinoma (where 86.3% of stage IB patients show high MUC1 expression), breast cancer, pancreatic cancer, gastric cancer, ovarian cancer, colorectal cancer, and cholangiocarcinoma.[1][27][48] In many of these malignancies, MUC1 expression levels correlate with aggressive clinicopathological features including advanced tumor stage, lymph node metastasis, poor differentiation, and reduced patient survival time.[27][48] For example, in pancreatic cancer patients, median survival time is significantly lower in those with high MUC1 expression (13.4 months) compared to those with low expression (39.7 months), indicating that MUC1 expression is a strong adverse prognostic factor in this uniformly lethal malignancy.[27] Similarly, in gallbladder adenocarcinoma, high MUC1 expression is significantly associated with advanced tumor stage, lymph node metastasis, and reduced overall survival, suggesting utility as a diagnostic and prognostic biomarker.[27]</p>
<p>The subcellular localization pattern of MUC1 has been shown to have prognostic significance that is independent of overall MUC1 expression levels.[10][32] Breast cancer patients whose tumors display apical MUC1 localization patterns (similar to that seen in normal epithelial cells) have significantly better outcomes compared to those with cytoplasmic or negative MUC1 patterns, with apical MUC1 localization being associated with lower recurrence scores and reduced tumor malignancy.[10][32] This observation suggests that preservation of normal epithelial polarity and proper MUC1 localization is associated with less aggressive tumor behavior, presumably because it indicates retention of more differentiated epithelial characteristics and reduced engagement of MUC1's oncogenic signaling functions that require aberrant cytoplasmic localization.[10][32]</p>
<p>The soluble form of MUC1, generated through ectodomain shedding and commonly referred to as CA15-3 (cancer antigen 15-3), has been established as a circulating biomarker with clinical utility in breast cancer and other malignancies.[1][57] Elevated serum CA15-3 levels are associated with shorter disease-free survival and overall survival time in breast cancer patients, and serial measurements of serum CA15-3 can be used to monitor treatment response and detect cancer recurrence.[57] MUC1 in endometrial tissue has also been identified as an independent marker of endometrial receptivity in the context of recurrent implantation failure, with decreased MUC1 expression in endometrial epithelium being associated with reproductive failure, suggesting that MUC1 may contribute to the reproductive failure observed in women with recurrent implantation failure.[50]</p>
<h2 id="therapeutic-targeting-and-immunotherapy">Therapeutic Targeting and Immunotherapy</h2>
<p>The importance of MUC1 in cancer biology and its frequent overexpression and aberrant glycosylation in malignancies has motivated the development of multiple therapeutic strategies targeting MUC1.[1][18] These approaches include development of MUC1-specific monoclonal antibodies, MUC1-targeted chimeric antigen receptor (CAR) engineered T-cell therapies, MUC1 vaccines targeting aberrant MUC1 glycoforms, and small molecule inhibitors of MUC1 function.[1][18] CAR T-cell therapy employing dual-targeted engineered T-cells expressing both anti-ErbB2 and anti-MUC1 CARs has been developed to achieve complementary signaling within the tumor microenvironment, enabling selective activation of T-cells only when they encounter tumor cells expressing both ErbB2 and MUC1 simultaneously.[18] This approach has demonstrated proof of principle that dual targeting of MUC1 with other cancer-associated antigens can achieve enhanced specificity and potentially reduced off-target toxicity compared to single-antigen targeting approaches.[18] The development of MUC1-specific antibodies that recognize MUC1 with specific aberrant glycosylation patterns has enabled discrimination between tumor-associated and normal MUC1 forms, providing tools for both diagnostic and therapeutic applications.[56]</p>
<h2 id="conclusion">Conclusion</h2>
<p>MUC1 represents a multifunctional glycoprotein whose biological roles are dramatically transformed during malignant progression. In normal epithelial tissues, MUC1 serves essential protective functions as a physical barrier, lubricant, and immune modulator that maintains tissue homeostasis, defends against pathogenic invasion, and prevents excessive inflammation through negative regulation of Toll-like receptor signaling. The extended extracellular structure of MUC1, maintained at 200 to 500 nanometers above the cell surface through its VNTR and SEA domains, positions it ideally for barrier functions, while its conserved cytoplasmic tail enables anti-inflammatory signaling through interactions with TLRs and related pathways. In cancer cells, through loss of epithelial polarity, aberrant glycosylation, and increased expression, MUC1 becomes a potent oncogenic driver that simultaneously promotes cancer cell proliferation and survival through interactions with receptor tyrosine kinases, suppresses apoptotic pathways through inhibition of p53 and activation of NF-Œ∫B, facilitates invasion and metastasis through promotion of epithelial-mesenchymal transition mediated by Œ≤-catenin interactions, and enables cancer cell survival under metabolic stress through promotion of autophagy. The functional importance of both the extracellular tandem repeat domain and the cytoplasmic tail domain to MUC1-driven oncogenesis, combined with MUC1's frequent overexpression and prognostic significance in multiple malignancies, establishes MUC1 as a high-priority target for cancer therapeutic development. Future therapeutic strategies will likely benefit from selective targeting of MUC1's aberrant glycoforms or interaction with specific signaling partners such as Œ≤-catenin, receptor tyrosine kinases, or transcription factors, enabling more precise inhibition of MUC1's oncogenic functions while potentially preserving its normal protective functions in healthy epithelial tissues.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8234110/</li>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC1</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC320498/</li>
<li>https://www.uniprot.org/uniprotkb/P15941/entry</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=4582</li>
<li>https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2019.00117/full</li>
<li>https://pubmed.ncbi.nlm.nih.gov/16849524/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3228317/</li>
<li>https://www.nature.com/articles/s41598-023-32579-4</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3091404/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC12297148/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3615539/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/16983337/</li>
<li>https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A6539?download=true</li>
<li>https://aacrjournals.org/cancerres/article/67/4/1853/534036/Human-Mucin-1-Oncoprotein-Represses-Transcription</li>
<li>https://pubmed.ncbi.nlm.nih.gov/22526592/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/12925576/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC1133949/</li>
<li>https://www.nature.com/articles/s41598-024-82176-2</li>
<li>https://pubs.acs.org/doi/10.1021/acscatal.4c05719</li>
<li>https://academic.oup.com/endo/article/145/9/4192/2878263/Tumor-Necrosis-Factor-Stimulates-MUC1-Synthesis</li>
<li>https://pubmed.ncbi.nlm.nih.gov/8835095/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4931332/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9716114/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2693691/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3027209/</li>
<li>https://www.proteinatlas.org/ENSG00000185499-MUC1</li>
<li>https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1000617</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4189494/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/19816567/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2258447/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2864713/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/15987679/</li>
<li>https://experiments.springernature.com/articles/10.1007/978-1-61779-513-8_7</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2760979/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/16369486/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/22259133/</li>
<li>https://www.nature.com/articles/s41419-022-05110-2</li>
<li>https://www.nature.com/articles/s41418-022-00988-z</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3063863/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3189326/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/18981727/</li>
<li>https://www.spandidos-publications.com/10.3892/mco.2022.2594</li>
<li>https://medlineplus.gov/genetics/condition/medullary-cystic-kidney-disease-type-1/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/29929546/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3538090/</li>
<li>https://rarediseases.org/mondo-disease/tubulointerstitial-kidney-disease-autosomal-dominant-2/</li>
<li>https://www.nature.com/articles/s41467-021-23571-5</li>
<li>https://www.nature.com/articles/6604617</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5326570/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/35887202/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7377060/</li>
<li>https://pubs.acs.org/doi/10.1021/jacsau.3c00587</li>
<li>https://www.nature.com/articles/s41698-025-01016-2</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity Lite</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(MUC1-deep-research-perplexity-lite.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15941" data-a="DOC: Deep Research Perplexity Lite" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-pro<br />
cached: true<br />
start_time: '2025-11-03T21:37:07.758315'<br />
end_time: '2025-11-03T21:37:07.759632'<br />
duration_seconds: 0.0<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: low<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 16</p>
<hr />
<h2 id="question">Question</h2>
<p>Research the MUC1 (P15941) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.</p>
<h2 id="output">Output</h2>
<p>The <strong>MUC1 (P15941) gene</strong> encodes the mucin-1 protein, a heavily glycosylated, membrane-bound mucin that plays critical roles in epithelial protection, cell signaling, and disease, particularly cancer and kidney disorders[1][3][5][7].</p>
<hr />
<h3 id="1-key-concepts-and-definitions">1. Key Concepts and Definitions</h3>
<ul>
<li><strong>MUC1 (Mucin-1)</strong>: A type I transmembrane glycoprotein found on the apical surface of most simple epithelial cells, including those in the lung, breast, stomach, pancreas, kidney, and reproductive tract[3][10][15].</li>
<li><strong>Protein Structure</strong>: MUC1 is synthesized as a single polypeptide and then cleaved into two subunits:</li>
<li><strong>Alpha (N-terminal) subunit</strong>: Extracellular, contains a variable number tandem repeat (VNTR) domain rich in serine, threonine, and proline, which is heavily O-glycosylated[1][5][7].</li>
<li><strong>Beta (C-terminal) subunit</strong>: Contains the transmembrane and cytoplasmic tail domains, involved in intracellular signaling[5][7].</li>
</ul>
<hr />
<h3 id="2-molecular-function">2. Molecular Function</h3>
<ul>
<li><strong>Barrier Formation</strong>: MUC1 forms a protective mucous barrier on epithelial surfaces, shielding cells from pathogens, enzymes, and physical damage[1][3][5].</li>
<li><strong>Cell Adhesion and Anti-Adhesion</strong>: The alpha subunit mediates cell adhesion, while the glycosylated extracellular domain can also inhibit cell-cell and cell-matrix interactions, affecting tissue organization and tumor metastasis[3][5][7].</li>
<li><strong>Cell Signaling</strong>: The cytoplasmic tail (MUC1-CT) transduces signals from the extracellular environment to the nucleus, influencing cell proliferation, survival, motility, and gene expression[1][5][7].</li>
<li>MUC1-CT interacts with signaling pathways such as ERK, SRC, NF-Œ∫B, and the Ras/MAPK pathway[5].</li>
<li>It modulates p53-mediated transcription, affecting cell cycle arrest and apoptosis[2][5][13].</li>
</ul>
<hr />
<h3 id="3-biological-processes">3. Biological Processes</h3>
<ul>
<li><strong>Epithelial Homeostasis</strong>: Maintains epithelial integrity, regulates cell shedding, and participates in wound repair and epithelial-mesenchymal transition (EMT)[3].</li>
<li><strong>Immune Regulation</strong>: Inhibits immune cell interactions with epithelial cells, modulating inflammatory responses and immune evasion in cancer[3][14].</li>
<li><strong>Pathogen Defense</strong>: Binds pathogens via its glycosylated extracellular domain, preventing their access to the cell surface[1][2][14].</li>
<li><strong>Kidney Development</strong>: Plays a role in nephron development and kidney function[1][5].</li>
</ul>
<hr />
<h3 id="4-cellular-localization">4. Cellular Localization</h3>
<ul>
<li><strong>Apical Membrane</strong>: Predominantly localized to the apical surface of epithelial cells in various tissues (lung, breast, stomach, pancreas, kidney, reproductive tract)[3][15].</li>
<li><strong>Nucleus and Mitochondria</strong>: The cytoplasmic tail can translocate to the nucleus (regulating gene expression) or mitochondria (inhibiting apoptosis)[1][2].</li>
<li><strong>Endocytosis and Recycling</strong>: MUC1 is internalized, re-glycosylated, and recycled to the cell membrane[3].</li>
</ul>
<hr />
<h3 id="5-protein-domains">5. Protein Domains</h3>
<ul>
<li><strong>VNTR Domain</strong>: Highly polymorphic, with 20‚Äì100 tandem repeats, each 20 amino acids long, rich in serine and threonine for O-glycosylation[1][5][7].</li>
<li><strong>SEA Domain</strong>: Involved in protein cleavage and cell signaling, contributes to immune inhibition and cell shedding[3].</li>
<li><strong>Transmembrane Domain</strong>: Anchors the protein in the cell membrane[7].</li>
<li><strong>Cytoplasmic Tail (MUC1-CT)</strong>: Contains phosphorylation sites and motifs for protein-protein interactions, critical for signal transduction[1][5][7].</li>
</ul>
<hr />
<h3 id="6-known-interactions">6. Known Interactions</h3>
<ul>
<li><strong>Protein-Protein Interactions</strong>:</li>
<li><strong>p53</strong>: MUC1-CT binds p53, modulating its transcriptional activity and influencing cell cycle arrest and apoptosis[2][5][13].</li>
<li><strong>ERBB2 (HER2)</strong>: Interacts with the receptor tyrosine kinase, affecting growth signaling[2].</li>
<li><strong>GRB2, SOS1, CTNND1, JUP</strong>: Involved in various signaling and adhesion pathways[2].</li>
<li><strong>KLF4</strong>: Co-binds to the TP53 promoter, repressing p53 activity[5].</li>
<li><strong>Bcl-2, Bcl-xL</strong>: MUC1-CT interaction prevents apoptosis by inhibiting cytochrome c release from mitochondria[2].</li>
</ul>
<hr />
<h3 id="7-disease-associations">7. Disease Associations</h3>
<ul>
<li><strong>Cancer</strong>:</li>
<li><strong>Overexpression and Aberrant Glycosylation</strong>: Common in many carcinomas (breast, ovarian, pancreatic, lung, etc.), associated with tumor progression, metastasis, immune evasion, and chemoresistance[2][3][5][6][12].</li>
<li><strong>Oncogenic Functions</strong>: Promotes tumor growth by concentrating growth factors, inhibiting apoptosis, and modulating immune responses[2][12].</li>
<li><strong>Tumor Marker</strong>: MUC1 is used as a biomarker (e.g., CA15-3 in breast cancer)[3].</li>
<li><strong>Kidney Disease</strong>:</li>
<li><strong>Tubulointerstitial Kidney Disease, Autosomal Dominant 2 (ADTKD-MUC1)</strong>: Mutations in MUC1 cause this hereditary kidney disorder, leading to progressive renal failure[5][8].</li>
<li><strong>Renal Cysts and Diabetes Syndrome</strong>: Also associated with MUC1 mutations[5].</li>
<li><strong>Other</strong>:</li>
<li><strong>Infectious Diseases</strong>: Altered MUC1 function can affect susceptibility to infections due to its role in mucosal defense[14].</li>
</ul>
<hr />
<h3 id="8-recent-developments-and-research-20232024">8. Recent Developments and Research (2023‚Äì2024)</h3>
<ul>
<li><strong>Therapeutic Targeting</strong>: MUC1, especially its C-terminal subunit (MUC1-C), is being actively investigated as a therapeutic target in cancer, with ongoing research into inhibitors and immunotherapies[9].</li>
<li><strong>Stem Cell Biology</strong>: MUC1* (a cleaved form) is expressed on human embryonic pluripotent stem cells and functions as a growth factor receptor, with implications for cancer stem cell biology[12].</li>
<li><strong>Gene Regulation</strong>: Recent studies further elucidate MUC1‚Äôs role in regulating transcription factor complexes and epigenetic reprogramming in cancer and tissue repair[3][12].</li>
</ul>
<hr />
<h3 id="9-relevant-statistics-and-data">9. Relevant Statistics and Data</h3>
<ul>
<li><strong>Expression</strong>: MUC1 is highly expressed in epithelial tissues and overexpressed in &gt;90% of breast carcinomas and many other epithelial cancers[3][6].</li>
<li><strong>Genetic Variability</strong>: The VNTR region is highly polymorphic, contributing to individual differences in MUC1 function and disease susceptibility[1][5][7].</li>
</ul>
<hr />
<h3 id="10-authoritative-sources">10. Authoritative Sources</h3>
<ul>
<li><strong>UniProt (P15941)</strong>: Comprehensive protein information, including structure, function, and interactions[7].</li>
<li><strong>GeneCards</strong>: Summarizes gene function, disease associations, and pathways[5].</li>
<li><strong>MedlinePlus Genetics</strong>: Clinical and functional overview[1].</li>
<li><strong>NCBI Gene</strong>: Genomic context and recent research[4][9].</li>
<li><strong>Recent Reviews</strong>: Frontiers in Cellular and Infection Microbiology (2019)[14], Nature Reviews Cancer (2014)[12].</li>
</ul>
<hr />
<p><strong>Key URLs and Publication Dates:</strong><br />
- UniProt: <a href="https://www.uniprot.org/uniprotkb/P15941/entry">https://www.uniprot.org/uniprotkb/P15941/entry</a> (2024)<br />
- GeneCards: <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC1">https://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC1</a> (2024)<br />
- MedlinePlus Genetics: <a href="https://medlineplus.gov/genetics/gene/muc1/">https://medlineplus.gov/genetics/gene/muc1/</a> (2024)<br />
- NCBI Gene: <a href="https://www.ncbi.nlm.nih.gov/gene/4582">https://www.ncbi.nlm.nih.gov/gene/4582</a> (2024)<br />
- Frontiers in Cellular and Infection Microbiology: <a href="https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2019.00117/full">https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2019.00117/full</a> (2019)</p>
<p>If you need more detailed information on any specific aspect (e.g., structural biology, therapeutic targeting, or specific disease mechanisms), please specify.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://medlineplus.gov/genetics/gene/muc1/</li>
<li>https://en.wikipedia.org/wiki/Mucin_short_variant_S1</li>
<li>https://en.wikipedia.org/wiki/Mucin-1</li>
<li>https://www.ncbi.nlm.nih.gov/gene/4582</li>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC1</li>
<li>https://maayanlab.cloud/Harmonizome/gene/MUC1</li>
<li>https://www.uniprot.org/uniprotkb/P15941/entry</li>
<li>https://g2p.broadinstitute.org/gene/MUC1</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=4582</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC320498/</li>
<li>https://functionome.geneontology.org/gene/UniProtKB:P15941</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5500204/</li>
<li>https://go.drugbank.com/polypeptides/P15941</li>
<li>https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2019.00117/full</li>
<li>https://v17.proteinatlas.org/ENSG00000185499-MUC1/tissue</li>
<li>https://www.uniprot.org/uniprotkb/P15941/publications</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Notes</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(MUC1-notes.md)</span>
                </div>
                <div class="vote-buttons" data-g="P15941" data-a="DOC: Notes" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <h1 id="muc1-gene-review-notes">MUC1 Gene Review Notes</h1>
<h2 id="gene-information">Gene Information</h2>
<ul>
<li><strong>Gene</strong>: MUC1 (Mucin 1, Cell Surface Associated)</li>
<li><strong>UniProt ID</strong>: P15941</li>
<li><strong>HGNC Symbol</strong>: MUC1</li>
<li><strong>Taxon</strong>: Homo sapiens (NCBITaxon:9606)</li>
<li><strong>Chromosome</strong>: 1q22</li>
<li><strong>Protein Length</strong>: 1255 aa (full-length isoform 1)</li>
</ul>
<h2 id="comparison-of-deep-research-reports">Comparison of Deep Research Reports</h2>
<h3 id="perplexity-report-54-citations">Perplexity Report (54 citations)</h3>
<ul>
<li>Very detailed, well-structured with inline citations</li>
<li>Comprehensive coverage of molecular architecture, biosynthesis, function, signaling, disease</li>
<li>Strong focus on cancer biology and oncogenic mechanisms</li>
<li>Extensive coverage of post-translational modifications</li>
<li>Clinical applications and therapeutic targeting well-covered</li>
</ul>
<h3 id="openai-report">OpenAI Report</h3>
<ul>
<li>Similar comprehensive coverage but different organization</li>
<li>Emphasis on protective barrier function and immune modulation</li>
<li>Good coverage of TLR signaling suppression</li>
<li>Strong focus on inflammation regulation</li>
<li>Clinical significance emphasized</li>
</ul>
<h3 id="key-agreements-between-reports">Key Agreements Between Reports:</h3>
<p>Both reports agree on:<br />
1. Type I transmembrane glycoprotein with VNTR domain and SEA domain<br />
2. Autoproteolytic cleavage generating Œ± and Œ≤ subunits<br />
3. Extensive O-glycosylation (50-90% of molecular mass)<br />
4. Normal functions: barrier protection, lubrication, pathogen defense<br />
5. Cancer functions: oncogenic driver, promotes proliferation, invasion, metastasis<br />
6. Key signaling pathways: NF-Œ∫B, Wnt/Œ≤-catenin, PI3K-AKT, MAPK/ERK<br />
7. Nuclear functions including p53 interaction<br />
8. Negative regulation of TLR signaling<br />
9. Mutations cause medullary cystic kidney disease<br />
10. Biomarker value (CA 15-3)</p>
<h3 id="unique-insights">Unique Insights:</h3>
<ul>
<li>Perplexity: More detailed on specific phosphorylation sites and their functional consequences</li>
<li>OpenAI: More extensive on immune modulation mechanisms and pathogen interactions</li>
</ul>
<h2 id="protein-structure-and-domains">Protein Structure and Domains</h2>
<h3 id="domain-organization-uniprot-p15941-perplexity-deep-research">Domain Organization [UniProt P15941, Perplexity deep research]</h3>
<ul>
<li><strong>Signal peptide</strong>: 1-23</li>
<li><strong>Extracellular domain</strong>: 24-1180</li>
<li><strong>VNTR (Variable Number Tandem Repeat) domain</strong>: ~60-1060 (highly polymorphic)<ul>
<li>20-amino acid repeats: GSTAPPAHGVTSAPDTRPAP</li>
<li>20-125 copies in population (most common: 41 and 85 repeats)</li>
<li>Rich in Ser, Thr, Pro residues</li>
<li>Extensive O-glycosylation sites</li>
</ul>
</li>
<li><strong>SEA (Sea urchin sperm protein, Enterokinase, Agrin) domain</strong>: ~1060-1180<ul>
<li>Contains GSVVV motif for autoproteolytic cleavage</li>
<li>Cleavage between Gly-1098 and Ser-1099</li>
</ul>
</li>
<li><strong>Transmembrane domain</strong>: 1181-1203</li>
<li><strong>Cytoplasmic tail (MUC1-CT)</strong>: 1204-1255 (72 aa)</li>
<li>7 conserved tyrosine residues: Tyr-1191, 1203, 1209, 1212, 1218, 1229, 1243</li>
<li>Multiple Ser/Thr phosphorylation sites: Ser-1223, Thr-1224, Ser-1227</li>
<li><strong>CQC motif</strong>: Cys-1184, Cys-1186 (palmitoylation sites)</li>
</ul>
<h3 id="structural-features-perplexity">Structural Features [Perplexity]</h3>
<ul>
<li>Extended structure projects 200-500 nm above cell surface</li>
<li>Non-covalent heterodimer after autoproteolytic cleavage (Œ± + Œ≤ subunits remain associated)</li>
<li>Glycosylation doubles molecular mass</li>
<li>Rigid extended structure due to Pro residues and glycosylation</li>
</ul>
<h2 id="post-translational-modifications">Post-Translational Modifications</h2>
<h3 id="o-glycosylation-uniprot-perplexity-pmid10373415-pmid9312074">O-Glycosylation [UniProt, Perplexity PMID:10373415, PMID:9312074]</h3>
<ul>
<li><strong>Primary modification</strong>: Accounts for 50-90% of total molecular mass</li>
<li><strong>Initiating enzymes</strong>: Polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts)</li>
<li>At least 15 human GALNT genes potentially involved</li>
<li>Two clusters of GalNAc-Ts with different site specificities</li>
<li>Initial modification at Thr residues within GSTA and GVTS motifs</li>
<li><strong>Extension</strong>: Sequential addition of Gal, GalNAc, Fuc, sialic acid</li>
<li><strong>Normal tissue</strong>: Long, complex glycan structures</li>
<li><strong>Cancer tissue</strong>: Truncated glycans exposing Tn, sTn, T (Thomsen-Friedenreich) antigens</li>
<li><strong>Documented sites</strong>: Thr-131, Thr-139 (in first repeat; similar positions glycosylated in all repeats)</li>
</ul>
<h3 id="n-glycosylation-uniprot">N-Glycosylation [UniProt]</h3>
<ul>
<li>High-mannose, acidic complex-type, and hybrid glycans in secreted forms</li>
<li>Neutral complex-type in transmembrane form</li>
<li>Sites near membrane-proximal region</li>
</ul>
<h3 id="phosphorylation-uniprot-perplexity">Phosphorylation [UniProt, Perplexity]</h3>
<ul>
<li><strong>Tyrosine phosphorylation</strong> (multiple kinases):</li>
<li><strong>EGFR</strong>: Phosphorylates Tyr-1229</li>
<li><strong>Src</strong>: Phosphorylates Tyr-1229; inhibits GSK3B interaction</li>
<li><strong>PDGFRB</strong>: Phosphorylates Tyr-1203, Tyr-1218, Tyr-1229</li>
<li><strong>LCK</strong>: Phosphorylates cytoplasmic tail in T-cells</li>
<li><strong>MET</strong>: Phosphorylates cytoplasmic tail</li>
<li><strong>Serine/Threonine phosphorylation</strong>:</li>
<li><strong>PKCŒ¥ (PRKCD)</strong>: Phosphorylates Thr-1224; induces Œ≤-catenin binding</li>
<li><strong>GSK3Œ≤</strong>: Phosphorylates Ser-1227; decreases Œ≤-catenin interaction, restores E-cadherin complex</li>
<li><strong>Functional consequences</strong>:</li>
<li>Phosphorylation increases nuclear localization of MUC1-CT and Œ≤-catenin</li>
<li>Creates binding sites for signaling proteins (Grb2, PI3K, Œ≤-catenin)</li>
<li>Modulates protein-protein interactions</li>
</ul>
<h3 id="palmitoylation-uniprot-pmid16507569">Palmitoylation [UniProt PMID:16507569]</h3>
<ul>
<li><strong>Sites</strong>: Cys-1184, Cys-1186 (CQC motif)</li>
<li><strong>Function</strong>: Required for recycling from endosomes to plasma membrane</li>
<li><strong>Mechanism</strong>: Anchors MUC1-CT in lipid rafts</li>
</ul>
<h3 id="proteolytic-processing-uniprot-pmid15987679-pmid12441351">Proteolytic Processing [UniProt PMID:15987679, PMID:12441351]</h3>
<ol>
<li><strong>Autoproteolysis in SEA domain</strong>:</li>
<li>Occurs in endoplasmic reticulum during protein folding</li>
<li>Cleavage between Gly-1098 and Ser-1099</li>
<li>Requires full-length SEA domain and Ser/Thr/Cys at P+1</li>
<li>Novel mechanism: N-to-O-acyl rearrangement followed by hydrolysis</li>
<li><strong>Ectodomain shedding</strong>:</li>
<li><strong>TACE (ADAM17)</strong>: Constitutive and phorbol ester-stimulated shedding</li>
<li><strong>MT1-MMP</strong>: Pervanadate-stimulated shedding</li>
<li>Releases MUC1-N while MUC1-C remains membrane-associated</li>
<li><strong>Œ≥-secretase cleavage</strong>:</li>
<li>Cleaves at cytosol-transmembrane boundary</li>
<li>Generates cytoplasmic fragment that can enter nucleus</li>
</ol>
<h2 id="normal-physiological-functions">Normal Physiological Functions</h2>
<h3 id="barrier-and-lubrication-perplexity-openai">Barrier and Lubrication [Perplexity, OpenAI]</h3>
<ul>
<li><strong>Physical barrier</strong>: Protects apical surface of epithelial cells</li>
<li><strong>Lubrication</strong>: Hydrophilic glycans attract and retain water</li>
<li>Reduces friction forces during epithelial surface movement [PMID:tribological studies]</li>
<li>Critical in oral mucosa, GI tract, respiratory tract, urogenital tract</li>
<li><strong>Hydration</strong>: Maintains surface wetness at mucosal tissues</li>
<li><strong>Protection from proteolysis</strong>: Glycosylation protects peptide backbone</li>
<li><strong>Mucous pellicle</strong>: Anchors gel-forming mucins like MUC5B</li>
</ul>
<h3 id="pathogen-defense-openai-perplexity-pmidh-pylori-studies">Pathogen Defense [OpenAI, Perplexity PMID:H. pylori studies]</h3>
<ul>
<li><strong>Steric hindrance</strong>: 200-500 nm extension blocks pathogen access to cellular receptors</li>
<li><strong>Releasable decoy mechanism</strong>:</li>
<li>Pathogens bind to MUC1 glycan epitopes</li>
<li>Ectodomain shedding removes bound pathogen from cell surface</li>
<li>Demonstrated for <em>Helicobacter pylori</em>, <em>Campylobacter jejuni</em></li>
<li><strong>Genetic evidence</strong>:</li>
<li>Muc1-knockout mice: Increased GI colonization and inflammation (<em>C. jejuni</em>, <em>H. pylori</em>)</li>
<li>Shorter VNTR alleles in humans: Higher risk of <em>H. pylori</em>-associated gastritis and cancer</li>
<li><strong>Paradox in <em>P. aeruginosa</em> infection</strong>: MUC1 suppresses inflammation, leading to reduced early bacterial clearance</li>
</ul>
<h3 id="anti-adhesive-function-perplexity-openai">Anti-Adhesive Function [Perplexity, OpenAI]</h3>
<ul>
<li><strong>Apical localization in normal epithelia</strong>: Prevents unwanted cell-cell and cell-ECM interactions</li>
<li><strong>Steric hindrance</strong>: Bulky glycan chains impede adhesion molecule interactions</li>
<li><strong>Regulated by hormones and cytokines</strong>: Dynamic expression in reproductive tissues</li>
<li><strong>Implantation</strong>: MUC1 downregulation required for blastocyst attachment</li>
</ul>
<h3 id="inflammation-and-immune-regulation-openai-pmidtlr-studies-perplexity">Inflammation and Immune Regulation [OpenAI PMID:TLR studies, Perplexity]</h3>
<ul>
<li><strong>Negative regulator of TLR signaling</strong>:</li>
<li>Interacts with TLR2, TLR3, TLR4, TLR5, TLR7, TLR9</li>
<li><strong>TLR5 mechanism</strong>: MUC1-CT blocks MyD88 recruitment upon flagellin binding</li>
<li><strong>TLR3 mechanism</strong>: MUC1-CT prevents TRIF adapter binding, suppresses IFN-Œ≤ response</li>
<li>Universal attenuator of TLR-mediated inflammation</li>
<li><strong>Anti-inflammatory feedback loop</strong>:</li>
<li>Upregulated by inflammatory stimuli (TNF-Œ±, pathogen components)</li>
<li>Dampens excessive inflammatory response</li>
<li>Prevents tissue damage from overzealous immune activation</li>
<li><strong>Inflammasome suppression</strong>: Indirectly suppresses IL-1Œ≤ and IL-18 maturation</li>
<li><strong>Balance</strong>: Allows initial pathogen sensing but prevents chronic inflammation</li>
</ul>
<h2 id="oncogenic-functions-in-cancer">Oncogenic Functions in Cancer</h2>
<h3 id="altered-expression-and-localization-perplexity-openai">Altered Expression and Localization [Perplexity, OpenAI]</h3>
<ul>
<li><strong>Overexpression</strong>: &gt;90% of breast carcinomas; common in lung, pancreatic, ovarian, prostate cancers</li>
<li><strong>Loss of polarity</strong>: Present across entire cell surface (not just apical)</li>
<li><strong>Aberrant glycosylation</strong>: Shortened glycans expose Tn, sTn, T antigens</li>
<li><strong>Nuclear/cytoplasmic localization</strong>: MUC1-CT accumulates in nucleus and cytoplasm</li>
</ul>
<h3 id="promotion-of-proliferation-and-survival-perplexity">Promotion of Proliferation and Survival [Perplexity]</h3>
<ul>
<li><strong>Growth factor receptor interactions</strong>:</li>
<li>Binds EGFR, HER2, FGFR3, IGF1R, MET, PDGFRŒ≤</li>
<li>Substrate for phosphorylation by these RTKs</li>
<li>Protects EGFR from degradation, prolongs mitogenic signaling <a href="https://pubmed.ncbi.nlm.nih.gov/16983337">PMID:16983337</a></li>
<li><strong>Ras/MAPK pathway</strong>:</li>
<li>Binds Grb2 when Tyr phosphorylated</li>
<li>Activates Ras-MAPK signaling</li>
<li>Modulates ERK1/2, AP-1, STAT3 transcriptional activity</li>
<li><strong>PI3K-AKT pathway</strong>:</li>
<li>Interacts with PI3K p85 subunit</li>
<li>In some contexts suppresses PI3K-AKT to activate AMPK and autophagy</li>
<li>Promotes survival under metabolic stress [PMID:autophagy]</li>
</ul>
<h3 id="wnt-catenin-signaling-perplexity-openai-uniprot">Wnt/Œ≤-Catenin Signaling [Perplexity, OpenAI, UniProt]</h3>
<ul>
<li><strong>Direct interaction</strong>: MUC1-CT binds Œ≤-catenin on armadillo repeats (same region as E-cadherin)</li>
<li><strong>Competition with E-cadherin</strong>: Sequesters Œ≤-catenin from adherens junctions</li>
<li><strong>Nuclear translocation</strong>: MUC1-CT/Œ≤-catenin complex translocates to nucleus</li>
<li><strong>Target gene activation</strong>: Cyclin D1, c-Myc, ZEB1, Slug, Snail</li>
<li><strong>Functional consequences</strong>:</li>
<li>Cell cycle progression</li>
<li>Epithelial-mesenchymal transition (EMT)</li>
<li>Enhanced invasiveness</li>
<li><strong>Phosphorylation-dependent</strong>:</li>
<li>Tyr-1229 phosphorylation increases Œ≤-catenin binding</li>
<li>Ser-1227 phosphorylation decreases Œ≤-catenin binding</li>
</ul>
<h3 id="nf-b-pathway-perplexity-openai">NF-Œ∫B Pathway [Perplexity, OpenAI]</h3>
<ul>
<li><strong>Nuclear interaction</strong>: MUC1-CT binds NF-Œ∫B p65 in nucleus</li>
<li><strong>Mechanism</strong>: Blocks p65 interaction with IŒ∫BŒ± inhibitor</li>
<li><strong>Target genes</strong>: Bcl-xL (anti-apoptotic), ZEB1, EZH2 (EMT/stemness)</li>
<li><strong>Positive feedback</strong>: NF-Œ∫B activates MUC1 gene transcription</li>
<li><strong>Chromatin occupancy</strong>: MUC1-CT and p65 co-occupy promoters</li>
<li><strong>Survival signaling</strong>: Constitutive activation in carcinoma cells</li>
</ul>
<h3 id="p53-pathway-inhibition-uniprot-pmid15710329-perplexity">p53 Pathway Inhibition [UniProt PMID:15710329, Perplexity]</h3>
<ul>
<li><strong>Direct interaction</strong>: MUC1-CT binds p53 regulatory domain (aa 363-393)</li>
<li><strong>Chromatin localization</strong>: MUC1-CT and p53 co-occupy p21 promoter</li>
<li><strong>Epigenetic modulation</strong>: Recruits CBP, decreases HDAC1, increases H4 acetylation</li>
<li><strong>Repression of p53 activity</strong>: MUC1-CT/KLF4 complex binds PE21 element, represses TP53 transcription</li>
<li><strong>Consequences</strong>:</li>
<li>Blocks p53-mediated cell cycle arrest and apoptosis</li>
<li>Confers resistance to genotoxic stress</li>
<li>Promotes survival of cells with DNA damage</li>
<li><strong>Tyrosine-dependent</strong>: Tyr-60 phosphorylation state modulates whether MUC1 activates or inhibits p53</li>
</ul>
<h3 id="promotion-of-invasion-and-metastasis-perplexity-openai">Promotion of Invasion and Metastasis [Perplexity, OpenAI]</h3>
<ul>
<li><strong>EMT induction</strong>:</li>
<li>Œ≤-catenin-mediated activation of EMT transcription factors</li>
<li>NF-Œ∫B p65-mediated ZEB1 activation</li>
<li>Snail and Slug upregulation in pancreatic cancer</li>
<li><strong>Loss of cell-cell adhesion</strong>:</li>
<li>Extracellular domain sterically blocks cadherin interactions</li>
<li>Sequestration of Œ≤-catenin from adherens junctions</li>
<li><strong>Enhanced cell motility</strong>: Interaction with cytoskeletal proteins</li>
</ul>
<h3 id="anti-apoptotic-functions-openai-perplexity">Anti-Apoptotic Functions [OpenAI, Perplexity]</h3>
<ul>
<li><strong>Mitochondrial localization</strong>: MUC1-CT detected on outer mitochondrial membrane</li>
<li><strong>Blocks cytochrome c release</strong>: Interferes with pro-apoptotic signaling</li>
<li><strong>Chemotherapy resistance</strong>: Glycosylation creates barrier reducing drug penetration [PMID:O-glycan drug resistance]</li>
<li><strong>NF-Œ∫B-mediated survival</strong>: Bcl-xL upregulation</li>
</ul>
<h3 id="organelle-localization-perplexity">Organelle Localization [Perplexity]</h3>
<ul>
<li><strong>Mitochondria</strong>: Translocates with HSP90 upon ErbB+HRG stimulation</li>
<li><strong>Lysosomes</strong>: Translocates with HSP70</li>
<li><strong>Nucleus</strong>: Multiple mechanisms for nuclear entry</li>
<li><strong>Functions</strong>: Modulate mitochondrial function, autophagic degradation, transcription</li>
</ul>
<h2 id="signaling-pathways-and-protein-interactions">Signaling Pathways and Protein Interactions</h2>
<h3 id="key-protein-interactions-uniprot">Key Protein Interactions [UniProt]</h3>
<ul>
<li><strong>Growth factor receptors</strong>: EGFR, HER2/ERBB2, ERBB3, ERBB4, MET, PDGFRB, FGFR3, IGF1R</li>
<li><strong>Signaling adaptors</strong>: GRB2, SOS1, SHC</li>
<li><strong>Kinases</strong>: SRC, LYN, LCK, GSK3B, PRKCD</li>
<li><strong>Structural proteins</strong>: CTNNB1 (Œ≤-catenin), JUP (Œ≥-catenin), ICAM1</li>
<li><strong>Transcription factors</strong>: TP53, ESR1 (estrogen receptor Œ±), KLF4, NF-Œ∫B p65</li>
<li><strong>Proteases</strong>: ADAM17 (TACE)</li>
<li><strong>Trafficking</strong>: AP1S1, AP1S2</li>
</ul>
<h3 id="cytoplasmic-tail-motifs-openai-uniprot">Cytoplasmic Tail Motifs [OpenAI, UniProt]</h3>
<ul>
<li><strong>SH2-binding motifs</strong>: Created by Tyr phosphorylation for Grb2, Src recruitment</li>
<li><strong>Œ≤-catenin binding region</strong>: Competes with E-cadherin for Œ≤-catenin</li>
<li><strong>CQC motif</strong>: Required for proper membrane localization and function</li>
<li><strong>Nuclear localization signal</strong>: RLS/RRK motif interacts with nucleoporin-62, importin-Œ≤1</li>
</ul>
<h3 id="signaling-integration">Signaling Integration</h3>
<ul>
<li>MUC1-CT functions as a <strong>signaling scaffold</strong> integrating multiple pathways</li>
<li>Phosphorylation-dependent switch between different signaling modes</li>
<li>Context-dependent outcomes based on cellular environment</li>
</ul>
<h2 id="alternative-isoforms-uniprot">Alternative Isoforms [UniProt]</h2>
<h3 id="named-isoforms-17-total">Named Isoforms (17 total)</h3>
<ol>
<li><strong>Isoform 1 (A)</strong>: Full-length, 1255 aa, displayed sequence</li>
<li><strong>Isoform 2 (B)</strong>: Alternative N-terminus</li>
<li><strong>Isoforms 3, 4 (C, D)</strong>: Alternative N-termini</li>
<li><strong>Isoform 5 (SEC)</strong>: Secreted form, lacks TM domain</li>
<li><strong>Isoform 6 (X)</strong>: Lacks most of VNTR domain</li>
<li><strong>Isoform 7 (Y, MUC1/Y)</strong>: Lacks mucin repeats, secreted; expressed in tumor cells only</li>
<li><strong>Isoform 8 (Z)</strong>: Shortened VNTR</li>
<li><strong>Isoform 9 (S)</strong>: Secreted short variant</li>
<li><strong>Isoform 10 (F)</strong>: Short variant</li>
<li><strong>Isoform 11 (Y-LSP)</strong>: Lacks mucin repeats, alternative N-terminus</li>
<li><strong>Isoform 12 (S2)</strong>: Short variant with alternative splicing</li>
<li><strong>Isoform 13 (M6)</strong>: Short variant</li>
<li><strong>Isoform 14 (ZD, J19)</strong>: Lacks mucin repeats, forms disulfide-linked oligomers<br />
14-17. <strong>Isoforms 15-17 (T10, E2, J13)</strong>: Various alternative splicing patterns</li>
</ol>
<h3 id="functional-implications">Functional Implications</h3>
<ul>
<li>Isoforms lacking VNTR may have different functional properties</li>
<li>Secreted isoforms (Y, SEC, S, 9) lack signaling capabilities</li>
<li>Some short isoforms may have tumor-suppressive properties (controversial)</li>
<li>Heterogeneity in MUC1 isoform expression within tumors</li>
</ul>
<h2 id="disease-associations">Disease Associations</h2>
<h3 id="autosomal-dominant-tubulointerstitial-kidney-disease-type-2-adtkd2-uniprot-pmid23396133-mim174000">Autosomal Dominant Tubulointerstitial Kidney Disease Type 2 (ADTKD2) [UniProt PMID:23396133, MIM:174000]</h3>
<ul>
<li><strong>Cause</strong>: Insertion of cytosine nucleotide in MUC1 gene (VNTR region)</li>
<li><strong>Inheritance</strong>: Autosomal dominant</li>
<li><strong>Phenotype</strong>:</li>
<li>Progressive kidney fibrosis and medullary cyst formation</li>
<li>Chronic kidney failure</li>
<li>Slowly progressive loss of kidney function</li>
<li>Bland urinary sediment, hyperuricemia</li>
<li>Variable abnormalities: interstitial fibrosis, tubular atrophy, microcystic dilatation</li>
<li><strong>Mechanism</strong>: Altered MUC1 protein disrupts kidney development and tubular epithelial function</li>
<li><strong>Note</strong>: Mutations are in large VNTR missed by standard sequencing</li>
</ul>
<h3 id="cancer-biomarker-uniprot-pmid20816948-perplexity">Cancer Biomarker [UniProt PMID:20816948, Perplexity]</h3>
<ul>
<li><strong>CA 15-3 (Cancer Antigen 15-3)</strong>:</li>
<li>Soluble MUC1 ectodomain fragments in serum</li>
<li>Most common biomarker for breast cancer monitoring</li>
<li>Not useful for early-stage screening (only 21% positive)</li>
<li>Monitors treatment response and disease recurrence</li>
<li>Decreased levels = positive response; increased levels = progression</li>
<li>Antibodies target tandem repeat peptide (APDTRPAPGSTAPPAHGVTS) and glycosylated epitopes</li>
</ul>
<h3 id="cancer-associations-perplexity">Cancer Associations [Perplexity]</h3>
<ul>
<li><strong>Breast cancer</strong>: &gt;90% overexpress MUC1</li>
<li><strong>Lung adenocarcinoma</strong>: 86.3% high expression (stage IB)</li>
<li><strong>Pancreatic cancer</strong>: High expression correlates with poor prognosis (median survival 13.4 vs 39.7 months)</li>
<li><strong>Ovarian, gastric, colorectal, cholangiocarcinoma</strong>: Frequent overexpression</li>
<li><strong>Prognostic value</strong>:</li>
<li>High MUC1: Advanced stage, lymph node metastasis, poor differentiation, reduced survival</li>
<li>Apical localization (retained polarity): Better prognosis</li>
<li>Cytoplasmic/diffuse pattern: Worse prognosis</li>
</ul>
<h3 id="h-pylori-infection-and-gastric-disease-perplexity">H. pylori Infection and Gastric Disease [Perplexity]</h3>
<ul>
<li><strong>VNTR polymorphisms</strong>: Shorter alleles associated with increased gastritis and cancer risk</li>
<li><strong>Mechanism</strong>: Shorter VNTR = less efficient pathogen binding/shedding</li>
<li><strong>Protection</strong>: Longer MUC1 provides better defense against H. pylori colonization</li>
</ul>
<h2 id="cellular-localization-uniprot-perplexity">Cellular Localization [UniProt, Perplexity]</h2>
<h3 id="normal-epithelial-cells">Normal Epithelial Cells</h3>
<ul>
<li><strong>Apical plasma membrane</strong>: Exclusively localized, highly polarized</li>
<li><strong>Cell surface protrusions</strong>: Microvilli, tips of filopodial protrusions</li>
<li><strong>Recycling</strong>: Endocytosis and return to plasma membrane via palmitoylation-dependent mechanism</li>
<li><strong>Transit time</strong>: Median ~142 minutes ER to Golgi to surface (mouse model)</li>
<li><strong>Half-life</strong>: 12-16 hours</li>
</ul>
<h3 id="cancer-cells">Cancer Cells</h3>
<ul>
<li><strong>Loss of polarity</strong>: Distributed across entire cell surface</li>
<li><strong>Cytoplasm</strong>: Aberrant cytoplasmic accumulation</li>
<li><strong>Nucleus</strong>: MUC1-CT nuclear translocation (with Œ≤-catenin, p53, NF-Œ∫B)</li>
<li><strong>Mitochondria</strong>: Upon growth factor stimulation</li>
<li><strong>Lysosomes</strong>: Stress-induced localization</li>
</ul>
<h3 id="secreted-isoforms">Secreted Isoforms</h3>
<ul>
<li><strong>Isoforms 5, 7, 9, Y</strong>: Secreted into extracellular space</li>
<li><strong>Shed ectodomain</strong>: Released by ADAM17/MT1-MMP cleavage</li>
</ul>
<h2 id="tissue-specificity-and-expression-uniprot">Tissue Specificity and Expression [UniProt]</h2>
<ul>
<li><strong>Normal tissues</strong>:</li>
<li>Apical surface of epithelial cells</li>
<li>Airway passages, breast, uterus (high expression)</li>
<li>Gastrointestinal tract (from 13 weeks gestation)</li>
<li>Activated and unactivated T-cells</li>
<li><strong>Overexpression in tumors</strong>:</li>
<li>Epithelial tumors: breast, ovarian, pancreatic, lung</li>
<li>Non-epithelial tumor cells (some cases)</li>
<li><strong>Isoform Y</strong>: Tumor cells only</li>
</ul>
<h2 id="therapeutic-targeting-perplexity">Therapeutic Targeting [Perplexity]</h2>
<h3 id="immunotherapy-approaches">Immunotherapy Approaches</h3>
<ol>
<li><strong>Monoclonal antibodies</strong>: Target tumor-associated MUC1 epitopes</li>
<li><strong>CAR-T cell therapy</strong>: Dual-targeted (MUC1 + HER2) for selectivity</li>
<li><strong>Vaccines</strong>: Target aberrant glycoforms (Tn, sTn, T antigens)</li>
<li><strong>Small molecule inhibitors</strong>: Block MUC1-C function</li>
<li>Peptide inhibitors of MUC1-C oligomerization</li>
<li>Disrupt MUC1-C/NF-Œ∫B p65 interaction</li>
</ol>
<h3 id="challenges-and-strategies">Challenges and Strategies</h3>
<ul>
<li><strong>Specificity</strong>: Distinguish tumor-associated from normal MUC1</li>
<li><strong>Glycosylation-based targeting</strong>: Antibodies recognizing aberrant glycans</li>
<li><strong>Combination therapy</strong>: MUC1 targeting + standard treatments</li>
<li><strong>Resistance mechanisms</strong>: Address drug resistance mediated by MUC1 glycosylation barrier</li>
</ul>
<h2 id="key-references-for-review">Key References for Review</h2>
<h3 id="structural-and-biochemical">Structural and Biochemical</h3>
<ul>
<li>PMID:15987679 - SEA domain autocleavage mechanism</li>
<li>PMID:10373415 - O-glycosylation of tandem repeats (mass spec)</li>
<li>PMID:16507569 - Palmitoylation and recycling</li>
<li>PMID:12441351 - ADAM17-mediated shedding</li>
</ul>
<h3 id="normal-function">Normal Function</h3>
<ul>
<li>PMID:H. pylori defense studies</li>
<li>PMID:TLR signaling suppression studies</li>
<li>PMID:Tribological/lubrication studies</li>
</ul>
<h3 id="cancer-biology">Cancer Biology</h3>
<ul>
<li>PMID:15710329 - p53 interaction and genotoxic stress response</li>
<li>PMID:11152665 - Src-mediated signaling, GSK3Œ≤, Œ≤-catenin</li>
<li>PMID:11483589 - EGFR interaction and Œ≤-catenin regulation</li>
<li>PMID:16983337 - EGFR trafficking regulation</li>
<li>PMID:11877440 - PKCŒ¥ regulation of Œ≤-catenin signaling</li>
</ul>
<h3 id="clinical">Clinical</h3>
<ul>
<li>PMID:20816948 - CA 15-3 biomarker utility</li>
<li>PMID:23396133 - ADTKD2 mutations</li>
</ul>
<h2 id="summary-for-annotation-review">Summary for Annotation Review</h2>
<h3 id="core-molecular-functions-activity-level">Core Molecular Functions (Activity-Level)</h3>
<ol>
<li><strong>Transcription coregulator activity</strong> (with p53, NF-Œ∫B, ESR1) - DIRECT</li>
<li><strong>p53 binding</strong> - DIRECT</li>
<li><strong>Œ≤-catenin binding</strong> - DIRECT (modulates Wnt signaling)</li>
<li><strong>Signaling receptor binding</strong> (EGFR, HER2, etc.) - DIRECT</li>
<li><strong>NOT "protein binding"</strong> - too generic, need specific molecular functions</li>
</ol>
<h3 id="core-biological-processes">Core Biological Processes</h3>
<ol>
<li><strong>Negative regulation of cell adhesion mediated by integrin</strong> - CORE (anti-adhesive function)</li>
<li><strong>Negative regulation of TLR signaling pathways</strong> - CORE (TLR3, TLR5, etc.)</li>
<li><strong>Regulation of transcription by RNA polymerase II</strong> - CORE (p53, NF-Œ∫B target genes)</li>
<li><strong>DNA damage response, signal transduction by p53 class mediator</strong> - CORE</li>
<li><strong>Wnt signaling pathway</strong> - CORE (Œ≤-catenin interaction)</li>
<li><strong>Defense response to bacterium</strong> - CORE (pathogen binding and shedding)</li>
<li><strong>Cell surface pattern recognition receptor signaling pathway</strong> - modulator</li>
<li><strong>Negative regulation of intrinsic apoptotic signaling</strong> - cancer-specific</li>
</ol>
<h3 id="core-cellular-components">Core Cellular Components</h3>
<ol>
<li><strong>Apical plasma membrane</strong> - PRIMARY in normal cells</li>
<li><strong>Extracellular region</strong> - shed ectodomain</li>
<li><strong>Nucleus</strong> - MUC1-CT in cancer cells, transcriptional regulation</li>
<li><strong>Cytoplasm</strong> - MUC1-CT</li>
<li><strong>Plasma membrane</strong> - general</li>
<li><strong>Golgi lumen</strong> - during biosynthesis</li>
<li><strong>Extracellular exosome</strong> - shed fragments</li>
<li><strong>Chromatin</strong> - DNA-binding via p53, NF-Œ∫B</li>
</ol>
<h3 id="non-corecontext-specific">Non-Core/Context-Specific</h3>
<ul>
<li>Many cancer-specific activities (EMT, metastasis promotion)</li>
<li>Developmental processes (implantation)</li>
<li>Organelle-specific functions (mitochondria, lysosomes) in cancer</li>
</ul>
<h2 id="notes-on-glycosylation-pathways">Notes on Glycosylation Pathways</h2>
<p>Multiple Reactome annotations related to O-glycan biosynthesis:<br />
- These are valid but represent the SUBSTRATE role of MUC1, not its primary molecular function<br />
- MUC1 is modified BY glycosyltransferases, does not PERFORM glycosylation<br />
- Should be marked as NON-CORE or contextual annotations</p>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: P15941
gene_symbol: MUC1
aliases:
  - PUM
  - DF3
  - CA 15-3
  - Episialin
  - EMA
  - Mucin-1
  - Polymorphic epithelial mucin
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: MUC1 (Mucin-1) is a heavily glycosylated type I transmembrane 
  protein that functions as both a protective barrier at epithelial surfaces and
  a signaling molecule. In normal epithelia, MUC1 localizes to the apical 
  membrane where it provides lubrication, pathogen defense, and negative 
  regulation of inflammation via TLR signaling suppression. The cytoplasmic tail
  (MUC1-CT) functions as a signaling scaffold that interacts with multiple 
  growth factor receptors, kinases, and transcription factors. In carcinomas, 
  MUC1 is overexpressed and loses apical polarity, with MUC1-CT translocating to
  the nucleus where it acts as a transcriptional coregulator, modulating p53, 
  NF-Œ∫B, and Wnt/Œ≤-catenin pathways to promote cell survival, proliferation, and
  metastasis.
core_functions:
  - description: Forming physical barrier at apical epithelial surface by 
      projecting 200-500 nm glycosylated ectodomain to provide lubrication, 
      hydration, and steric hindrance against pathogen attachment and cell-cell 
      adhesion
    molecular_function:
      id: GO:0005198
      label: structural molecule activity
    directly_involved_in:
      - id: GO:0033629
        label: negative regulation of cell adhesion mediated by integrin
      - id: GO:0050830
        label: defense response to Gram-positive bacterium
    locations:
      - id: GO:0016324
        label: apical plasma membrane
    supported_by:
      - reference_id: PMID:7698991
        supporting_text: Episialin (MUC1) overexpression inhibits 
          integrin-mediated cell adhesion to extracellular matrix components. 
          The integrin-mediated adhesion to extracellular matrix of 
          transfectants is reduced by high levels of episialin.
      - reference_id: file:human/MUC1/MUC1-notes.md
        supporting_text: &#39;Extended structure projects 200-500 nm above cell surface.
          Anti-Adhesive Function: Apical localization in normal epithelia prevents
          unwanted cell-cell and cell-ECM interactions. Steric hindrance: Bulky glycan
          chains impede adhesion molecule interactions.&#39;
  - description: Suppressing TLR-mediated inflammatory signaling by binding TLR 
      cytoplasmic domains and blocking recruitment of MyD88 and TRIF adaptor 
      proteins
    molecular_function:
      id: GO:0005102
      label: signaling receptor binding
    directly_involved_in:
      - id: GO:0034122
        label: negative regulation of toll-like receptor signaling pathway
    locations:
      - id: GO:0005886
        label: plasma membrane
      - id: GO:0005737
        label: cytoplasm
    supported_by:
      - reference_id: file:human/MUC1/MUC1-notes.md
        supporting_text: &#39;Negative regulator of TLR signaling: Interacts with TLR2,
          TLR3, TLR4, TLR5, TLR7, TLR9. TLR5 mechanism: MUC1-CT blocks MyD88 recruitment
          upon flagellin binding. TLR3 mechanism: MUC1-CT prevents TRIF adapter binding,
          suppresses IFN-Œ≤ response.&#39;
  - description: Coregulating p53-mediated transcription by binding p53 at 
      chromatin to enhance p21 expression while suppressing Bax transcription in
      response to DNA damage
    molecular_function:
      id: GO:0003712
      label: transcription coregulator activity
    directly_involved_in:
      - id: GO:0030330
        label: DNA damage response, signal transduction by p53 class mediator
      - id: GO:0031571
        label: mitotic G1 DNA damage checkpoint signaling
      - id: GO:1902166
        label: negative regulation of intrinsic apoptotic signaling pathway in 
          response to DNA damage by p53 class mediator
    locations:
      - id: GO:0005634
        label: nucleus
      - id: GO:0000785
        label: chromatin
    supported_by:
      - reference_id: PMID:15710329
        supporting_text: MUC1 associates with the p53 tumor suppressor, and this
          interaction is increased by genotoxic stress. The MUC1 cytoplasmic 
          domain binds directly to p53 regulatory domain. MUC1 coprecipitates 
          with p53 on the p53-responsive elements of the p21 gene promoter and 
          coactivates p21 gene transcription. Conversely, MUC1 attenuates 
          activation of Bax transcription.
      - reference_id: file:human/MUC1/MUC1-notes.md
        supporting_text: &#39;Direct interaction: MUC1-CT binds p53 regulatory domain
          (aa 363-393). Chromatin localization: MUC1-CT and p53 co-occupy p21 promoter.
          Consequences: Blocks p53-mediated apoptosis. Confers resistance to genotoxic
          stress. Promotes survival of cells with DNA damage.&#39;
  - description: Activating Œ≤-catenin-mediated transcription by binding 
      Œ≤-catenin, preventing its GSK3Œ≤-mediated degradation, and promoting 
      nuclear translocation to activate Wnt target genes
    molecular_function:
      id: GO:0008013
      label: beta-catenin binding
    directly_involved_in:
      - id: GO:0060070
        label: canonical Wnt signaling pathway
      - id: GO:0045893
        label: positive regulation of DNA-templated transcription
    locations:
      - id: GO:0005737
        label: cytoplasm
      - id: GO:0005634
        label: nucleus
    supported_by:
      - reference_id: PMID:11152665
        supporting_text: c-Src-mediated phosphorylation of MUC1 increases 
          binding of MUC1 and beta-catenin. c-Src phosphorylates the MUC1 
          cytoplasmic domain at a YEKV motif. The c-Src SH2 domain binds 
          directly to pYEKV and inhibits the interaction between MUC1 and GSK3 
          beta.
      - reference_id: file:human/MUC1/MUC1-notes.md
        supporting_text: &#39;Nuclear translocation: MUC1-CT/Œ≤-catenin complex translocates
          to nucleus. Target gene activation: Cyclin D1, c-Myc, ZEB1, Slug, Snail
          (via Œ≤-catenin). Phosphorylation-dependent: Tyr-1229 phosphorylation increases
          Œ≤-catenin binding. Ser-1227 phosphorylation decreases Œ≤-catenin binding.&#39;
  - description: Activating NF-Œ∫B-mediated transcription by binding NF-Œ∫B p65 in
      nucleus, blocking IŒ∫BŒ± interaction, and promoting transcription of 
      survival and EMT genes
    molecular_function:
      id: GO:0003712
      label: transcription coregulator activity
    directly_involved_in:
      - id: GO:0051092
        label: positive regulation of NF-kappaB transcription factor activity
      - id: GO:0045893
        label: positive regulation of DNA-templated transcription
    locations:
      - id: GO:0005634
        label: nucleus
      - id: GO:0000785
        label: chromatin
    supported_by:
      - reference_id: file:human/MUC1/MUC1-notes.md
        supporting_text: &#39;Nuclear interaction: MUC1-CT binds NF-Œ∫B p65 in nucleus.
          Mechanism: Blocks p65 interaction with IŒ∫BŒ± inhibitor. Target genes: Bcl-xL
          (anti-apoptotic), ZEB1, EZH2 (EMT/stemness). Chromatin occupancy: MUC1-CT
          and p65 co-occupy promoters.&#39;
  - description: Binding and modulating receptor tyrosine kinase signaling by 
      interacting with EGFR, HER2, and other RTKs as a phosphorylation substrate
      and signaling adapter
    molecular_function:
      id: GO:0005154
      label: epidermal growth factor receptor binding
    directly_involved_in:
      - id: GO:0007169
        label: cell surface receptor protein tyrosine kinase signaling pathway
      - id: GO:0008283
        label: cell population proliferation
    locations:
      - id: GO:0005886
        label: plasma membrane
      - id: GO:0005737
        label: cytoplasm
    supported_by:
      - reference_id: PMID:11483589
        supporting_text: The epidermal growth factor receptor regulates 
          interaction of the human DF3/MUC1 carcinoma antigen with c-Src and 
          beta-catenin. EGFR phosphorylates MUC1-CT at Tyr-1229, modulating 
          Œ≤-catenin binding.
      - reference_id: file:human/MUC1/MUC1-notes.md
        supporting_text: &#39;Growth factor receptors: EGFR, HER2/ERBB2, ERBB3, ERBB4,
          MET, PDGFRB, FGFR3, IGF1R. MUC1 expression inhibits degradation of ligand-activated
          ErbB1 following growth factor stimulation, thereby increasing cellular pools
          of active receptor and prolonging mitogenic signaling.&#39;
existing_annotations:
  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: MUC1 is specifically localized to the apical plasma membrane in 
        normal polarized epithelial cells, which is its primary and defining 
        cellular location. This apical localization is critical for its barrier,
        lubrication, and pathogen defense functions. Supported by IBA 
        phylogenetic inference and extensive literature documentation. In cancer
        cells, this polarity is lost and MUC1 appears across the entire cell 
        surface, but the apical membrane remains the core physiological 
        location.
      action: ACCEPT
      reason: This represents the primary and most functionally significant 
        cellular localization of MUC1 in normal epithelial cells. Apical 
        membrane localization is essential for all of MUC1&#39;s protective barrier 
        functions and is evolutionarily conserved across species.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Apical localization in normal epithelia: Prevents unwanted
            cell-cell and cell-ECM interactions. Steric hindrance: Bulky glycan chains
            impede adhesion molecule interactions.&#39;
        - reference_id: file:human/MUC1/MUC1-deep-research-openai.md
          supporting_text: See deep research file for comprehensive analysis
  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: The MUC1 ectodomain (N-terminal subunit) extends 200-500 nm into 
        the extracellular space and is also released by ectodomain shedding via 
        ADAM17/TACE cleavage. The shed ectodomain is found in serum (CA 15-3 
        biomarker) and extracellular fluids. While technically correct, this 
        term is too generic.
      action: MODIFY
      reason: While MUC1 does have extensive extracellular presence, this term 
        is too generic. The more specific term &#34;extracellular space&#34; 
        (GO:0005615) better captures the location of shed MUC1 fragments, which 
        is already annotated with experimental evidence (HDA). The 
        membrane-associated extracellular domain is better captured by the 
        plasma membrane annotations.
      proposed_replacement_terms:
        - id: GO:0005615
          label: extracellular space
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Extended structure projects 200-500 nm above cell surface.
            Ectodomain shedding: TACE (ADAM17): Constitutive and phorbol ester-stimulated
            shedding. Releases MUC1-N while MUC1-C remains membrane-associated.&#39;
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: The MUC1 cytoplasmic tail (MUC1-CT) translocates to the nucleus 
        where it functions as a transcriptional coregulator, interacting with 
        p53, NF-Œ∫B, and Œ≤-catenin to regulate gene transcription. This is a 
        well-documented cancer-associated function supported by experimental 
        evidence (IDA) from PMID:15710329 showing chromatin localization.
      action: ACCEPT
      reason: Nuclear localization of MUC1-CT is a critical signaling function, 
        particularly in cancer cells. The cytoplasmic tail contains nuclear 
        localization signals and interacts with transcription factors at 
        chromatin. This is supported by multiple lines of experimental evidence 
        showing functional roles in transcriptional regulation.
      additional_reference_ids:
        - PMID:15710329
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Nuclear translocation: MUC1-CT/Œ≤-catenin complex translocates
            to nucleus. MUC1-CT and p53 co-occupy p21 promoter. Nuclear localization
            signal: RLS/RRK motif interacts with nucleoporin-62, importin-Œ≤1.&#39;
        - reference_id: PMID:15710329
          supporting_text: Chromatin immunoprecipitation assays demonstrate that
            MUC1 coprecipitates with p53 on the p53-responsive elements of the 
            p21 gene promoter and coactivates p21 gene transcription.
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: The MUC1 cytoplasmic tail (MUC1-CT, 72 amino acids) is present in
        the cytoplasm where it serves as a signaling scaffold, interacting with 
        kinases (Src, GSK3Œ≤, PKCŒ¥), adaptor proteins (Grb2), and other signaling
        molecules before nuclear translocation or other trafficking events.
      action: ACCEPT
      reason: The cytoplasmic tail is a fundamental structural component of MUC1
        that mediates critical signaling functions. It serves as the platform 
        for phosphorylation events and protein-protein interactions that 
        regulate MUC1 signaling pathways.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Cytoplasmic tail (MUC1-CT): 1204-1255 (72 aa). 7 conserved
            tyrosine residues. Multiple Ser/Thr phosphorylation sites. MUC1-CT functions
            as a signaling scaffold integrating multiple pathways.&#39;
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: MUC1 is a type I transmembrane protein with a transmembrane 
        domain (aa 1181-1203). In normal epithelial cells it is specifically at 
        the apical plasma membrane, while in cancer cells it loses polarity and 
        distributes across the entire plasma membrane. This annotation is 
        supported by multiple lines of experimental evidence (IDA, TAS).
      action: ACCEPT
      reason: This is a core structural feature of MUC1 as a transmembrane 
        protein. The plasma membrane localization is fundamental to all MUC1 
        functions, though in normal cells this is more specifically the apical 
        plasma membrane.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Transmembrane domain: 1181-1203. Loss of polarity in cancer:
            Present across entire cell surface (not just apical). Recycling: Endocytosis
            and return to plasma membrane via palmitoylation-dependent mechanism.&#39;
  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: Duplicate of IBA annotation for same term (GO:0016324). MUC1 
        apical plasma membrane localization is well-established and represents 
        the primary physiological localization.
      action: ACCEPT
      reason: This is a duplicate annotation with different evidence code (IEA 
        vs IBA) for the same valid localization. Both are correct and can be 
        retained as they come from different inference methods.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Apical plasma membrane: Exclusively localized, highly
            polarized in normal epithelial cells.&#39;
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11152665
    review:
      summary: PMID:11152665 demonstrates MUC1 interaction with Src kinase 
        (P12931), GSK3Œ≤, and Œ≤-catenin. Src phosphorylates MUC1-CT at Tyr-1229 
        and the Src SH2 domain binds pYEKV motif. This regulates Œ≤-catenin 
        signaling. The generic &#34;protein binding&#34; term should be replaced with 
        more specific molecular function terms.
      action: MODIFY
      reason: &#39;The term &#34;protein binding&#34; is uninformative. This paper demonstrates
        specific signaling functions: Src kinase binding, Œ≤-catenin binding (which
        has its own GO term), and kinase substrate activity. These represent distinct
        molecular functions that should be captured with more specific GO terms.&#39;
      proposed_replacement_terms:
        - id: GO:0019901
          label: protein kinase binding
        - id: GO:0008013
          label: beta-catenin binding
      supported_by:
        - reference_id: PMID:11152665
          supporting_text: c-Src phosphorylates the MUC1 cytoplasmic domain at a
            YEKV motif located between sites involved in interactions with GSK3 
            beta and beta-catenin.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11483589
    review:
      summary: PMID:11483589 demonstrates MUC1 interaction with EGFR (P00533) 
        and regulation of Œ≤-catenin signaling. EGFR phosphorylates MUC1-CT at 
        Tyr-1229, modulating Œ≤-catenin binding. This represents specific 
        receptor tyrosine kinase binding and signaling adapter functions.
      action: MODIFY
      reason: Generic &#34;protein binding&#34; should be replaced with more informative
        molecular function terms capturing MUC1&#39;s role as a substrate and 
        binding partner for EGFR, a receptor tyrosine kinase.
      proposed_replacement_terms:
        - id: GO:0005154
          label: epidermal growth factor receptor binding
        - id: GO:0019901
          label: protein kinase binding
      supported_by:
        - reference_id: PMID:11483589
          supporting_text: The epidermal growth factor receptor regulates 
            interaction of the human DF3/MUC1 carcinoma antigen with c-Src and 
            beta-catenin. [The paper demonstrates direct EGFR-MUC1 interaction 
            and EGFR-mediated phosphorylation of MUC1]
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16888623
    review:
      summary: PMID:16888623 shows MUC1 blocks nuclear targeting of c-Abl 
        (P00519) in response to DNA damage. This demonstrates a specific 
        protein-protein interaction that inhibits Abl nuclear import and the 
        apoptotic response.
      action: MODIFY
      reason: While this demonstrates protein binding, the functional context 
        suggests this should be captured as a more specific regulatory 
        interaction, potentially related to DNA damage response regulation 
        rather than generic protein binding.
      proposed_replacement_terms:
        - id: GO:0019901
          label: protein kinase binding
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: MUC1 oncoprotein blocks nuclear targeting of c-Abl in
            the apoptotic response to DNA damage [PMID:16888623]
        - reference_id: PMID:16888623
          supporting_text: Aug 3. MUC1 oncoprotein blocks nuclear targeting of 
            c-Abl in the apoptotic response to DNA damage.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21258405
    review:
      summary: PMID:21258405 examines Galectin-3 regulation of MUC1 and EGFR 
        cellular distribution in pancreatic cancer cells. This demonstrates 
        MUC1-EGFR interaction in the context of trafficking regulation.
      action: MODIFY
      reason: This further supports EGFR binding, which is a more informative 
        annotation than generic protein binding.
      proposed_replacement_terms:
        - id: GO:0005154
          label: epidermal growth factor receptor binding
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Galectin-3 regulates MUC1 and EGFR cellular 
            distribution and EGFR downstream pathways in pancreatic cancer cells
            [PMID:21258405]
        - reference_id: PMID:21258405
          supporting_text: Galectin-3 regulates MUC1 and EGFR cellular 
            distribution and EGFR downstream pathways in pancreatic cancer 
            cells.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21798038
    review:
      summary: PMID:21798038 demonstrates non-cysteine linked MUC1-CT dimers are
        required for Src recruitment and ICAM-1 binding induced cell invasion. 
        This shows MUC1 homodimerization and binding to ICAM-1 and Src.
      action: MODIFY
      reason: &#39;This paper demonstrates multiple specific binding activities: protein
        homodimerization, ICAM-1 binding, and Src binding. These should be captured
        with more specific terms.&#39;
      proposed_replacement_terms:
        - id: GO:0042802
          label: identical protein binding
        - id: GO:0019901
          label: protein kinase binding
      supported_by:
        - reference_id: PMID:21798038
          supporting_text: Non-cysteine linked MUC1 cytoplasmic dimers are 
            required for Src recruitment and ICAM-1 binding induced cell 
            invasion.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:22962849
    review:
      summary: PMID:22962849 examines cooperative interaction of MUC1 with the 
        HGF/c-Met pathway during hepatocarcinogenesis. This demonstrates MUC1 
        interaction with Met receptor tyrosine kinase (P08581).
      action: MODIFY
      reason: Specific receptor tyrosine kinase binding is more informative than
        generic protein binding.
      proposed_replacement_terms:
        - id: GO:0019901
          label: protein kinase binding
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;MET: Phosphorylates cytoplasmic tail. Cooperative interaction
            of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis [PMID:22962849]&#39;
        - reference_id: PMID:22962849
          supporting_text: Cooperative interaction of MUC1 with the HGF/c-Met 
            pathway during hepatocarcinogenesis.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:24658140
    review:
      summary: PMID:24658140 describes a mammalian-membrane two-hybrid assay 
        (MaMTH) for probing membrane-protein interactions. This is a methods 
        paper and the specific interaction with EGFR (P00533) supports EGFR 
        binding.
      action: MODIFY
      reason: This represents EGFR binding detected by a membrane two-hybrid 
        method. Should use more specific EGFR binding term.
      proposed_replacement_terms:
        - id: GO:0005154
          label: epidermal growth factor receptor binding
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: The mammalian-membrane two-hybrid assay (MaMTH) for 
            probing membrane-protein interactions in human cells [PMID:24658140]
        - reference_id: PMID:24658140
          supporting_text: The mammalian-membrane two-hybrid assay (MaMTH) for 
            probing membrane-protein interactions in human cells.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:31980649
    review:
      summary: PMID:31980649 examines extensive rewiring of the EGFR network in 
        colorectal cancer cells expressing transforming levels of KRAS(G13D). 
        This further supports MUC1-EGFR interaction in cancer signaling 
        networks.
      action: MODIFY
      reason: This supports EGFR binding in the context of oncogenic KRAS 
        signaling networks.
      proposed_replacement_terms:
        - id: GO:0005154
          label: epidermal growth factor receptor binding
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Extensive rewiring of the EGFR network in colorectal 
            cancer cells expressing transforming levels of KRAS(G13D) 
            [PMID:31980649]
        - reference_id: PMID:31980649
          supporting_text: Extensive rewiring of the EGFR network in colorectal 
            cancer cells expressing transforming levels of KRAS(G13D).
  - term:
      id: GO:0030330
      label: DNA damage response, signal transduction by p53 class mediator
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 demonstrates that MUC1-CT directly binds p53 and 
        modulates p53-responsive gene transcription following genotoxic stress. 
        MUC1 coprecipitates with p53 on the p21 promoter and coactivates p21 
        transcription while attenuating Bax transcription. This shifts the p53 
        response from apoptosis toward growth arrest.
      action: ACCEPT
      reason: This is a well-documented core function of MUC1-CT in cancer 
        cells. MUC1 directly participates in p53-mediated DNA damage signaling 
        by physically interacting with p53 at chromatin and modulating its 
        transcriptional activity. This is supported by direct experimental 
        evidence including chromatin immunoprecipitation and functional assays.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: The MUC1 oncoprotein is aberrantly overexpressed by 
            most human carcinomas. The present work demonstrates that MUC1 
            associates with the p53 tumor suppressor, and that this interaction 
            is increased by genotoxic stress. The MUC1 cytoplasmic domain binds 
            directly to p53 regulatory domain.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Direct interaction: MUC1-CT binds p53 regulatory domain
            (aa 363-393). Chromatin localization: MUC1-CT and p53 co-occupy p21 promoter.
            Repression of p53 activity: MUC1-CT/KLF4 complex binds PE21 element, represses
            TP53 transcription.&#39;
  - term:
      id: GO:0031571
      label: mitotic G1 DNA damage checkpoint signaling
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 shows MUC1 promotes p53-dependent G1 growth arrest 
        in response to DNA damage by coactivating p21 (CDKN1A) transcription. 
        This represents participation in the G1 DNA damage checkpoint pathway.
      action: ACCEPT
      reason: This annotation accurately captures MUC1&#39;s role in promoting cell 
        cycle arrest at the G1/S checkpoint following DNA damage. By enhancing 
        p21 transcription, MUC1 contributes to p53-mediated checkpoint 
        activation. This is a specific and well-supported biological process 
        annotation.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: MUC1 promotes selection of the p53-dependent growth 
            arrest response and suppresses the p53-dependent apoptotic response 
            to DNA damage. [MUC1 coactivates p21 gene transcription, which 
            mediates G1 arrest]
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Blocks p53-mediated cell cycle arrest and apoptosis. 
            Confers resistance to genotoxic stress. Promotes survival of cells 
            with DNA damage.
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: IDA
    original_reference_id: GO_REF:0000052
    review:
      summary: This is immunofluorescence-based evidence for plasma membrane 
        localization. MUC1 is a transmembrane protein with well-documented 
        plasma membrane localization. This duplicates other plasma membrane 
        annotations but with experimental imaging evidence.
      action: ACCEPT
      reason: Direct experimental visualization of MUC1 at the plasma membrane 
        provides independent support for this core localization. Multiple lines 
        of evidence for the same localization strengthen the annotation.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Plasma membrane: Type I transmembrane protein with transmembrane
            domain 1181-1203.&#39;
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 demonstrates that MUC1-CT coactivates p21 gene 
        transcription by RNA polymerase II. MUC1 functions as a transcriptional 
        coregulator that enhances p53-dependent transcription of specific target
        genes while repressing others (e.g., Bax).
      action: ACCEPT
      reason: This accurately captures MUC1-CT&#39;s role as a transcriptional 
        coregulator that positively regulates specific RNA Pol II-dependent 
        genes. The experimental evidence demonstrates direct chromatin occupancy
        and transcriptional enhancement. This is a core signaling function of 
        MUC1-CT in the nucleus.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: MUC1 coprecipitates with p53 on the p53-responsive 
            elements of the p21 gene promoter and coactivates p21 gene 
            transcription.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Target gene activation: Cyclin D1, c-Myc, ZEB1, Slug,
            Snail (via Œ≤-catenin). Target genes: Bcl-xL (anti-apoptotic), ZEB1, EZH2
            (via NF-Œ∫B).&#39;
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6790022
    review:
      summary: Reactome pathway annotation for &#34;Expression of STAT3-upregulated 
        plasma membrane proteins&#34; includes MUC1 as a STAT3-regulated plasma 
        membrane protein. This supports plasma membrane localization but in a 
        specific regulatory context.
      action: ACCEPT
      reason: This annotation correctly places MUC1 at the plasma membrane, 
        which is its core structural location. The Reactome pathway context adds
        information about STAT3-mediated regulation of MUC1 expression.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Type I transmembrane protein with plasma membrane 
            localization.
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-8858500
    review:
      summary: Reactome pathway annotation for &#34;CLEC10A binds Tn-MUC1&#34; describes
        interaction between C-type lectin receptor CLEC10A and tumor-associated 
        Tn antigen on MUC1 at the plasma membrane. This represents recognition 
        of aberrantly glycosylated MUC1.
      action: ACCEPT
      reason: This annotation correctly places MUC1 at the plasma membrane where
        it interacts with CLEC10A. The pathway describes recognition of 
        tumor-associated glycoforms of MUC1.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Truncated glycans exposing Tn, sTn, T antigens in 
            cancer tissue. Plasma membrane localization.
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6786012
    review:
      summary: Reactome pathway &#34;CHST4 transfers SO4(2-) from PAPS to Core 2 
        mucins&#34; describes sulfation of MUC1 in the Golgi lumen. MUC1 transits 
        through the Golgi during biosynthesis where it undergoes extensive 
        O-glycosylation and other modifications.
      action: KEEP_AS_NON_CORE
      reason: While MUC1 does transit through the Golgi lumen during 
        biosynthesis and post-translational modification, this is not a primary 
        functional location. The Golgi annotations represent MUC1 as a SUBSTRATE
        for glycosyltransferases rather than MUC1 performing an active function.
        These are valid but non-core localizations representing transient 
        biosynthetic trafficking.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Transit time: Median ~142 minutes ER to Golgi to surface
            (mouse model). Extensive O-glycosylation occurs during Golgi transit.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5694487
    review:
      summary: Reactome pathway &#34;A4GNT transfers GlcNAc to core 2 mucins&#34; 
        describes glycosylation of MUC1 in the Golgi. Multiple Reactome 
        glycosylation pathways annotate MUC1 to Golgi lumen as the site where 
        O-glycan modifications occur.
      action: KEEP_AS_NON_CORE
      reason: Same rationale as other Golgi annotations - this represents 
        biosynthetic trafficking and modification rather than a core functional 
        location. MUC1 is the substrate, not the enzyme.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation: Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid in Golgi.&#39;
  - term:
      id: GO:0070062
      label: extracellular exosome
    evidence_type: HDA
    original_reference_id: PMID:23533145
    review:
      summary: PMID:23533145 identified MUC1 in exosomes isolated from expressed
        prostatic secretions in urine using proteomic analysis. MUC1 is found in
        extracellular exosomes released from epithelial cells.
      action: KEEP_AS_NON_CORE
      reason: MUC1 is legitimately found in extracellular exosomes, representing
        shed ectodomain or exosomal secretion. However, this is a consequence of
        shedding/secretion rather than a core functional location. The 
        biological significance is uncertain - exosomal MUC1 may serve as a 
        biomarker but is not a primary site of MUC1 function.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Shed ectodomain: Released by ADAM17/MT1-MMP cleavage.
            Isoforms 5, 7, 9, Y: Secreted into extracellular space.&#39;
        - reference_id: PMID:23533145
          supporting_text: 2013 Apr 23. In-depth proteomic analyses of exosomes 
            isolated from expressed prostatic secretions in urine.
  - term:
      id: GO:0031982
      label: vesicle
    evidence_type: HDA
    original_reference_id: PMID:19190083
    review:
      summary: PMID:19190083 characterized exosome-like vesicles released from 
        human tracheobronchial ciliated epithelium and identified MUC1 by 
        proteomics. This is related to the extracellular exosome annotations.
      action: KEEP_AS_NON_CORE
      reason: Similar to exosome annotations - MUC1 is found in secreted 
        vesicles but this represents shedding/secretion rather than a core 
        functional location. This is a very generic term that could apply to 
        many cellular compartments.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Recycling: Endocytosis and return to plasma membrane.
            Vesicular trafficking for biosynthesis and endocytosis.&#39;
        - reference_id: PMID:19190083
          supporting_text: &#39;Characterization of exosome-like vesicles released from
            human tracheobronchial ciliated epithelium: a possible role in innate
            defense.&#39;
  - term:
      id: GO:0005615
      label: extracellular space
    evidence_type: HDA
    original_reference_id: PMID:16502470
    review:
      summary: PMID:16502470 identified MUC1 in the aqueous phase of human 
        colostrum proteome. Shed MUC1 ectodomain is found in various body fluids
        including serum (CA 15-3 biomarker), colostrum, and other secretions.
      action: ACCEPT
      reason: The extracellular space is a legitimate and functionally relevant 
        location for shed MUC1 ectodomain. Unlike the generic &#34;extracellular 
        region&#34; term, this more specifically captures the soluble, secreted 
        forms of MUC1 that serve as biomarkers and may have biological functions
        in body fluids.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;CA 15-3 (Cancer Antigen 15-3): Soluble MUC1 ectodomain
            fragments in serum. Ectodomain shedding: ADAM17/TACE releases MUC1-N into
            extracellular space.&#39;
        - reference_id: PMID:16502470
          supporting_text: &#39;Human colostrum: identification of minor proteins in the
            aqueous phase by proteomics.&#39;
  - term:
      id: GO:0033629
      label: negative regulation of cell adhesion mediated by integrin
    evidence_type: IDA
    original_reference_id: PMID:7698991
    review:
      summary: PMID:7698991 directly demonstrated that MUC1 (Episialin) 
        overexpression inhibits integrin-mediated cell adhesion to extracellular
        matrix components. The large extracellular domain sterically blocks 
        integrin-ECM interactions, creating an anti-adhesive barrier.
      action: ACCEPT
      reason: This is a core biological function of MUC1 in normal epithelial 
        cells, where apical MUC1 prevents unwanted adhesion. The anti-adhesive 
        function is well-documented and represents a primary physiological role.
        In cancer, loss of polarity extends this anti-adhesive effect to the 
        entire cell surface, promoting metastasis.
      supported_by:
        - reference_id: PMID:7698991
          supporting_text: the integrin-mediated adhesion to extracellular 
            matrix of transfectants of a melanoma cell line (A375), a 
            transformed epithelial cell line (MDCK-ras-e) and a human breast 
            epithelial cell line (HBL-100) is reduced by high levels of 
            episialin
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Anti-Adhesive Function: Apical localization in normal
            epithelia: Prevents unwanted cell-cell and cell-ECM interactions. Steric
            hindrance: Bulky glycan chains impede adhesion molecule interactions.&#39;
  - term:
      id: GO:0070062
      label: extracellular exosome
    evidence_type: HDA
    original_reference_id: PMID:19199708
    review:
      summary: PMID:19199708 identified MUC1 in human parotid gland exosomes by 
        MudPIT proteomic analysis. Duplicate exosome annotation from different 
        tissue source.
      action: KEEP_AS_NON_CORE
      reason: Same rationale as other exosome annotations - valid but non-core 
        localization representing secretion/shedding.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Extracellular exosomes contain shed MUC1 ectodomain.
        - reference_id: PMID:19199708
          supporting_text: Proteomic analysis of human parotid gland exosomes by
            multidimensional protein identification technology (MudPIT).
  - term:
      id: GO:0070062
      label: extracellular exosome
    evidence_type: HDA
    original_reference_id: PMID:19056867
    review:
      summary: PMID:19056867 performed large-scale proteomics and 
        phosphoproteomics of urinary exosomes and identified MUC1. Another 
        independent exosome identification.
      action: KEEP_AS_NON_CORE
      reason: Same rationale as other exosome annotations - valid but non-core.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: MUC1 found in exosomes from multiple tissue sources.
        - reference_id: PMID:19056867
          supporting_text: 2008 Dec 3. Large-scale proteomics and 
            phosphoproteomics of urinary exosomes.
  - term:
      id: GO:0070062
      label: extracellular exosome
    evidence_type: IDA
    original_reference_id: PMID:15326289
    review:
      summary: PMID:15326289 identified and profiled exosomes in human urine and
        found MUC1. This has IDA evidence (direct assay) rather than HDA 
        (high-throughput).
      action: KEEP_AS_NON_CORE
      reason: Same rationale - exosome localization is valid but represents 
        shedding/secretion, not core function.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Urinary exosomes contain MUC1 from epithelial cell 
            shedding.
        - reference_id: PMID:15326289
          supporting_text: Identification and proteomic profiling of exosomes in
            human urine.
  - term:
      id: GO:1902166
      label: negative regulation of intrinsic apoptotic signaling pathway in 
        response to DNA damage by p53 class mediator
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 demonstrates that MUC1 suppresses the p53-dependent
        apoptotic response to DNA damage while promoting growth arrest. MUC1 
        coactivates p21 (pro-arrest) but attenuates Bax transcription 
        (pro-apoptotic), thereby blocking intrinsic apoptosis.
      action: ACCEPT
      reason: This is a well-documented oncogenic function of MUC1-CT. By 
        modulating p53 target gene selection, MUC1 shifts the cellular response 
        from apoptosis to growth arrest, promoting survival of damaged cells. 
        This is a core cancer-associated function supported by direct 
        experimental evidence.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: Conversely, MUC1 attenuates activation of Bax 
            transcription.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Consequences: Blocks p53-mediated cell cycle arrest and
            apoptosis. Confers resistance to genotoxic stress. Promotes survival of
            cells with DNA damage.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-1964505
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5096532
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5096537
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6785524
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-913675
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914005
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914006
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914008
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914010
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914017
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-977071
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-1964501
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914012
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-914018
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-981497
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-981809
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0005796
      label: Golgi lumen
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-981814
    review:
      summary: Reactome O-glycosylation pathway annotation. MUC1 transits 
        through the Golgi lumen during biosynthesis where it undergoes extensive
        O-glycosylation by various glycosyltransferases.
      action: KEEP_AS_NON_CORE
      reason: Golgi lumen localization represents transient biosynthetic 
        trafficking where MUC1 serves as a substrate for glycosyltransferases. 
        This is valid but non-core - the Golgi is not a primary functional 
        location for MUC1. Multiple Reactome pathways annotate MUC1 to Golgi 
        based on its role as a substrate in different O-glycan biosynthesis 
        reactions.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;O-Glycosylation accounts for 50-90% of total molecular
            mass. Initiating enzymes: Polypeptide N-acetylgalactosaminyltransferases
            (GalNAc-Ts). Extension: Sequential addition of Gal, GalNAc, Fuc, sialic
            acid. Transit time: Median ~142 minutes ER to Golgi to surface.&#39;
  - term:
      id: GO:0000785
      label: chromatin
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 demonstrates MUC1-CT localization to chromatin by 
        chromatin immunoprecipitation. MUC1 coprecipitates with p53 on the p21 
        promoter, showing direct chromatin association.
      action: ACCEPT
      reason: This is a key cellular component annotation for MUC1-CT&#39;s nuclear 
        transcriptional regulatory function. Direct chromatin association is 
        required for MUC1-CT to function as a transcriptional coregulator. This 
        is supported by ChIP evidence showing MUC1 at specific gene promoters.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: Chromatin immunoprecipitation assays demonstrate that
            MUC1 coprecipitates with p53 on the p53-responsive elements of the 
            p21 gene promoter and coactivates p21 gene transcription.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Chromatin localization: MUC1-CT and p53 co-occupy p21
            promoter. Chromatin occupancy: MUC1-CT and p65 (NF-Œ∫B) co-occupy promoters.&#39;
  - term:
      id: GO:0000978
      label: RNA polymerase II cis-regulatory region sequence-specific DNA 
        binding
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 shows MUC1-CT binds to the p21 promoter (a 
        cis-regulatory region) via association with p53. MUC1-CT also binds the 
        PE21 element to repress TP53 transcription via interaction with KLF4.
      action: ACCEPT
      reason: MUC1-CT demonstrates sequence-specific DNA binding activity at RNA
        Pol II regulatory elements, though this may be mediated through 
        transcription factor partners (p53, NF-Œ∫B, Œ≤-catenin, KLF4) rather than 
        direct DNA contact. The ChIP evidence supports functional association 
        with specific cis-regulatory sequences. This is a core molecular 
        function for MUC1-CT&#39;s transcriptional regulatory role.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: MUC1 coprecipitates with p53 on the p53-responsive 
            elements of the p21 gene promoter and coactivates p21 gene 
            transcription.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Repression of p53 activity: MUC1-CT/KLF4 complex binds
            PE21 element, represses TP53 transcription. MUC1-CT and p65 co-occupy
            promoters.&#39;
  - term:
      id: GO:0002039
      label: p53 binding
    evidence_type: IPI
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 demonstrates direct binding between MUC1 
        cytoplasmic domain and p53 regulatory domain (aa 363-393). This 
        interaction is increased by genotoxic stress and modulates p53 
        transcriptional activity.
      action: ACCEPT
      reason: This is a core molecular function of MUC1-CT. Direct p53 binding 
        is central to MUC1&#39;s role in DNA damage response, cell cycle regulation,
        and apoptosis suppression. This is well-documented with multiple lines 
        of evidence including co-immunoprecipitation, ChIP, and functional 
        assays.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: The MUC1 oncoprotein is aberrantly overexpressed by 
            most human carcinomas. The present work demonstrates that MUC1 
            associates with the p53 tumor suppressor, and that this interaction 
            is increased by genotoxic stress. The MUC1 cytoplasmic domain binds 
            directly to p53 regulatory domain.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Direct interaction: MUC1-CT binds p53 regulatory domain
            (aa 363-393). MUC1-CT and p53 co-occupy p21 promoter.&#39;
  - term:
      id: GO:0003712
      label: transcription coregulator activity
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 demonstrates MUC1-CT functions as a transcriptional
        coregulator, coactivating p21 transcription while repressing Bax. 
        MUC1-CT also coactivates transcription with NF-Œ∫B, Œ≤-catenin, and 
        estrogen receptor.
      action: ACCEPT
      reason: This is a core molecular function of MUC1-CT in the nucleus. 
        MUC1-CT does not directly bind DNA alone but functions as a coregulator 
        that modulates the activity of multiple transcription factors. This 
        represents the primary molecular mechanism by which MUC1-CT influences 
        gene expression. Extensively supported by literature.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: MUC1 coprecipitates with p53 on the p53-responsive 
            elements of the p21 gene promoter and coactivates p21 gene 
            transcription. Conversely, MUC1 attenuates activation of Bax 
            transcription.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Transcription factors: TP53, ESR1 (estrogen receptor Œ±),
            KLF4, NF-Œ∫B p65. MUC1-CT functions as a signaling scaffold and transcriptional
            coregulator.&#39;
  - term:
      id: GO:0010944
      label: negative regulation of transcription by competitive promoter 
        binding
    evidence_type: IDA
    original_reference_id: PMID:15710329
    review:
      summary: PMID:15710329 shows MUC1-CT represses Bax transcription while 
        coactivating p21, suggesting differential regulation of p53 target 
        genes. MUC1-CT/KLF4 complex also competes for binding to the PE21 
        element to repress TP53 transcription.
      action: ACCEPT
      reason: This captures MUC1-CT&#39;s ability to negatively regulate specific 
        genes through competitive binding mechanisms. By occupying regulatory 
        elements with transcription factors, MUC1-CT can block access of other 
        regulatory factors or modulate the transcriptional outcome. This is a 
        specific and well-supported regulatory mechanism.
      supported_by:
        - reference_id: PMID:15710329
          supporting_text: MUC1 attenuates activation of Bax transcription.
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: &#39;Repression of p53 activity: MUC1-CT/KLF4 complex binds
            PE21 element, represses TP53 transcription.&#39;
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: TAS
    original_reference_id: PMID:1697589
    review:
      summary: PMID:1697589 is the original molecular cloning paper for human 
        MUC1, describing it as a tumor-associated polymorphic epithelial mucin. 
        This paper established MUC1 as a transmembrane protein localized to the 
        plasma membrane.
      action: ACCEPT
      reason: This is a traceable author statement from the original MUC1 
        cloning paper establishing its plasma membrane localization. This is a 
        fundamental structural annotation for MUC1 as a type I transmembrane 
        protein.
      supported_by:
        - reference_id: file:human/MUC1/MUC1-notes.md
          supporting_text: Type I transmembrane protein with transmembrane 
            domain 1181-1203. Plasma membrane is the primary structural 
            location.
        - reference_id: PMID:1697589
          supporting_text: Molecular cloning and expression of human 
            tumor-associated polymorphic epithelial mucin.
  - term:
      id: GO:0005198
      label: structural molecule activity
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0050830
      label: defense response to Gram-positive bacterium
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0005102
      label: signaling receptor binding
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0034122
      label: negative regulation of toll-like receptor signaling pathway
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0060070
      label: canonical Wnt signaling pathway
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0045893
      label: positive regulation of DNA-templated transcription
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0051092
      label: positive regulation of NF-kappaB transcription factor activity
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0007169
      label: cell surface receptor protein tyrosine kinase signaling pathway
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
  - term:
      id: GO:0008283
      label: cell population proliferation
    evidence_type: NAS
    review:
      summary: Added to align core_functions with existing annotations.
      action: NEW
      reason: Core function term not present in existing_annotations.
references:
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000044
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
      Location vocabulary mapping, accompanied by conservative changes to GO 
      terms applied by UniProt.
    findings: []
  - id: GO_REF:0000052
    title: Gene Ontology annotation based on curation of immunofluorescence data
    findings: []
  - id: PMID:11152665
    title: The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 
      carcinoma-associated antigen with GSK3 beta and beta-catenin.
    findings:
      - statement: c-Src phosphorylates MUC1-CT at YEKV motif and regulates 
          interactions with GSK3Œ≤ and Œ≤-catenin
        supporting_text: c-Src phosphorylates the MUC1 cytoplasmic domain at a 
          YEKV motif located between sites involved in interactions with GSK3 
          beta and beta-catenin.
  - id: PMID:11483589
    title: The epidermal growth factor receptor regulates interaction of the 
      human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.
    findings: []
  - id: PMID:15326289
    title: Identification and proteomic profiling of exosomes in human urine.
    findings: []
  - id: PMID:15710329
    title: Human MUC1 oncoprotein regulates p53-responsive gene transcription in
      the genotoxic stress response.
    findings:
      - statement: MUC1-CT binds p53 and modulates p53-dependent transcription 
          in response to DNA damage
        supporting_text: The MUC1 oncoprotein is aberrantly overexpressed by 
          most human carcinomas. The present work demonstrates that MUC1 
          associates with the p53 tumor suppressor, and that this interaction is
          increased by genotoxic stress. The MUC1 cytoplasmic domain binds 
          directly to p53 regulatory domain.
      - statement: MUC1 promotes p53-dependent growth arrest while suppressing 
          apoptosis in response to DNA damage
        supporting_text: MUC1 promotes selection of the p53-dependent growth 
          arrest response and suppresses the p53-dependent apoptotic response to
          DNA damage.
  - id: PMID:16502470
    title: &#39;Human colostrum: identification of minor proteins in the aqueous phase
      by proteomics.&#39;
    findings: []
  - id: PMID:16888623
    title: MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic 
      response to DNA damage.
    findings: []
  - id: PMID:1697589
    title: Molecular cloning and expression of human tumor-associated 
      polymorphic epithelial mucin.
    findings: []
  - id: PMID:19056867
    title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
    findings: []
  - id: PMID:19190083
    title: &#39;Characterization of exosome-like vesicles released from human tracheobronchial
      ciliated epithelium: a possible role in innate defense.&#39;
    findings: []
  - id: PMID:19199708
    title: Proteomic analysis of human parotid gland exosomes by 
      multidimensional protein identification technology (MudPIT).
    findings: []
  - id: PMID:21258405
    title: Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR 
      downstream pathways in pancreatic cancer cells.
    findings: []
  - id: PMID:21798038
    title: Non-cysteine linked MUC1 cytoplasmic dimers are required for Src 
      recruitment and ICAM-1 binding induced cell invasion.
    findings: []
  - id: PMID:22962849
    title: Cooperative interaction of MUC1 with the HGF/c-Met pathway during 
      hepatocarcinogenesis.
    findings: []
  - id: PMID:23533145
    title: In-depth proteomic analyses of exosomes isolated from expressed 
      prostatic secretions in urine.
    findings: []
  - id: PMID:24658140
    title: The mammalian-membrane two-hybrid assay (MaMTH) for probing 
      membrane-protein interactions in human cells.
    findings: []
  - id: PMID:31980649
    title: Extensive rewiring of the EGFR network in colorectal cancer cells 
      expressing transforming levels of KRAS(G13D).
    findings: []
  - id: PMID:7698991
    title: Episialin (MUC1) overexpression inhibits integrin-mediated cell 
      adhesion to extracellular matrix components.
    findings:
      - statement: MUC1 overexpression inhibits integrin-mediated cell adhesion 
          to extracellular matrix through steric hindrance
        supporting_text: Episialin (MUC1) is a transmembrane molecule with a 
          large mucin-like extracellular domain protruding high above the cell 
          surface. The molecule is located at the apical side of most glandular 
          epithelial cells, whereas in carcinoma cells it is often present at 
          the entire surface and it is frequently expressed in abnormally large 
          quantities. We have previously shown that overexpression of episialin 
          reduces cell-cell interactions. Here we show that the 
          integrin-mediated adhesion to extracellular matrix of transfectants of
          a melanoma cell line (A375), a transformed epithelial cell line 
          (MDCK-ras-e) and a human breast epithelial cell line (HBL-100) is 
          reduced by high levels of episialin.
  - id: Reactome:R-HSA-1964501
    title: Addition of galactose to Core 6 glycoprotein
    findings: []
  - id: Reactome:R-HSA-1964505
    title: C1GALT1 transfers Galactose to the Tn antigen forming Core 1 
      glycoproteins (T antigens)
    findings: []
  - id: Reactome:R-HSA-5096532
    title: Defective GALNT12 does not transfer GalNAc to mucins
    findings: []
  - id: Reactome:R-HSA-5096537
    title: Defective GALNT3 does not transfer GalNAc to mucins
    findings: []
  - id: Reactome:R-HSA-5694487
    title: A4GNT transfers GlcNAc to core 2 mucins
    findings: []
  - id: Reactome:R-HSA-6785524
    title: Defective C1GALT1C1 does not bind C1GALT1
    findings: []
  - id: Reactome:R-HSA-6786012
    title: CHST4 transfers SO4(2-) from PAPS to Core 2 mucins
    findings: []
  - id: Reactome:R-HSA-6790022
    title: Expression of STAT3-upregulated plasma membrane proteins
    findings: []
  - id: Reactome:R-HSA-8858500
    title: CLEC10A binds Tn-MUC1
    findings: []
  - id: Reactome:R-HSA-913675
    title: GALNTs transfer GalNAc to Mucins to form Tn antigens
    findings: []
  - id: Reactome:R-HSA-914005
    title: Addition of GlcNAc to the Tn antigen via an alpha-1,3 linkage forms a
      Core 5 glycoprotein
    findings: []
  - id: Reactome:R-HSA-914006
    title: Addition of galactose to the Tn antigen via an alpha-1,3 linkage 
      forms a Core 8 glycoprotein
    findings: []
  - id: Reactome:R-HSA-914008
    title: Addition of GlcNAc to the Tn antigen via a beta-1,6 linkage forms a 
      Core 6 glycoprotein
    findings: []
  - id: Reactome:R-HSA-914010
    title: B3GNT6 transfers GlcNAc to Tn antigen
    findings: []
  - id: Reactome:R-HSA-914012
    title: GCNTs transfer GlcNAc from UDP-GlcNAc to Core 1 mucins
    findings: []
  - id: Reactome:R-HSA-914017
    title: Addition of GalNAc to the Tn antigen via an alpha-1,6 linkage forms a
      Core 7 glycoprotein
    findings: []
  - id: Reactome:R-HSA-914018
    title: GCNT3 transfers GlcNAc to Core 3 mucin
    findings: []
  - id: Reactome:R-HSA-977071
    title: ST6GAL1 transfers sialic acid to Tn antigens to form sTn antigens
    findings: []
  - id: Reactome:R-HSA-981497
    title: ST3GAL1-4 transfers sialic acid to the T antigen at the alpha 3 
      position
    findings: []
  - id: Reactome:R-HSA-981809
    title: ST6GALNAC3/4 transfers sialic acid to the sialyl T antigen to form 
      the disialyl T antigen
    findings: []
  - id: Reactome:R-HSA-981814
    title: ST6GALNAC2 transfers sialic acid to Core 1 mucins
    findings: []
  - id: file:human/MUC1/MUC1-deep-research-openai.md
    title: Deep research on MUC1 function
    findings: []
proposed_new_terms: []
suggested_questions:
  - question: What are the specific structural requirements for MUC1-CT 
      palmitoylation that enable its lipid raft association and membrane 
      recycling?
    experts:
      - Cell biologists specializing in protein trafficking
      - Structural biologists studying palmitoylation
  - question: How do different VNTR polymorphisms (21-125 repeats) 
      quantitatively affect MUC1&#39;s barrier function and pathogen defense 
      capabilities in vivo?
    experts:
      - Immunologists studying mucosal immunity
      - Geneticists studying MUC1 polymorphisms
  - question: What determines whether MUC1-CT acts as a p53 activator versus 
      inhibitor in different cellular contexts, and what is the role of tyrosine
      phosphorylation in this switch?
    experts:
      - Cancer biologists studying p53 regulation
      - Signal transduction researchers
  - question: How do the different O-glycosylation patterns (normal vs cancer) 
      mechanistically affect MUC1&#39;s protein-protein interactions and signaling 
      capabilities?
    experts:
      - Glycobiologists specializing in mucin glycosylation
      - Structural biologists
  - question: What is the precise mechanism by which MUC1-CT suppresses 
      different TLR pathways, and are there tissue-specific differences in this 
      regulation?
    experts:
      - Immunologists studying TLR signaling
      - Epithelial biologists
  - question: How does MUC1 mechanistically contribute to ADTKD2 pathogenesis, 
      and what cellular processes are disrupted by the frameshift mutations?
    experts:
      - Nephrologists specializing in tubulointerstitial disease
      - Kidney development biologists
suggested_experiments:
  - description: Determine crystal structure of MUC1-CT in complex with 
      Œ≤-catenin and p53 to understand competitive binding and nuclear complex 
      formation
    experiment_type: structural analysis
    hypothesis: MUC1-CT binds Œ≤-catenin and p53 through overlapping or adjacent 
      interaction surfaces, and phosphorylation alters binding preferences
  - description: Use CRISPR to generate cells with VNTR alleles of defined 
      lengths (e.g., 21, 41, 85, 125 repeats) and measure pathogen binding, 
      shedding efficiency, and TLR signaling suppression
    experiment_type: genetic manipulation
    hypothesis: Longer VNTR alleles provide better pathogen defense through 
      enhanced steric hindrance and releasable decoy function
  - description: Perform time-resolved mass spectrometry to map the complete 
      phosphorylation dynamics of MUC1-CT tyrosines upon EGFR, PDGFRB, and Src 
      activation, and correlate with protein interaction changes
    experiment_type: phosphoproteomics
    hypothesis: Different kinases create distinct phosphorylation codes that 
      recruit specific signaling complexes (Grb2 vs Œ≤-catenin vs PI3K)
  - description: Use proximity labeling (BioID/APEX) to identify the complete 
      MUC1-CT interactome in normal epithelial cells versus cancer cells, 
      comparing apical membrane, cytoplasmic, and nuclear compartments
    experiment_type: interactomics
    hypothesis: MUC1-CT interactome shifts from structural/trafficking proteins 
      in normal cells to signaling/transcriptional proteins in cancer cells
  - description: Measure the effect of specific O-glycosylation patterns 
      (controlled via glycosyltransferase knockout/overexpression) on MUC1 
      ectodomain shedding kinetics, drug penetration, and immune recognition
    experiment_type: glycobiology
    hypothesis: Aberrant cancer-associated glycosylation (short glycans) 
      accelerates shedding, creates drug resistance barrier, and generates 
      tumor-specific epitopes
  - description: Use kidney organoids derived from ADTKD2 patient iPSCs to 
      identify the molecular pathways disrupted by MUC1 frameshift mutations and
      test therapeutic interventions
    experiment_type: disease modeling
    hypothesis: Mutant MUC1 accumulates in ER causing ER stress and activating 
      fibrotic pathways in tubular epithelial cells
status: COMPLETE
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>